
<html lang="en"     class="pb-page"  data-request-id="f447799e-0097-44b5-8555-9978f76a474f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00565;issue:issue:10.1021/jmcmar.2019.62.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors" /></meta><meta name="dc.Creator" content="Hanna  Cho" /></meta><meta name="dc.Creator" content="Injae  Shin" /></meta><meta name="dc.Creator" content="Kyungseon  Cho" /></meta><meta name="dc.Creator" content="Hojong  Yoon" /></meta><meta name="dc.Creator" content="Eun Kyung  Yoo" /></meta><meta name="dc.Creator" content="Mi-Jin  Kim" /></meta><meta name="dc.Creator" content="Sungmi  Park" /></meta><meta name="dc.Creator" content="In-Kyu  Lee" /></meta><meta name="dc.Creator" content="Nam Doo  Kim" /></meta><meta name="dc.Creator" content="Taebo  Sim" /></meta><meta name="dc.Description" content="Pyruvate dehydrogenase kinases (PDHKs) promote abnormal respiration in cancer cells. Studies with novel resorcinol amide derivatives based on VER-246608 (6) led to the identification of 19n and 19t..." /></meta><meta name="Description" content="Pyruvate dehydrogenase kinases (PDHKs) promote abnormal respiration in cancer cells. Studies with novel resorcinol amide derivatives based on VER-246608 (6) led to the identification of 19n and 19t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 30, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00565" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00565" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00565" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00565" /></link>
        
    
    

<title>Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00565" /></meta><meta property="og:title" content="Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0017.jpeg" /></meta><meta property="og:description" content="Pyruvate dehydrogenase kinases (PDHKs) promote abnormal respiration in cancer cells. Studies with novel resorcinol amide derivatives based on VER-246608 (6) led to the identification of 19n and 19t containing five-membered heteroaromatic rings as unique structural features. These substances possess single-digit nanomolar activities against PDHKs. 19t exhibits higher potencies against PDHK1/2/4 than does 6 and inhibits only PDHKs among 366 kinases. Moreover, 19g, 19l, and 19s were found to be isotype-selective PDHK inhibitors. Molecular dynamics simulations provide a better understanding of how the heteroaromatic rings affect the activities of 19n and 19t on PDHK1/2/3/4. Moreover, 19n possesses a much higher antiproliferative activity against cancer cells than does 6. We demonstrated that the results of PDH assays better correlate with cellular activities than do those of PDHK kinase assays. Furthermore, 19n induces apoptosis of cancer cells via mitochondrial dysfunction, suppresses tumorigenesis, and displays a synergistic effect on satraplatin suppression of cancer cell proliferation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00565"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00565">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00565&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00565&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00565&amp;href=/doi/10.1021/acs.jmedchem.9b00565" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8461-8479</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00445" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00728" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hanna Cho</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hanna Cho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hanna++Cho">Hanna Cho</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Injae Shin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Injae Shin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Injae++Shin">Injae Shin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Kyungseon Cho</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kyungseon Cho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Kinomics Research Center, Korea Institute of Science and Technology (KIST), 5 Hwarangro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kyungseon++Cho">Kyungseon Cho</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hojong Yoon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hojong Yoon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Kinomics Research Center, Korea Institute of Science and Technology (KIST), 5 Hwarangro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hojong++Yoon">Hojong Yoon</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9334-0252" title="Orcid link">http://orcid.org/0000-0002-9334-0252</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Eun Kyung Yoo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eun Kyung Yoo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eun+Kyung++Yoo">Eun Kyung Yoo</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mi-Jin Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mi-Jin Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mi-Jin++Kim">Mi-Jin Kim</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sungmi Park</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sungmi Park</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sungmi++Park">Sungmi Park</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">In-Kyu Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">In-Kyu Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, Republic of Korea</div><div class="loa-info-affiliations-info">Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=In-Kyu++Lee">In-Kyu Lee</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Nam Doo Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nam Doo Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Daegu-Gyeongbuk Medical Innovation Foundation, 2387 Dalgubeol-daero, Suseong-gu, Daegu 42019, Republic of Korea</div><div class="loa-info-affiliations-info">NDBio Therapeutics Inc., 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nam+Doo++Kim">Nam Doo Kim</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Taebo Sim</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Taebo Sim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea</div><div class="loa-info-affiliations-info">Chemical Kinomics Research Center, Korea Institute of Science and Technology (KIST), 5 Hwarangro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#4e3a2c3d27230e25273d3a603c2b60253c"><span class="__cf_email__" data-cfemail="295d4b5a40446942405a5d075b4c07425b">[emailÂ protected]</span></a>, <a href="/cdn-cgi/l/email-protection#136771607a7e53787c6176723d72703d7861"><span class="__cf_email__" data-cfemail="01756372686c416a6e7364602f60622f6a73">[emailÂ protected]</span></a>. Phone: +82-2-958-6437.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Taebo++Sim">Taebo Sim</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3015-2059" title="Orcid link">http://orcid.org/0000-0003-3015-2059</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00565&amp;href=/doi/10.1021%2Facs.jmedchem.9b00565" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8461â8479</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 30, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 April 2019</li><li><span class="item_label"><b>Published</b> online</span>30 August 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 September 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00565" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00565</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8461%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHanna%2BCho%252C%2BInjae%2BShin%252C%2BKyungseon%2BCho%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D18%26contentID%3Dacs.jmedchem.9b00565%26title%3DIdentification%2Bof%2BNovel%2BResorcinol%2BAmide%2BDerivatives%2Bas%2BPotent%2Band%2BSpecific%2BPyruvate%2BDehydrogenase%2BKinase%2B%2528PDHK%2529%2BInhibitors%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8479%26publicationDate%3DSeptember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00565"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2216</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00565" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hanna&quot;,&quot;last_name&quot;:&quot;Cho&quot;},{&quot;first_name&quot;:&quot;Injae&quot;,&quot;last_name&quot;:&quot;Shin&quot;},{&quot;first_name&quot;:&quot;Kyungseon&quot;,&quot;last_name&quot;:&quot;Cho&quot;},{&quot;first_name&quot;:&quot;Hojong&quot;,&quot;last_name&quot;:&quot;Yoon&quot;},{&quot;first_name&quot;:&quot;Eun&quot;,&quot;last_name&quot;:&quot;Kyung Yoo&quot;},{&quot;first_name&quot;:&quot;Mi-Jin&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Sungmi&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;In-Kyu&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Nam&quot;,&quot;last_name&quot;:&quot;Doo Kim&quot;},{&quot;first_name&quot;:&quot;Taebo&quot;,&quot;last_name&quot;:&quot;Sim&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8461-8479&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00565&quot;},&quot;abstract&quot;:&quot;Pyruvate dehydrogenase kinases (PDHKs) promote abnormal respiration in cancer cells. Studies with novel resorcinol amide derivatives based on VER-246608 (6) led to the identification of 19n and 19t containing five-membered heteroaromatic rings as unique structural features. These substances possess single-digit nanomolar activities against PDHKs. 19t exhibits higher potencies against PDHK1/2/4 than does 6 and inhibits only PDHKs among 366 kinases. Moreover, 19g, 19l, and 19s were found to be isotype-selective PDHK inhibitors. Molecular dynamics simulations provide a better understanding of how the heteroaromatic rings affect the activities of 19n and 19t on PDHK1/2/3/4. Moreover, 19n possesses a much higher antiproliferative activity against cancer cells than does 6. We demonstrated that the results of PDH assays better correlate with cellular activities than do those of PDHK kinase assays. Furthermore, 19n induces apoptosis of cancer cells via mitochondrial dysfunction, suppresses tumorigenesis, and displays&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00565&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00565" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00565&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00565" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00565&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00565" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00565&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00565&amp;href=/doi/10.1021/acs.jmedchem.9b00565" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00565" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00565" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00565%26sid%3Dliteratum%253Aachs%26pmid%3D31469962%26genre%3Darticle%26aulast%3DCho%26date%3D2019%26atitle%3DIdentification%2Bof%2BNovel%2BResorcinol%2BAmide%2BDerivatives%2Bas%2BPotent%2Band%2BSpecific%2BPyruvate%2BDehydrogenase%2BKinase%2B%2528PDHK%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D18%26spage%3D8461%26epage%3D8479%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/jmcmar.2019.62.issue-18/20190926/jmcmar.2019.62.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pyruvate dehydrogenase kinases (PDHKs) promote abnormal respiration in cancer cells. Studies with novel resorcinol amide derivatives based on VER-246608 (<b>6</b>) led to the identification of <b>19n</b> and <b>19t</b> containing five-membered heteroaromatic rings as unique structural features. These substances possess single-digit nanomolar activities against PDHKs. <b>19t</b> exhibits higher potencies against PDHK1/2/4 than does <b>6</b> and inhibits only PDHKs among 366 kinases. Moreover, <b>19g</b>, <b>19l</b>, and <b>19s</b> were found to be isotype-selective PDHK inhibitors. Molecular dynamics simulations provide a better understanding of how the heteroaromatic rings affect the activities of <b>19n</b> and <b>19t</b> on PDHK1/2/3/4. Moreover, <b>19n</b> possesses a much higher antiproliferative activity against cancer cells than does <b>6</b>. We demonstrated that the results of PDH assays better correlate with cellular activities than do those of PDHK kinase assays. Furthermore, <b>19n</b> induces apoptosis of cancer cells via mitochondrial dysfunction, suppresses tumorigenesis, and displays a synergistic effect on satraplatin suppression of cancer cell proliferation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer cells display a distinct metabolic phenomenon, known as the Warburg effect, in order to rapidly produce energy to support growth. Specifically, cancer cells prefer to utilize aerobic glycolysis, in which glucose is converted to lactic acid, rather than a normal oxidative phosphorylation pathway to produce ATP.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> For these reasons, enzymes involved in aerobic glycolysis including GLUT (glucose transporters), HK (hexokinase), PDHK (pyruvate dehydrogenase kinase), NADH-ubiquinone reductase, and ATP transporter have gained attention as potential targets for cancer chemotherapy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Most cancer cells express high levels of PDHK, a serine threonine kinase that negatively regulates activity of the PDH complex by phosphorylation of the PDH E1a subunit. The PDH complex in the mitochondrial membrane plays a key role in aerobic glycolysis by irreversibly converting pyruvate into acetyl-CoA used for energy generation in normal cells.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Indeed, aberrant expression of PDHKs occurs in multiple human tumors. Not only is PDHK1 overexpressed in gastric cancer, RCC, and myeloma,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> but it also promotes migration in NSCLC.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In addition, PDHK2 and PDHK3 are highly activated in breast and colon cancers, and NSCLC,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and especially high levels of expression of these enzymes are associated with poor prognosis in patients.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> PDHK4 is also intimately associated with colon<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and bladder<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> cancers. In contrast, low expression levels of the PDHKs occur in noncancerous cells. This finding suggests that side effects caused by PDHK inhibition should be minimal.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Hence, PDHKs have become attractive targets for cancer chemotherapy and many types of PDHK inhibitors have progressed to the preclinical/clinical stage (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). However, no PDHK inhibitors have been approved for use thus far.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative PDHK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dichloroacetic acid (DCA, <b>1</b>), a pyruvate analogue that inhibits PDHK by binding to the N-terminal regulatory region (R-domain) of the enzyme, has been found to suppress cancer growth.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> However, clinical trials revealed the limitation of <b>1</b> associated with low potency and neurological toxicity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> A number of <b>1</b> analogues have been developed, and progress has been made in enhancing anticancer potency.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The PDHK2 inhibitors Nov3r (<b>2</b>) and AZD7545 (<b>3</b>)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> also bind to the lipoyl group binding site in the R-domain and display limited cytotoxicity against cancer cells.<a onclick="showRef(event, 'cit13b ref14'); return false;" href="javascript:void(0);" class="ref cit13b ref14">(13b,14)</a> Allosteric inhibitors including Pfz3 (<b>4</b>) bind to a distant site located at the other side of the R domain and have been observed to have moderate cellular activities.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Moreover, radicicol (<b>5</b>) and 4,5-diarylisoxazoles are inhibitors competitively bind to the ATP binding pocket in PDHK. Because PDHK and HSP90 are members of the GHKL ATPase/kinase super family that have conserved ATP binding sites, it is difficult to develop inhibitors that display selectivity in binding to PDHK over other members of the GHKL ATPase/kinase super family.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> It is worth noting that <b>6</b> displays a 1000-fold higher activity against PDHK over HSP90 with cytostatic activity in a context-dependent manner.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Continuing investigations have identified novel PDHK inhibitors<a onclick="showRef(event, 'cit3a ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref cit3a ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(3a,4â18)</a> such as derivatives of the liver specific inhibitor dihydroxyphenyl sulfonylisoindoline used for treatment of obesity and type 2 diabetes.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The disulfide-based PDHK inhibitor <b>7</b>, which covalently binds to a conserved cysteine in the ATP binding region, displays a ca. 40-fold selectivity for PDHK1 over other subtypes, and it significantly suppresses the growth and tumor mass in the A549 xenograft model.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A study aimed at optimization of <b>6</b> derivatives as selective pan-PDHK inhibitors has recently been reported. In this effort, binding affinity was assessed by using a fluorescence polarization assay rather than by using an assay based on inhibition of kinase activity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">In an effort to discover potent and specific PDHK inhibitors, we designed and synthesized a series of new resorcinol amide derivatives and performed an SAR study that is based on an evaluation of inhibitory activities against PDHK1â4. This study led to identification of two outstanding lead compounds, <b>19n</b> and <b>19t</b>, which exhibit single-digit nanomolar activities against the PDHKs, values that are superior to that of <b>6</b>. In a kinome-wide selectivity profiling investigation using 366 kinases, we showed that <b>19t</b> binds to PDHKs only. We also demonstrated that <b>19n</b> suppresses proliferation of H1299 and DU145 with a GI<sub>50</sub> of 13.4 and 10.2 Î¼M, respectively, promotes apoptosis via mitochondrial dysfunction, and effectively blocks tumorigenesis of H1299 cells. Moreover, we found that <b>19n</b> synergistically increases the cytotoxicity of satraplatin against lung carcinoma H1299 cells.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Two synthetic routes were employed to generate the resorcinol amide derivatives and analogues <b>14</b>, <b>15a</b>â<b>g</b>, <b>19a</b>â<b>t</b>, and <b>21a</b>,<b>b</b> shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The synthesis of <b>15a</b>â<b>g</b> commenced with reductive amination of methyl 4-aminobenzoate (<b>8</b>) with 4-nitrobenzaldehyde to form the secondary amine <b>9</b>. The substituted benzoic acid <b>10a</b> was converted to the corresponding acid chlorides using oxalyl chloride and treated with <b>9</b> to generate tertiary amide <b>11</b>. Reduction of the nitro group in <b>11</b> using catalytic hydrogenation followed by acetylation of the resulting amine produced <b>13</b>, which upon removal of the acetyl groups and hydrolysis of the methyl ester formed <b>14</b>. Amide coupling reactions using HATU carried out on <b>14</b> yielded the target amides <b>15a</b>â<b>g</b>. Compounds <b>19a</b>â<b>t</b> and <b>21a</b>,<b>b</b> were prepared by the synthetic strategy described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The aniline <b>16</b> was submitted to reductive amination reactions to afford the secondary amines <b>17a</b>â<b>t</b>. <b>17a</b>â<b>t</b> were coupled with the benzoic acid <b>10a</b> to furnish the tertiary amides <b>18a</b>â<b>t</b> of which acetyl groups were hydrolyzed to yield the desired targets <b>19a</b>â<b>t</b>. <b>21a</b>,<b>b</b> were synthesized by using <b>10b</b>,<b>c</b> in the same synthetic route as that for <b>19a</b>â<b>t</b> synthesis.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>14</b> and <b>15a</b>â<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-nitrobenzaldehyde, acetic acid, NaBH<sub>3</sub>CN, MeOH, rt, 5 h, 81%; (b) (i) <b>10a</b>, oxalyl chloride, <i>cat</i>. DMF, DCM, rt, 2 h, (ii) <b>9</b>, DIPEA, DMF, 0 Â°C to rt, 2 h, 49% over two steps; (c) Pd/C, H<sub>2</sub>, MeOH, rt, 12 h; (d) acetic anhydride, TEA, DCM, 0 Â°C to rt, 2 h, 71% over two steps; (e) NaOH, MeOH/H<sub><i>2</i></sub>O, 80 Â°C, 2 h, 79%; (f) HATU, various amines, <i>N</i>-methylmorpholine, DMF, rt, 3 h, 21â58%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>19a</b>â<b>t</b> and <b>21a</b>,<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) various aldehydes, acetic acid, NaBH<sub>3</sub>CN, MeOH, rt, 5 h; (b) (i) <b>10a</b>â<b>c</b>, oxalyl chloride, <i>cat</i>. DMF, DCM, rt, 2 h, (ii) <b>17a</b>â<b>t</b>, DIPEA, DMF, 0 Â°C to rt, 2 h; (c) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, 1 h, 17â45%, over four steps.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure and Activity Relationships</h3><div class="NLM_p">An analysis of the crystal structure of the complex between <b>6</b> and PDHK2 shows that the resorcinol moiety of <b>6</b> forms direct and water-mediated hydrogen bonds with Asp282 and Thr346 in the ATP binding site of PDHK2. This is the major reason why resorcinol-containing substances were selected as potential PDHK inhibitors. In the complex, the difluorobenzylacetamide moiety of <b>6</b> is oriented toward the solvent-exposed region of the enzyme, and as a result, it is not expected to be critical for binding to the PDHKs. Thus, a phenylacetamide instead of the difluorobenzylacetamide of <b>6</b> was incorporated in the inhibitors owing to synthetic accessibility reasons. The selected inhibitors <b>14</b> and <b>15a</b>â<b>g</b> contain various amide substituents (R<sub>1</sub>) that replace the chloromethylpyrimidine moiety of <b>6</b>. Inspection of the X-ray structure of the complex between <b>6</b> and PDHK2 shows<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> that the 2-nitrogen of the chloromethylpyrimidine moiety of the inhibitor interacts with Arg250 of PDHK2. We assumed that the amide carbonyl oxygen in R<sub>1</sub> would mimic the 2-nitrogen in the chloromethylpyrimidine group by engaging in H-bonding with Arg250 of PDHK2.</div><div class="NLM_p">An <i>in vitro</i> kinase assay was used to evaluate the inhibitory activities of <b>14</b> and <b>15a</b>â<b>g</b> against PDHK2/4. As the data in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> demonstrate, the R<sub>1</sub> = carboxyl acid containing derivative <b>14</b> has only moderate activities against both PDHK2 (IC<sub>50</sub> = 7.220 Î¼M) and PDHK4 (IC<sub>50</sub> = 4.670 Î¼M). Moreover, changing the R<sub>1</sub> group to a cyclopropyl amide (<b>15a</b>), methyl amide (<b>15b</b>), and ethanolamide (<b>15c</b>) does not lead to an improvement of kinase-inhibitory potency. As expected, when a dimethylamide (<b>15d</b>) is the R<sub>1</sub> group, a remarkable enhancement in kinase-inhibitory activity against both PDHK2 (IC<sub>50</sub> = 0.503 Î¼M) and PDHK4 (IC<sub>50</sub> = 0.311 Î¼M) occurs. This observation is consistent with the previous report<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> that incorporation of a dimethylamide moiety leads to sub-micromolar potencies against PDHK2. The amides <b>15e</b>â<b>g</b>, which contain the cyclic amines piperidine, morpholine, and pyrrolidine, display lower activities than does dimethylamide (<b>15d</b>). These results show that the dimethylamide in <b>15d</b> is an optimized R<sub>1</sub> substituent.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities of <b>14</b> and <b>15a</b>â<b>g</b> against PDHK2/4</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0013.gif" alt="" id="GRAPHIC-d7e861-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0014.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Radiometric biochemical kinase assay.</p></div></div><div></div></div><div class="NLM_p">Our attention next focused on optimization of the R<sub>2</sub> substituent that corresponds to the difluorobenzylacetamide moiety in <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Utilizing phenyl in <b>19a</b> as the R<sub>2</sub> group causes only slight enhancements of inhibitory activities against PDHK2 and PDHK4. This finding suggests that the acetamide moiety in <b>6</b> does not greatly contribute to activity. We next explored derivatives <b>19b</b>â<b>f</b>, which contain electron-withdrawing groups (F, Cl, CF<sub>3</sub>, NO<sub>2</sub>, and CN, respectively) at the <i>para</i>-position of the phenyl ring. Use of fluorine as the <i>para</i>-substituent (<b>19b</b>) results in a slightly higher potency than that of <b>19a</b> for inhibition of both PDHK1 (IC<sub>50</sub> = 0.067 Î¼M) and PDHK2 (IC<sub>50</sub> = 0.113 Î¼M). The activities of the <b>19b</b> analogues, <b>21a</b> and <b>21b</b>, that contain a phenol instead of a resorcinol moiety are significantly lower, which is in accord with a previous report<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> that the resorcinol moiety in <b>6</b> plays a pivotal role in activity. Other electron-withdrawing groups (<b>19c</b>â<b>f</b>) have little influence on the inhibitory activities against PDHK2/4. However, <b>19g</b>, which contains a phenol moiety as R<sub>2</sub>, exhibits a 2-fold higher activity against PDHK4 than does <b>19a</b>. It should be emphasized that <b>19g</b> possesses a 5-fold selectivity for PDHK4 over PDHK1/2/3, and to the best our knowledge, it is the first reported isotype-selective PDHK4 inhibitor. Use of the large hydrophobic naphthalene moiety as R<sub>2</sub> (<b>19h</b>) brings about a moderate decrease in activity against both PDHK2 and PDHK4 compared with that of <b>19a</b>. Similarly, incorporation of a bulky <i>t</i>-butyl group (<b>19i</b>) also diminishes activities against PDHK2/4. Using a cyclohexyl (<b>19j</b>) in place of the phenyl group (<b>19a</b>) results in lower activity against both PDHK3 and PDHK4 and comparable activity against PDHK1/2.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activities of <b>15d</b>, <b>19a</b>â<b>t</b>, and <b>21a</b>,<b>b</b> against PDHK1/2/3/4</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0015.gif" alt="" id="GRAPHIC-d7e999-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0016.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Radiometric biochemical kinase assay.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">ND stands for not determined.</p></div><div class="footnote" id="t2fn3"><sup><sup>*</sup></sup><p class="last">Average value of two independent assays.</p></div></div><div></div></div><div class="NLM_p">An exploration of various groups as R<sub>2</sub> shows that the five-membered heteroaromatic ring containing derivatives <b>19k</b>â<b>t</b> has enhanced inhibitory activities. Specifically, the furan containing analogue <b>19k</b> displays a 3-fold enhancement of activity against PDHK3 (IC<sub>50</sub> = 0.067 Î¼M) relative to that of <b>19a</b>. Significantly, the 2-bromofuran analogue <b>19n</b> exhibits high potency on both PDHK2 (IC<sub>50</sub> = 10 nM) and PDHK4 (IC<sub>50</sub> = 13 nM). Interestingly, the 2-iodofuran derivative <b>19o</b> has a 12-fold higher inhibitory activity on PDHK3 (IC<sub>50</sub> = 5 nM) and a 10-fold lower potency on PDHK2 (IC<sub>50</sub> = 98 nM) compared with those of the 2-bromofuran analogue <b>19n</b>. In addition, <b>19o</b> has a 6â14-fold enhanced activity on PDHK3 (IC<sub>50</sub> = 5 nM) and PDHK4 (IC<sub>50</sub> = 11 nM) relative to that of the unsubstituted furan derivative <b>19k</b>. On the basis of the results of this study, it is possible to conclude that the 2-substituent on the furan ring of the R<sub>2</sub> group significantly influences inhibitory activity against PDHK2/3, but it does not greatly influence the activity against PDHK1. Also, incorporation of 2-bromo and 2-iodo substituents on the furan ring leads to substantially increased activity against PDHK2/4 and PDHK3/4, respectively.</div><div class="NLM_p last">We next investigated the activities of substances possessing a thiophene ring as the R<sub>2</sub> substituent. The results show that the inhibitory activity of <b>19p</b>, containing a 2-boromothiophene group, is comparable to that of <b>19n</b>. The 2-cyano-substituted derivative <b>19q</b> was found to have an inferior activity against both PDHK2 and PDHK4 as compared to that of the 2-bromo analogue <b>19p</b>. Moreover, the 3-bromothiophene derivative <b>19t</b> has a 5-fold enhanced activity against PDHK1 relative to the 2-bromo-substituted derivative <b>19p</b>. It is of note that the potencies of <b>19t</b> against PDHK1/2/4 are 4â8-fold higher than those of <b>6</b>. A study of analogues containing a thiazole as the R<sub>2</sub> group shows that <b>19r</b> containing a 2-bromothiazole group has a 7â11-fold lower activity for inhibition of PDHK2/4 as compared to that of the 2-boromothiophene derivative <b>19p</b> and that <b>19s</b>, with a 5-bromothiazole group, is 4-fold less active against PDHK2 (IC<sub>50</sub> = 64 nM) than is <b>19p</b>. It is worth noting that small changes in the nature and location of the substituent (<b>19p</b> vs <b>19t</b>) and the presence or absence of a nitrogen (<b>19p</b> vs <b>19r</b>) in the 5-membered heteroaromatic ring markedly influence inhibitory activity. The results of this SAR study show that substances in this series containing 5-membered heteroaromatic rings as R<sub>2</sub> substituents have higher activities than those of derivatives bearing phenyl rings.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Dynamics Simulation</h3><div class="NLM_p"><b>19n</b> possesses high potency against PDHK2/4 and selectivity over PDHK1/3. To gain insight into the factors governing the activities of <b>19n</b> in inhibiting the PDHKs, molecular dynamics simulations were performed to understand its binding modes in the ATP site of these kinases (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The results reveal that the resorcinol moiety of <b>19n</b> participates in water-mediated hydrogen-bonding networks with Gly322 in PDHK1, Leu244 in PDHK2, Ser252 in PDHK3, and Gly297 in PDHK4 as well as in direct hydrogen bonding with Asp318 in PDHK1, Asp282 in PDHK2, Asp287 in PDHK3, and Asp293 in PDHK4. The carbonyl oxygen in the resorcylic acid amide forms a hydrogen bond with Thr383 in PDHK1, Thr346 in PDHK2, Gly291 in PDHK3, and Thr358 in PDHK4. It is worth noting that the carbonyl oxygen of resorcylic acid amide forms an additional water-mediated H-bond only with a residue in the ATP binding site of PDHK2. This unique interaction could contribute to the high activity (IC<sub>50</sub> = 10 nM) of <b>19n</b> against PDHK2. The noticeable differences between the inhibitory activities of <b>19n</b> on the PDHK isotypes appear to be mainly a consequence of the degree of interactions between its <i>N</i>,<i>N</i>-dimethylbenzamide moiety and Arg residues in the kinases. Indeed, both Arg250 in PDHK2 and Arg261 in PDHK4 strongly interact with the carbonyl oxygen of the <i>N</i>,<i>N</i>-dimethylbenzamide group (respective interaction scores of 95 and 83%), while Arg286 in PDHK1 and Arg254 in PDHK3 only weakly interact with the carbonyl oxygen of <b>19n</b> (respective interaction scores of 31 and 35%). It appears that cationâpi interaction (an interaction score of 84%) between the phenyl ring of the <i>N</i>,<i>N</i>-dimethylbenzamide moiety and Arg261 in PDHK4 also contributes to the high potency (IC<sub>50</sub> = 5 nM) of <b>19n</b> against PDHK4. The representative docking poses of the <b>19n</b> with PDHKs are shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. Overall, the carbonyl of <i>N</i>,<i>N</i>-dimethylbenzamide forms a hydrogen bond with Arg residue (Arg286, Arg250, Arg254, and Arg261, respectively) and the resorcinol moiety also makes interactions with Asp (Asp318, Asp282, Asp287, and Asp293, respectively) and Thr (Thr383, Thr346, Thr352, and Thr358, respectively) in PDHKs. Unlike other isoforms, Thr352 of PDHK3 forms an indirect interaction with <b>19n</b>.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Ligand interaction diagrams and interaction profile analysis of molecular dynamics simulations of <b>19n</b> within PDHK isoforms (a) PDHK1, (b) PDHK2, (c) PDHK3, and (d) PDHK4. The dotted arrows indicate H-bonds to side chains of the PDHKs, and the full arrows indicate H-bonds to backbones of the PDHKs. Red connectors denote cationâpi stacking interactions. Green, H-bonds; pink, ionic interactions; purple, hydrophobic interactions; blue, water bridges.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking structures of <b>19n</b> with the ATP binding sites of the PDHKs: (a) PDHK1, (b) PDHK2, (c) PDHK3, and (d) PDHK4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To gain an understanding of why <b>19t</b> possesses excellent activities (IC<sub>50</sub> = 5â9 nM) against PDHK1/2/4 but a much lower potency (IC<sub>50</sub> = 80 nM) against PDHK3, molecular dynamics simulations were carried out to determine its binding modes to the PDHKs (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In a manner that is similar to the binding modes of <b>19n</b> to PDHK1/2/3/4, the carbonyl oxygen of the resorcylic acid amide group in <b>19t</b> forms a hydrogen bond with Thr383 in PDHK1 and Thr346 in PDHK2, which could contribute to its potencies against PDHK1/2. In contrast, the amide carbonyl oxygen in <b>19t</b> does not participate in direct hydrogen bonding with residues in PDHK3/4. In addition, the carbonyl oxygen of the <i>N</i>,<i>N</i>-dimethylbenzamide group in <b>19t</b> engages in direct H-bonding interactions with Arg286 in PDHK1, Arg250 in PDHK2, and Arg261 and Thr313 in PDHK4, but it is not involved in H-bonding with residues in PDHK3. Neither of the two carbonyl oxygens in <b>19t</b> participate in direct H-bonding interactions with residues in PDHK3, which could be the source of its low inhibitory activity (IC<sub>50</sub> = 80 nM) against PDHK3. Furthermore, cationâpi interactions between the <i>N</i>,<i>N</i>-dimethylbenzamide moiety in <b>19t</b> and Arg286 in PDHK1 and Arg261 in PDHK4 could be the reason for its high activity against PDHK1/4. In summary, the results of molecular dynamics simulations provide a better understanding of how the R<sub>2</sub> substituent affects inhibitory activities of <b>19n</b> and <b>19t</b> against PDHK1/2/3/4. We also performed molecular dynamics simulations of <b>6</b> on PDHK1/2/3/4 (<a class="ref internalNav" href="#notes1" aria-label="Figure S1">Figure S1</a>) for comparison. The results of molecular dynamics simulation of <b>6</b> are quite similar with those of both <b>19n</b> and <b>19t</b> even though all interaction % scores are not completely in accordance with the kinase-inhibitory activities of <b>19n</b>, <b>19t</b>, and <b>6</b>.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ligand interaction diagrams of molecular dynamic simulations of <b>19t</b> with PDHK isoforms: (a) PDHK1, (b) PDHK2, (c) PDHK3, and (d) PDHK4. The dotted arrows indicate H-bonds to side chains of the PDHKs, and the full arrows indicate H-bonds to backbones of PDHKs. The red connector denotes cationâpi stacking interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <b>19b</b> and <b>19t</b> Are Specific PDHK Inhibitors</h3><div class="NLM_p">Kinome-wide selectivity profiling of both <b>19t</b> and <b>19b</b> was carried out using a panel of 366 kinases. To our surprise, the profiling data reveal that among 366 kinases only the PDHKs are inhibited by more than 90% by 1 Î¼M <b>19t</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a class="ref internalNav" href="#notes1" aria-label="Table S2">Table S2</a>) and <b>19b</b> (<a class="ref internalNav" href="#notes1" aria-label="Figure S2">Figure S2</a> and <a class="ref internalNav" href="#notes1" aria-label="Table S1">Table S1</a>). This observation indicates that both <b>19t</b> and <b>19b</b> are specific PDHK inhibitors. It is of note that 10 Î¼M <b>6</b> inhibits 8 out of 96 kinases by more than 65%.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition to its exceptional kinome-wide selectivity, <b>19t</b> has ca. 10-fold greater kinase-inhibitory activity against PDHK1/2/4 than does <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). To assess the selectivity on the GHKLs (gyrase, Hsp90, histidine kinase, MutL), which have ATP binding sites that are similar to those of the PDHKs,<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> we measured the kinase-inhibitory activities of selected compounds against HSP90. Even though <b>19k</b> and <b>19n</b> are reasonably strong inhibitors of HSP90 (IC<sub>50</sub> values of ca. 1 Î¼M), the other analogues listed in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C possess low kinase-inhibitory activity (IC<sub>50</sub> = ca. 8 to >10 Î¼M) against HSP90 and excellent selectivity for the PDHKs over HSP90.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Overall kinase selectivity profiling of <b>19t</b>. Kinases showing >50% inhibition are clustered on the kinome tree. PDHK1/2/3/4 out of 366 kinases are inhibited more than 90% by 1 Î¼M <b>19t</b>. This illustration was reproduced courtesy of Cell Signaling Technology, Inc. (<a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>). (B) The percent inhibition of PDHK activities in the presence of <b>19t</b> and <b>19b</b> (1 Î¼M). (C) Inhibitory activities of selected compounds against PDHK1/2/3/4 and HSP90. Compounds were tested in 10 doses with a 3-fold serial dilution starting at 10 Î¼M.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vitro</i> Potency of Resorcinol Amide Derivatives against Cancer Cells and Reconstituted PDC-Reaction System</h3><div class="NLM_p">In order to assess the cellular activities of the resorcinol amide derivatives that have potent inhibitory activity against the PDHKs (IC<sub>50</sub> < 200 nM), we determined their antiproliferative activities in p53-deficient human non-small-cell lung carcinoma H1299 cells and DU145 prostate cancer cells (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The results show that <b>19n</b>, which has a one-digit nanomolar IC<sub>50</sub> against PDHK2 and PDHK4, suppresses growth of H1299 and DU145 with a GI<sub>50</sub> of 13.4 and 10.2 Î¼M, respectively, whereas <b>6</b> has an extremely low antiproliferative activity against H1299 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref internalNav" href="#notes1" aria-label="Figure S3">Figure S3</a>). In order to support the notion that <b>19n</b> suppresses cancer cell growth through targeting PDHK, we investigated whether knockdown of PDHK expression affects the antitumor activity of <b>19n</b> (<a class="ref internalNav" href="#notes1" aria-label="Figure S4">Figure S4</a>). PDHK1/2 double knockdown in H1299 cells resulted in about 40% inhibition of cancer cell growth (<a class="ref internalNav" href="#notes1" aria-label="Figure S4B">Figure S4B</a>). In H1299 cells treated with siCTL (control siRNA), 10 Î¼M <b>19n</b> reduced the proliferation of the H1299 cells by around 50% compared to DMSO treated cells. On the other hand, in PDHK1/2 double knockdown cells, 10 Î¼M <b>19n</b> suppressed the proliferation of the H1299 cells by 32% compared to DMSO treated cells, suggesting that <b>19n</b> suppresses the growth of H1299 cancer cells through targeting PDHK1 and PDHK2. Interestingly, <b>19g</b> and <b>19k</b> have appreciable antiproliferative activities against both H1299 and DU145 cells with respective GI<sub>50</sub> values ranging from 3.5 to 9.0 Î¼M. Considering the moderate PDHK inhibitory activities of <b>19g</b> and <b>19k</b> (respective IC<sub>50</sub> of 30 nM to ca. 150 nM), it is clear that their inhibitory activities are not well-correlated with their cellular potencies. Finally, <b>19g</b> does not inhibit HSP90, indicating that its antiproliferative activity against H1299 and DU145 results from off-target effects.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antiproliferative Activities against H1299 and DU145 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char="Â±">H1299<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±">DU145<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char="Â±">H1299<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±">DU145<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char="Â±">GI<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="Â±">GI<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char="Â±">GI<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="Â±">GI<sub>50</sub> (Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="char" char="Â±">57.1Â Â±Â 4.3</td><td class="colsep0 rowsep0" align="char" char="Â±">69.7Â Â±Â 29.0</td><td class="colsep0 rowsep0" align="left"><b>19o</b></td><td class="colsep0 rowsep0" align="char" char="Â±">39.19Â Â±Â 5.3</td><td class="colsep0 rowsep0" align="char" char="Â±">15.9Â Â±Â 2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="char" char="Â±">31.5Â Â±Â 2.6</td><td class="colsep0 rowsep0" align="char" char="Â±">51.0Â Â±Â 5.54</td><td class="colsep0 rowsep0" align="left"><b>19p</b></td><td class="colsep0 rowsep0" align="char" char="Â±">49.8Â Â±Â 8.9</td><td class="colsep0 rowsep0" align="char" char="Â±">42.25Â Â±Â 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="char" char="Â±">97.1Â Â±Â 2.9</td><td class="colsep0 rowsep0" align="char" char="Â±">44.5Â Â±Â 20.0</td><td class="colsep0 rowsep0" align="left"><b>19q</b></td><td class="colsep0 rowsep0" align="char" char="Â±">107.2Â Â±Â 24.3</td><td class="colsep0 rowsep0" align="char" char="Â±">59.8Â Â±Â 6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19g</b></td><td class="colsep0 rowsep0" align="char" char="Â±">4.9Â Â±Â 0.9</td><td class="colsep0 rowsep0" align="char" char="Â±">3.5Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="left"><b>19r</b></td><td class="colsep0 rowsep0" align="char" char="Â±">32.16Â Â±Â 2.15</td><td class="colsep0 rowsep0" align="char" char="Â±">18.9Â Â±Â 8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19k</b></td><td class="colsep0 rowsep0" align="char" char="Â±">7.8Â Â±Â 1.7</td><td class="colsep0 rowsep0" align="char" char="Â±">9.0Â Â±Â 0.8</td><td class="colsep0 rowsep0" align="left"><b>19s</b></td><td class="colsep0 rowsep0" align="char" char="Â±">60.2Â Â±Â 29.4</td><td class="colsep0 rowsep0" align="char" char="Â±">40.8Â Â±Â 2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19m</b></td><td class="colsep0 rowsep0" align="char" char="Â±">30.0Â Â±Â 4.58</td><td class="colsep0 rowsep0" align="char" char="Â±">29.9Â Â±Â 3.9</td><td class="colsep0 rowsep0" align="left"><b>19t</b></td><td class="colsep0 rowsep0" align="char" char="Â±">51.6Â Â±Â 3.2</td><td class="colsep0 rowsep0" align="char" char="Â±">41.9Â Â±Â 4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19n</b></td><td class="colsep0 rowsep0" align="char" char="Â±">13.4Â Â±Â 2.6</td><td class="colsep0 rowsep0" align="char" char="Â±">10.2Â Â±Â 22.4</td><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="Â±">>50</td><td class="colsep0 rowsep0" align="char" char="Â±">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">GI<sub>50</sub> is the concentration at which half-maximal growth inhibition occurs. The cells were treated with compounds for 72 h in a dose escalation manner. A CellTiter-Glo assay was performed to assess cell viability. Average GI<sub>50</sub> values with SD (<i>n</i> = 2) are shown.</p></div></div></div><div class="NLM_p">To understand the discrepancy between enzyme inhibition and cellular activities, we utilized a pyruvate dehydrogenase (PDH) assay, which is a reconstituted PDC-reaction system used to measure PDH activity <i>in vitro</i> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). PDH is a component of the PDC complex converting pyruvate to acetylCoA via NAD<sup>+</sup> reduction. PDHKs inhibit PDH activity and cause decreased levels of NADH production. Thus, inhibition of PDHK results in higher PDH activity and an increase in the amount of NADH formed from NAD<sup>+</sup>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The effects of <b>19g</b>, <b>19k</b>, and <b>19n</b>, which have high antiproliferative activities (GI<sub>50</sub> < 15 Î¼M) against H1299 and DU145, on PDH activity were determined by measuring the rate of NAD<sup>+</sup> reduction. As the results in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B show, <b>19n</b> has the lowest IC<sub>50</sub> value against both PDHK2 (IC<sub>50</sub> = 0.58 Î¼M) and PDHK4 (IC<sub>50</sub> = 0.31 Î¼M). The activities of <b>19g</b> and <b>19k</b> are approximately 3 times lower than that of <b>19n</b> in PDC assay, while <b>19g</b> and <b>19k</b> are over 15 times less potent than <b>19n</b> against PDHK2 in biochemical kinase assay. Considering the antiproliferative activities of <b>19g</b>, <b>19k</b>, and <b>19n</b> on H1299 and DU145 cells, it appears that the PDH assay results better correlate with cellular activities than do the PDHK kinase-inhibitory activities. The IC<sub>50</sub> values derived from biochemical kinase assay depend on ATP concentration.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We assessed the IC<sub>50</sub> values of <b>19n</b> against PDHKs using three different ATP concentrations (10/50/200 Î¼M) (<a class="ref internalNav" href="#notes1" aria-label="Table S3">Table S3</a>). 200 Î¼M ATP is close to a physiological ATP concentration (ca. 1 mM). Compared with the 10 Î¼M ATP condition, potency of <b>19n</b> against PDHK1 is decreased by 11-fold at 200 Î¼M ATP concentration. The PDHK-inhibitory activity of <b>19n</b> would be much lower at physiological ATP concentration, which might be a reason for the discrepancy between its enzymatic activity and cellular potency. Also, the discrepancy might be in part attributed to low cellular permeability and/or high efflux ratio.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PDH assay results. (A) Schematic diagram depicting the principle of the reconstituted PDC-reaction system. NAD<sup>+</sup> reduction simultaneously occurs when the PDH complex (E1, E2, and E3) converts pyruvate to acetyl-CoA. Phosphorylation of E1 by PDHKs suppresses the activity of the PDC complex; thus, NAD<sup>+</sup> reduction is decreased. The activity of the PDH complex (E1, E2, and E3) was evaluated by measuring the rate of NAD<sup>+</sup> reduction for 30 min in the presence of <b>19g</b>, <b>19k</b>, and <b>19n</b>, respectively. (B) The result of PDH assays of <b>19g</b>, <b>19k</b>, and <b>19n</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> CYP Inhibition Profiles of <b>19g</b> and <b>19n</b></h3><div class="NLM_p">Because the resorcinol amide derivatives <b>19g</b> and <b>19n</b> display high activities in the PDH assay, we determined their inhibitory properties against five major cytochrome P450s, including CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. As the data in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> show, these substances have little to no inhibitory effects on CYP1A2, CYP2C9, and CYP2D6. <b>19n</b> is a moderate inhibitor (IC<sub>50</sub> > 1 Î¼M) of CYP2C19 and CYP3A4, while <b>19g</b> has favorable CYP inhibition profiles on all of the five major cytochrome P450s. We also assessed cytochromes P450-inhibitory activities of <b>19t</b> possessing excellent kinase-inhibitory activity on PDHKs and found that <b>19t</b> has little or no inhibition effects on CYP1A2, CYP2C9, CYP2C19, and CYP2D6, while it inhibits CYP3A4 with a IC<sub>50</sub> value less than 1 Î¼M.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. CYP Inhibition Profiles of <b>19g</b>, <b>19n</b>, and <b>19t</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="5" align="center">CYPÂ IC<sub>50</sub> (Î¼M)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">CYP1A2</th><th class="colsep0 rowsep0" align="center">CYP2C9</th><th class="colsep0 rowsep0" align="center">CYP2C19</th><th class="colsep0 rowsep0" align="center">CYP2D6</th><th class="colsep0 rowsep0" align="center">CYP3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19g</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">13.4</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">6.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19n</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19t</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">18.0</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left"><1</td></tr></tbody></table></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <b>19n</b> Blocks Phosphorylation of PDHE1a in H1299 and DU145 Cells</h3><div class="NLM_p">In order to determine if the PDHK inhibitory activities of the resorcinol amide derivatives have cellular consequences, Western blot analysis of H1299 cells was carried out to assess the effects of 10 Î¼M <b>19d</b>, <b>19g</b>, <b>19k</b>, and <b>19n</b> on levels of phosphorylation of Ser293 residue of PDHE1a promoted by all four PDHK isozymes. The results of Western blot analysis (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A) are consistent with those arising from the PDH assays (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Specifically, among the four derivatives, <b>19n</b> most strongly decreases the level of phosphorylation of PDHE1a. Moreover, <b>19n</b> inhibits phosphorylation of PDHE1a in a dose-dependent fashion (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), and at 20 Î¼M, it completely abolishes phosphorylation of PDHE1a (S293), an effect that is comparable to that of <b>6</b>. We also found that <b>19n</b> dose-dependently inhibited phosphorylation of Ser293 of PDHE1a in DU145 cells (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>19n</b> blocks PDHE1a phosphorylation in H1299 cells and DU145 cells. (A) Western blot analysis of H1299 cells treated with the selected compounds at 10 Î¼M for 2 h (110 mM) and a graph of the results (right panel). <b>19n</b> attenuated pPDHE1a phosphorylation 70â80%, while the other substances show only moderate inhibitory activities. (B) Phosphorylation of PDHE1a (S293) is attenuated by <b>19n</b> and <b>6</b> in a dose-dependent manner. (C) Western blot analysis of DU145 cells treated with the indicated concentration of <b>19n</b> for 2 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <b>19n</b> Induces OCR, ROS Production, and Mitochondrial Depolarization</h3><div class="NLM_p">To assess the energy metabolism in cancer cells, we measured the OCR (oxygen consumption rate) in H1299 cells treated with <b>19n</b> and <b>1</b>. We found that <b>19n</b> treatment increased both the spare respiratory capacity and maximal OCR, which were comparable to the effects of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). This result implies that inhibition of PDHK by <b>19n</b> can switch pyruvate consumption from lactate production to oxidative phosphorylation. We also determined whether PDHK inhibition by <b>19n</b> promotes mitochondrial dysfunction and ROS production. By using a flow cytometry based assay, we found that <b>19n</b> causes a dose-dependent increase in ROS production (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). It has been reported that inhibition of PDHK activity by <b>1</b> or its analogues decreases the mitochondrial membrane potential of cancer cells.<a onclick="showRef(event, 'cit12c ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref cit12c ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24">(12c,13â24)</a> In order to assess whether <b>19n</b> also alters the mitochondrial membrane potential, we measured changes in the ratio of red to green fluorescence intensities of the JC-1 probe in DU145 cells. JC-1 forms red fluorescent aggregates in the normal mitochondrial membrane, and the color of the fluorescence reversibly shifts from red (aggregate) to green (monomer) as the membrane potential decreases in the response to stimuli.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Thus, a decrease in the ratio of red to green fluorescence indicates the occurrence of depolarization of the mitochondrial membrane and/or dysfunction of the mitochondria. To detect the red/green fluorescence ratio, DU145 cells were incubated with indicated doses of <b>19n</b> and then stained with JC-1. Fluorescence microscopic images of the cells were quantified by using Image J (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C). As expected, <b>19n</b> dose-dependently promotes a decrease in the red/green fluorescence ratio. This result clearly demonstrates that mitochondrial function is impaired by <b>19n</b>.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of <b>19n</b> on mitochondrial respiration, ROS production, and mitochondrial membrane potential. (A) <b>19n</b> enhances mitochondrial respiration in H1299 cells. OCRs were measured in H1299 cells in the presence or absence of DCA (10 mM) and <b>19n</b> (10 Î¼M) for 1 h, and oligomycin A (1 Î¼M), FCCP (2 Î¼M), and rotenone/antimycin A (1 Î¼M) were sequentially delivered to the XFe96 assay medium through injection ports in the sensor cartridge (<i>n</i> = 6, Â±SD, <i>t</i> test, â < 0.05 vs control). (B) <b>19n</b> promotes strong generation of ROS in a dose-dependent manner (left panel, H1299; right panel, DU145). Fluorescence of DCF was detected by using FACS (<i>n</i> = 3, Â±SD, one-way ANOVA; ââââ <i>p</i> < 0.0001, âââ <i>p</i> < 0.0009, â < 0.05). (C) DU145 cells were treated with increasing concentrations of <b>19n</b> for 5 h and stained with JC-1 for 30 min. <b>19n</b> dose-dependently reduces the red/green fluorescence ratio. Scale bar = 25 Î¼m. The intensity of fluorescence was automatically measured by Image J (<i>n</i> = 3, Â±SD, one-way ANOVA; âââ <i>p</i> < 0.0007, ââ < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <b>19n</b> Promotes Apoptosis and Suppresses Tumorigenesis of H1299 and DU145 Cells</h3><div class="NLM_p">Because alteration of the mitochondrial membrane potential is a cellular event in the apoptotic process,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> we explored the apoptosis-inducing effect of <b>19n</b> on H1299 and DU145 cells. After treatment with <b>19n</b> for 48 h, cells were costained with FITC conjugated Annexin-V and propidium iodide and subjected to flow cytometric analysis (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). The results show that <b>19n</b> causes a gradual dose-dependent increase in the population of apoptotic cells. The apoptosis ratio promoted by treatment with 30 Î¼M <b>19n</b> was found to be 24.8% in H1299 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A, left panel). In DU145, <b>19n</b> dramatically induced apoptosis over 60% at 30 Î¼M. <b>1</b> does not promote apoptosis of H1299 and DU145 cells, indicating that the apoptosis-inducing effect of <b>1</b> may be dependent on cell type. Because caspase 3 cleavage is activated by cytochrome <i>c</i> released from mitochondria, it is a marker for mitochondria-mediated apoptosis.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To determine whether <b>19n</b> induces apoptosis via mitochondrial signaling, the degree of caspase 3 cleavage was measured by using Western blotting (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B, left panel). The results show that <b>19n</b> effectively induces cleavage of caspase 3 in a dose-dependent manner. Cleavage of PARP, a substrate of caspase 3, by <b>19n</b> was also assessed in DU145 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B, right panel). <b>19n</b> increased the level of cleaved PARP in a dose-dependent fashion, while cleaved PARP was not enhanced by <b>1</b>, which is consistent with the results of FACS analysis.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <b>19n</b> induces apoptosis of H1299 and DU145, and <b>19n</b> inhibits anchorage-independent growth in H1299. (A) The numbers of apoptotic cells after treatment of <b>19n</b> for 48 h were determined by using Annexin V/PI staining. <b>19n</b> causes a dose-dependent increase in apoptotic cells (left panel, H1299; right panel, DU145). (B) Caspase 3 cleavage or PARP cleavage is increased by dose-dependent treatment with <b>19n</b> (left panel, H1299; right panel, DU145). (C) Anchorage-independent growth inhibition of H1299 cells promoted by <b>19n</b>. Average numbers of colonies per well were automatically counted using Image J software and are shown in the bar-graph (<i>n</i> = 3, Â±SD, one-way ANOVA; ââââ <i>p</i> < 0.0001, ââ <i>p</i> < 0.01, â <i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Anchorage-independent growth <i>in vitro</i> reflects the tumorigenesis capacities of cells <i>in vivo</i>. Hence, we evaluated the ability of <b>19n</b> to suppress colony formation of H1299 cells in the soft agar assay. Agar embedded H1299 cells were treated with increasing concentrations of <b>19n</b> for 14 d and then subjected to colony formation analysis (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C). It was found that both the colony number and size of <b>19n</b> treated cells were greatly lower than those of the control. In addition, <b>19n</b> causes complete inhibition of colony formation at 20 Î¼M concentration. It is noteworthy that <b>19n</b> suppresses the proliferation of H1299 cells in a 2D culture system by 70% at 20 Î¼M, which indicates that antiproliferative activity of <b>19n</b> is higher in the 3D soft agar colony formation assay than in the 2D CellTiter-Glo assay. These results suggest that <b>19n</b> effectively prevents tumorigenesis of H1299 cells.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <b>19n</b> Increases <i>In Vitro</i> Cytotoxicity of Satraplatin</h3><div class="NLM_p">Co-treatment with <b>1</b> increases the antiproliferative activities in cancer cells of platinum compounds such as carboplatin and satraplatin.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Stimulated by this finding, we evaluated whether <b>19n</b> has synergistic effects on the activities of platinum compounds against H1299 cells. The antiproliferative effects of satraplatin, <b>19n</b>, and a combination of both compounds were determined (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). The results show that satraplatin and <b>19n</b> moderately suppress proliferation of H1299 cells with respective GI<sub>50</sub> values of 12.0 and 13.1 Î¼M. Interestingly, satraplatin in combination with 10 Î¼M <b>19n</b> suppresses (GI<sub>50</sub> = 5.5 Î¼M) proliferation of H1299 cells more effectively than does satraplatin alone (GI<sub>50</sub> = 12.0 Î¼M), while a combination of satraplatin and 10 mM <b>1</b> causes only a slight increase (GI<sub>50</sub> = 8.5 Î¼M) in proliferation. We next investigated the synergistic effect of <b>19n</b> and satraplatin promoted apoptosis (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). Treatment with 10 Î¼M satraplatin alone results in production of 7% apoptotic cells, while treatment with a combination of 10 Î¼M satraplatin and 10 Î¼M <b>19n</b> results in a 3â4-fold increase in the number of apoptotic cells (30â34%). Western blot analysis also revealed that caspase 3 cleavage increases upon co-treatment with satraplatin and <b>19n</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C). Together, the observations show that PDHK inhibition by <b>19n</b> synergistically increases the antiproliferative activity of satraplatin on H1299 cells via apoptosis. It is worthwhile noting that <b>6</b> does not synergistically affect the activity of cisplatin but it causes a 2-fold increase in the activity of doxorubicin against PC-3 prostate cancer cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. <b>19n</b> increases the cytotoxicity of satraplatin. (A) The antiproliferative activity of <b>19n</b> was determined by using the CellTiter-Glo assay. A combination of satraplatin and <b>19n</b> (10 Î¼M) promotes an increase in the antiproliferation effect of satraplatin alone. (B, C) A combination of satraplatin and <b>19n</b> has a synergistic effect in promoting apoptosis in H1299 cells (<i>n</i> = 3, one-way ANOVA; ââââ <i>p</i> < 0.0001, âââ <i>p</i> < 0.0005, ââ <i>p</i> < 0.005).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alteration of cellular metabolism is a cancer hallmark. Consequently, substances that affect cancer metabolism are attractive targets for cancer chemotherapy. Among the differences between normal and cancer cells are aberrant expressions of PDHK observed in various cancers including RCC, NSCLS, and breast and colon cancer. Thus, intensive efforts have been made to discover efficacious PDHK inhibitors. Recently, it was observed that <b>6</b> is an ATP competitive PDHK inhibitor and that it displays cytostatic activity in a context-dependent manner.<a onclick="showRef(event, 'cit16a'); return false;" href="javascript:void(0);" class="ref cit16a">(16a)</a> Also, binding-affinity-based optimization led to the development of active derivatives of <b>6</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In order to uncover more potent and selective PDHK inhibitors, we performed SAR studies on a series of resorcinol amide derivatives utilizing kinase-inhibitory and PDC activity assays, which are different from the previous binding-affinity-based SAR study<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> on the derivatives <b>6</b>. We observed that introduction of substituted five-membered heteroaromatic groups on the resorcinol amide core led to the potent PDHK inhibitors <b>19m</b>â<b>t</b> which have structural features that are distinct from those of <b>6</b> and its derivatives.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">In this effort, we showed that <b>19n</b> and <b>19t</b> are extremely potent and highly selective PDHK inhibitors. We observed that <b>19t</b> has excellent kinase-inhibitory activity against PDHK1, PDHK2, and PDHK4 with IC<sub>50</sub> values in the range 5â9 nM that are superior to those of <b>6</b>. Also, <b>19t</b> selectively inhibits the four PDHK isoforms out of 366 kinases and it has a 70-fold lower activity against HSP90. It is noteworthy that this investigation showed that the resorcinol amide derivatives <b>19g</b> and <b>19l</b> are isotype-selective PDHK inhibitors. Since the expression level and distribution of each isotype are tissue specific, each of the PDHK isoforms is associated with a specific disease.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> For example, PDHK4 is abundant in skeletal muscle in the type 1 diabetes animal model<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and highly associated with diabetes. Thus, a PDHK4 specific inhibitor could be potentially applied to diabetes disease. In addition, an isoform specific inhibitor should be a useful tool in studying a function of a specific isoform.</div><div class="NLM_p">Molecular dynamics simulation studies with PDHK isoforms revealed that the differences that exist between the activities of <b>19n</b> on different PDHK isotypes appear to be associated with the degree of hydrogen bonding interactions between the <i>N</i>,<i>N</i>-dimethylbenzamide moiety and the corresponding Arg residues (Arg250 in PDHK2 and Arg261 in PDHK4). The carbonyl oxygen of the resorcylic acid amide moiety in <b>19t</b> participated in H-bonding with Thr383 in PDHK1 and Thr346 in PDHK2, and cationâpi interactions between the <i>N</i>,<i>N</i>-dimethylbenzamide phenyl ring of <b>19t</b> and Arg286 in PDHK1 and Arg261 in PDHK4 are responsible for the excellent activity (IC<sub>50</sub> = 5â9 nM) of <b>19t</b> against PDHK1/2/4. Finally, oxygens of neither of the two carbonyl groups in <b>19t</b> participate in direct H-bonding interactions with residues in PDHK3, which is consistent with its only mild activity (IC<sub>50</sub> = 80 nM) against PDHK3.</div><div class="NLM_p">An assessment was made of the antiproliferative activities of p53-deficient human non-small-cell lung carcinoma H1299 and prostate cancer DU145 cells of substances that have potent enzymatic inhibitory activities. We observed that <b>19n</b>, which possesses excellent potency against both PDHK2 and PDHK4, suppresses growth of H1299 and DU145 cells with a GI<sub>50</sub> value of 13.4 and 10.2 Î¼M, respectively. We also found that the enzyme inhibitory activity of the resorcinol amide derivatives is not well-correlated with their cellular activity. It is worth noting that <b>6</b> has an extremely low antiproliferative activity against H1299 cells. A better understanding of the discrepancy between the enzymatic and cellular activities of <b>19n</b> was gained using a PDH assay. The results show that <b>19n</b> inhibits PDC activity in the reconstituted PDC reaction with a sub-micromolar IC<sub>50</sub>. The results of the PDH assay better correlate with cellular activity than do the results of the PDHK kinase assay, which is also true for <b>19g</b> and <b>19k</b>.</div><div class="NLM_p last">In this effort, we also demonstrated that <b>19n</b> dose-dependently decreases PDHE1a phosphorylation in H1299 and DU145 cells and that it induces oxygen consumption, induces apoptosis via mitochondrial dysfunction, and, thus, effectively suppresses tumorigenesis. It is worthwhile noting that the antiproliferative activity of <b>19n</b> is higher in the 3D soft agar colony formation assay than it is in a 2D culture system. In addition, <b>19n</b> treatment leads to an increase in the apoptosis-mediated antiproliferative activity of satraplatin. Taken together, the results of this study provide insight into the structural design of potent and selective PDHK inhibitors and the biological significance of PDHK inhibition in cancer cells.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Information</h4><div class="NLM_p">Unless otherwise noted, all reagents and solvents were purchased from commercial suppliers and used without further purification. All reactions were performed under a N<sub>2</sub> atmosphere in flame-dried glassware. Reactions were monitored by using TLC with 0.25 mm E. Merck precoated silica gel plates (60â¯F254). The progress of reactions was monitored by using TLC analysis and a UV lamp, ninhydrin, or <i>p</i>-anisaldehyde stain for detection. All solvents were purified by using standard techniques. Purification of reaction products was carried out using silica gel column chromatography with Kieselgel 60 Art. 9385 (230â400 mesh). The purity of all compounds was over 95%, and the purity of all compounds was analyzed using LC/mass spec analysis with a Waters LCMS system (Waters 2998 Photodiode Array Detector, Waters 3100 Mass Detector, Waters SFO System Fluidics Organizer, Water 2545 Binary Gradient Module, Waters Reagent Manager, Waters 2767 Sample Manager) using a SunFireTM C18 column (4.6 Ã 50 mm<sup>2</sup>, 5 Î¼m particle size): solvent gradient = 60% (or 95%) A at 0 min, 1% A at 5 min. Solvent A = 0.035% TFA in H<sub>2</sub>O; solvent B = 0.035% TFA in MeOH; flow rate 3.0 (or 2.5) mL/min. HPLC analysis was performed on an Agilent 1100 using a YMC-Pack Pro C18 column (250 Ã 4.6 mm<sup>2</sup>, 5 Î¼m particle size): solvent gradient = 5% B at 0 min, 5% B at 3 min, 100% B at 20 min, 100% B at 25 min. Solvent A = 0.03% TFA in H<sub>2</sub>O; solvent B = 0.03% TFA in acetonitrile; flow rate 0.5 mL/min. <sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained using a Bruker 400 MHz FT-NMR (400 MHz for <sup>1</sup>H and 100 MHz for <sup>13</sup>C) spectrometer. Standard abbreviations are used for denoting the signal multiplicities.</div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Methyl 4-((4-Nitrobenzyl)amino)benzoate (<b>9</b>)</h5><div class="NLM_p last">To a solution of <b>8</b> (6.0 g, 39.74 mmol) in dry MeOH (265 mL) was added 4-nitrobenzaldehyde (4.67 mL, 47.69 mmol) and acetic acid (0.3 mL) at room temperature. The mixture was stirred for 10 min and then treated slowly with NaBH<sub>3</sub>CN (3.75 g, 59.61 mmol). The reaction mixture was stirred for 5 h at room temperature and diluted with H<sub>2</sub>O and NaHCO<sub>3</sub>. The aqueous layer was extracted with DCM. The combined organic layers were dried over MgSO<sub>4</sub> and filtered and concentrated under reduced pressure. The residue was subjected to flash column chromatography on silica gel (30% EtOAc/hexane) to afford <b>9</b> (9.21 g, 81%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.19 (d, <i>J</i> = 8.4 Hz, 2H), 7.85 (d, <i>J</i> = 8.4 Hz, 2H), 7.50 (d, <i>J</i> = 8.4 Hz, 2H), 6.55 (d, <i>J</i> = 8.4 Hz, 2H), 4.53 (s, 2H), 3.84 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 167.1, 151.0, 147.3, 146.2, 131.6, 127.6, 124.0, 119.5, 111.8, 51.6, 47.0. LRMS (ESI) <i>m</i>/<i>z</i> 287 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 2,4-Diacetoxybenzoic Acid (<b>10a</b>)</h5><div class="NLM_p last">To a solution of 2,4-dihydroxybenzoic acid (10.0 g, 64.94 mmol) in acetic anhydride (61.4 mL, 649.35 mmol) was added H<sub>2</sub>SO<sub>4</sub> (5 mL) dropwise at 0 Â°C. The mixture was then stirred for 2 h at 60 Â°C, cooled to room temperature, and poured into iceâwater. The mixture was stirred at room temperature for 1 h, and the resulting solid was separated by filtration, washed with water, and dried using an air flow to give <b>10a</b> (8.66 g, 56%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) 8.05 (d, <i>J</i> = 8.8 Hz, 1H), 7.10 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 6.97 (d, <i>J</i> = 2.0 Hz, 1H), 2.27 (s, 3H), 2.25 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 171.2, 170.2, 167.0, 156.1, 153.1, 133.9, 122.5, 120.5, 118.6, 21.1, 21.0. LRMS (ESI) <i>m</i>/<i>z</i> 239 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 4-Acetoxybenzoic Acid (<b>10b</b>)</h5><div class="NLM_p last">To a solution of 4-hydroxybenzoic acid (10.0 g, 72.46 mmol) in acetic anhydride (34.2 mL, 362.32 mmol) was added H<sub>2</sub>SO<sub>4</sub> (5 mL) dropwise at room temperature. The mixture was stirred for 2 h at 60 Â°C, cooled to room temperature, and poured into iceâwater. The mixture was stirred at room temperature for 1 h, and the resulting solid was separated by filtration, washed with water, and dried using an air flow to give <b>10b</b> (7.04 g, 54%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 8.06â8.02 (m, 2H), 7.21â7.17 (m, 2H), 2.27 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 170.50, 168.93, 155.89, 132.19, 129.41, 122.82, 20.86. LRMS (ESI) <i>m</i>/<i>z</i> 181 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 2-Acetoxybenzoic Acid (<b>10c</b>)</h5><div class="NLM_p last">To a solution of 2-hydroxybenzoic acid (10.0 g, 74.07 mmol) in acetic anhydride (34.2 mL, 362.32 mmol) was added H<sub>2</sub>SO<sub>4</sub> (5 mL) dropwise at room temperature. The mixture was then stirred for 2 h at 60 Â°C, cooled to room temperature, and poured into iceâwater. The mixture was stirred at room temperature for 1 h, and the resulting solid was separated by filtration, washed with water, and dried using an air flow to give <b>10c</b> (8.53 g, 64%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 8.01 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.57 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.32 (td, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.12 (dd, <i>J</i> = 8.0, 0.8 Hz, 1H), 2.27 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 171.36, 167.51, 152.02, 134.79, 132.72, 126.94, 124.91, 124.68, 20.91. LRMS (ESI) <i>m</i>/<i>z</i> 181 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 4-((4-(Methoxycarbonyl)phenyl)(4-nitrobenzyl)carbamoyl)-1,3-phenylene Diacetate (<b>11</b>)</h5><div class="NLM_p last">To a solution of <b>10a</b> (3.0 g, 12.61 mmol) in DCM (42 mL) was added oxalyl chloride (5.34 mL, 63.05 mmol) and DMF (0.1 mL). The mixture was stirred for 2 h and concentrated under reduced pressure. To a solution of the resulting residue in dry DMF (42 mL) was added <b>9</b> (1.80 g, 6.31 mmol). After cooling the solution to 0 Â°C, DIPEA (3.21 mL, 18.93 mmol) was treated dropwise and the mixture was stirred for 2 h at room temperature. The mixture was diluted with H<sub>2</sub>O and extracted with EtOAc. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was subjected to flash column chromatography on silica gel (30% EtOAc/hexane to 70% EtOAc/hexane) to afford <b>11</b> (2. 94 g, 49% over two steps) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.19 (d, <i>J</i> = 8.0 Hz, 2H), 7.75 (d, <i>J</i> = 8.0 Hz, 2H), 7.58 (d, <i>J</i> = 8.0 Hz, 2H), 7.39 (d, <i>J</i> = 8.0 Hz, 1H), 7.31 (d, <i>J</i> = 8.0 Hz, 2H), 7.00 (s, 1H), 6.96 (d, <i>J</i> = 8.0 Hz, 2H), 5.29 (s, 2H), 3.76 (s, 3H), 2.28 (s, 3H), 2.21 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.51, 168.31, 166.11, 165.33, 151.40, 147.66, 146.75, 145.68, 144.81, 129.82, 128.80, 127.80, 127.21, 126.04, 123.60, 119.06, 116.74, 52.12, 51.46, 20.71. LRMS (ESI) <i>m</i>/<i>z</i> 507 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 4-((4-Acetamidobenzyl)(4-(methoxycarbonyl)phenyl)carbamoyl)-1,3-phenylene Diacetate (<b>13</b>)</h5><div class="NLM_p last">To a solution of <b>11</b> (1.71 g, 3.37 mmol) in MeOH (34 mL) was added Pd/C (170 mg) at room temperature. The reaction mixture was stirred under a hydrogen atmosphere for 12 h at room temperature, filtered through a celite pad, and concentrated. To a solution of the resulting residue in dry DCM (34 mL) was added acetic anhydride (0.45 mL, 4.72 mmol). The mixture was cooled to 0 Â°C and treated dropwise with TEA (1.41 mL, 10.11 mmol). The resulting solution was stirred at room temperature for 2 h and diluted with H<sub>2</sub>O. The aqueous layer was extracted with DCM. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was subjected to flash column chromatography on silica gel (70% EtOAc/hexane to 85% EtOAc/hexane) to afford <b>13</b> (1.24 g, 71% over two steps) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.76 (d, <i>J</i> = 8.8 Hz, 2H), 7.47 (d, <i>J</i> = 8.4 Hz, 2H), 7.22â7.18 (m, 5H), 6.92 (s, 1H), 6.81 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.08 (s, 2H), 2.23 (s, 3H), 2.16 (s, 3H), 2.07 (s, 3H), 1.39 (s, 6H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 171.47, 170.00, 168.56, 167.41, 153.32, 149.67, 147.33, 139.38, 139.04, 133.58, 131.18, 130.72, 128.78, 127.50, 126.07, 121.01, 119.84, 117.79, 52.63, 35.30, 30.85, 23.79, 20.93, 20.78. LRMS (ESI) <i>m</i>/<i>z</i> 519 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 4-(<i>N</i>-(4-Acetamidobenzyl)-2,4-dihydroxybenzamido)benzoic Acid (<b>14</b>)</h5><div class="NLM_p last">To a solution of <b>13</b> (0.41g, 0.75 mmol) in MeOH/H<sub>2</sub>O (20:1, 15 mL) was added NaOH (0.15 g, 3.77 mmol) at room temperature. The reaction mixture was stirred at 80 Â°C for 2 h, cooled to room temperature, and diluted sequentially with EtOAc and 1 N HCl to adjust the pH to 2. The mixture was then extracted with EtOAc, and the extracts were washed with H<sub>2</sub>O, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Diethyl ether was added, and the mixture was stirred at room temperature for 1 h. The resulting solid was filtered, washed with diethyl ether, and dried using an air flow to give <b>14</b> (248.9 mg, 79%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.45 (d, <i>J</i> = 8.4 Hz, 2H), 7.26 (d, <i>J</i> = 8.4 Hz, 2H), 7.12 (d, <i>J</i> = 8.4 Hz, 2H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 6.16 (d, <i>J</i> = 2.2 Hz, 1H), 6.07 (dd, <i>J</i> = 2.2, 8.6 Hz, 1H), 5.10 (s, 2H), 2.09 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 172.9, 171.8, 169.2, 162.3, 159.8, 148.9, 139.3, 134.3, 132.2, 131.4, 130.1, 130.0, 128.5, 121.3, 113.8, 107.8, 103.8, 54.0, 23.9. LRMS (ESI) <i>m</i>/<i>z</i> 443 [M + Na]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>NaO<sub>6</sub><sup>+</sup> [M + Na]<sup>+</sup>: 443.1214. Found: 443.1192.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> General Procedure A</h5><div class="NLM_p last">To a solution of <b>14</b> (1.0 equiv) in DMF (0.1 M) was added HATU (3.0 equiv) and various amines (1.5 equiv). The reaction mixture was stirred for 10 min, treated slowly with <i>N</i>-methylmorpholine (4.0 equiv), and stirred at room temperature for 3 h. Afterward, the mixture was diluted with EtOAc and NaHCO<sub>3</sub> solution. The mixture was then extracted with EtOAc, and the extracts were washed with H<sub>2</sub>O, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residues were subjected to flash column chromatography on silica gel.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>N</i>-(4-Acetamidobenzyl)-<i>N</i>-(4-(cyclopropylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>15a</b>)</h5><div class="NLM_p last">Compound <b>14</b> (200 mg, 0.48 mmol) was converted to the target compound using general procedure A. The crude product was purified using flash column chromatography (5% MeOH/DCM to 10% MeOH/DCM) on silica gel to afford <b>15a</b> (110.2 mg, 50%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.59 (d, <i>J</i> = 8.6 Hz, 2H), 7.44 (d, <i>J</i> = 8.4 Hz, 2H), 7.24 (d, <i>J</i> = 8.4 Hz, 2H), 7.10 (d, <i>J</i> = 8.6 Hz, 2H), 6.84 (d, <i>J</i> = 8.6 Hz, 1H), 6.13 (d, <i>J</i> = 2.2 Hz, 1H), 6.04 (dd, <i>J</i> = 2.3, 8.6 Hz, 1H), 5.09 (s, 2H), 2.78 (tt, <i>J</i> = 3.8, 7.3 Hz, 1H), 2.09 (s, 3H), 0.78â0.73 (m, 2H), 0.59â0.55 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 172.9, 171.8, 171.2, 162.2, 159.7, 147.6, 139.3, 134.3, 133.7, 132.1, 130.1, 129.0, 128.7, 121.2, 114.0, 107.8, 103.7, 54.0, 24.1, 23.9, 6.6. LRMS (ESI) <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>26</sub>N<sub>3</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 460.1873. Found: 460.1861.</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>N</i>-(4-Acetamidobenzyl)-2,4-dihydroxy-<i>N</i>-(4-(methylcarbamoyl)phenyl)benzamide (<b>15b</b>)</h5><div class="NLM_p last">Compound <b>14</b> (200 mg, 0.48 mmol) was converted to the target compound using general procedure A. The crude product was purified using flash column chromatography (5% MeOH/DCM to 10% MeOH/DCM) on silica gel to afford <b>15b</b> (43.6 mg, 21%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.87 (s, 1H), 8.30 (d, <i>J</i> = 4.4 Hz, 1H), 7.58 (d, <i>J</i> = 8.3 Hz, 2H), 7.45 (d, <i>J</i> = 8.3 Hz, 2H), 7.19 (d, <i>J</i> = 8.3 Hz, 2H), 7.09 (d, <i>J</i> = 8.3 Hz, 2H), 6.87 (d, <i>J</i> = 8.4 Hz, 1H), 6.08 (s, 1H), 6.04 (d, <i>J</i> = 8.3 Hz, 1H), 5.00 (s, 2H), 2.70 (d, <i>J</i> = 4.3 Hz, 3H), 2.00 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.3, 168.2, 165.8, 159.8, 156.4, 145.4, 138.2, 132.0, 131.7, 130.3, 128.0, 127.2, 126.6, 118.9, 114.0, 106.4, 102.3, 51.7, 26.2, 23.9. LRMS (ESI) <i>m</i>/<i>z</i> 434 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 434.1716. Found: 434.1703.</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>N</i>-(4-Acetamidobenzyl)-2,4-dihydroxy-<i>N</i>-(4-((2-hydroxyethyl)carbamoyl)phenyl)benzamide (<b>15c</b>)</h5><div class="NLM_p last">Compound <b>14</b> (200 mg, 0.48 mmol) was converted to the target compound using general procedure A. The crude product was purified using flash column chromatography (5% MeOH/DCM to 10% MeOH/DCM) on silica gel to afford <b>15c</b> (128.9 mg, 58%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.86 (d, <i>J</i> = 6.2 Hz, 2H), 9.56 (bs, 1H), 8.31 (t, <i>J</i> = 5.5 Hz, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.45 (d, <i>J</i> = 8.3 Hz, 2H), 7.18 (d, <i>J</i> = 8.3 Hz, 2H), 7.09 (d, <i>J</i> = 8.3 Hz, 2H), 6.88 (d, <i>J</i> = 8.3 Hz, 1H), 6.09 (s, 1H), 6.05 (d, <i>J</i> = 8.4 Hz, 1H), 5.00 (s, 2H), 4.67 (t, <i>J</i> = 5.6 Hz, 1H), 3.46â3.42 (m, 2H), 3.25 (q, <i>J</i> = 5.8 Hz, 2H), 2.00 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.2, 168.2, 165.5, 159.6, 156.3, 145.4, 138.2, 132.0, 131.7, 130.3, 128.1, 127.4, 126.5, 118.9, 114.2, 106.3, 102.3, 59.7, 51.7, 42.1, 23.9. LRMS (ESI) <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>26</sub>N<sub>3</sub>O<sub>6</sub><sup>+</sup> [M + H]<sup>+</sup>: 464.1822. Found: 464.1820.</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>N</i>-(4-Acetamidobenzyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>15d</b>)</h5><div class="NLM_p last">Compound <b>14</b> (200 mg, 0.48 mmol) was converted to the target compound using general procedure A. The crude product was purified using flash column chromatography (5% MeOH/DCM to 10% MeOH/DCM) on silica gel to afford <b>15d</b> (98.7 mg, 46%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.45 (d, <i>J</i> = 8.6 Hz, 2H), 7.26â7.23 (m, 4H), 7.14â7.11 (m, 2H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 6.13 (d, <i>J</i> = 2.3 Hz, 1H), 6.04 (dd, <i>J</i> = 2.3, 8.56 Hz, 1H), 5.09 (s, 2H), 3.04 (s, 3H), 2.87 (s, 3H), 2.09 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.2, 173.0, 171.7, 162.2, 159.6, 146.0, 139.4, 135.7, 134.3, 132.1, 130.1, 129.1, 128.7, 121.2, 114.2, 107.7, 103.7, 54.0, 40.0, 35.7, 23.9. LRMS (ESI) <i>m</i>/<i>z</i> 448 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>26</sub>N<sub>3</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 448.1873. Found: 448.1873.</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>N</i>-(4-Acetamidobenzyl)-2,4-dihydroxy-<i>N</i>-(4-(piperidine-1-carbonyl)phenyl)benzamide (<b>15e</b>)</h5><div class="NLM_p last">Compound <b>14</b> (200 mg, 0.48 mmol) was converted to the target compound using general procedure A. The crude product was purified using flash column chromatography (5% MeOH/DCM to 10% MeOH/DCM) on silica gel to afford <b>15e</b> (55.1 mg, 23%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.45 (d, <i>J</i> = 8.3 Hz, 2H), 7.25 (d, <i>J</i> = 8.3 Hz, 2H), 7.20 (d, <i>J</i> = 8.2 Hz, 2H), 7.12 (d, <i>J</i> = 8.2 Hz, 2H), 6.85 (d, <i>J</i> = 8.6 Hz, 1H), 6.12 (m, 1H), 6.05â6.02 (m, 1H), 5.09 (s, 2H), 3.64 (m, 2H), 3.21 (m, 2H), 1.68â1.62 (m, 4H), 1.48 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.0, 171.8, 162.2, 159.5, 145.8, 139.4, 135.7, 134.2, 132.0, 130.1, 129.3, 128.4, 121.1, 114.2, 107.6, 103.7, 54.0, 25.5, 23.9. LRMS (ESI) <i>m</i>/<i>z</i> 488 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>28</sub>H<sub>30</sub>N<sub>3</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 488.2185. Found: 488.2181.</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>N</i>-(4-Acetamidobenzyl)-2,4-dihydroxy-<i>N</i>-(4-(morpholine-4-carbonyl)phenyl)benzamide (<b>15f</b>)</h5><div class="NLM_p last">Compound <b>14</b> (200 mg, 0.48 mmol) was converted to the target compound using general procedure A. The crude product was purified using flash column chromatography (5% MeOH/DCM to 10% MeOH/DCM) on silica gel to afford <b>15f</b> (65.7 mg, 28%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.45 (d, <i>J</i> = 8.5 Hz, 2H), 7.26â7.23 (m, 4H), 7.15â7.13 (m, 2H), 6.86 (d, <i>J</i> = 8.5 Hz, 1H), 6.12 (d, <i>J</i> = 2.3 Hz, 1H), 6.04 (dd, <i>J</i> = 2.3, 8.5 Hz, 1H), 5.09 (s, 2H), 3.72â3.53 (m, 8H), 2.09 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 172.9, 171.9, 171.7, 162.1, 159.4, 146.1, 139.4, 134.8, 134.2, 132.0, 130.1, 129.3, 128.8, 121.2, 114.4, 107.7, 103.6, 67.8, 53.9, 49.8, 49.6, 49.4, 49.2, 48.9, 48.7, 48.5, 23.9. LRMS (ESI) <i>m</i>/<i>z</i> 490 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>28</sub>N<sub>3</sub>O<sub>6</sub><sup>+</sup> [M + H]<sup>+</sup>: 490.1978. Found: 490.1977.</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> <i>N</i>-(4-Acetamidobenzyl)-2,4-dihydroxy-<i>N</i>-(4-(pyrrolidine-1-carbonyl)phenyl)benzamide (<b>15g</b>)</h5><div class="NLM_p last">Compound <b>14</b> (200 mg, 0.48 mmol) was converted to the target compound using general procedure A. The crude product was purified using flash column chromatography (5% MeOH/DCM to 10% MeOH/DCM) on silica gel to afford <b>15g</b> (93.1 mg, 41%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.45 (d, <i>J</i> = 8.6 Hz, 2H), 7.34 (d, <i>J</i> = 8.4 Hz, 2H), 7.25 (d, <i>J</i> = 8.6 Hz, 2H), 7.12 (d, <i>J</i> = 8.6 Hz, 2H), 6.85 (d, <i>J</i> = 8.6 Hz, 1H), 6.13 (d, <i>J</i> = 2.3 Hz, 1H), 6.04 (dd, <i>J</i> = 2.3, 8.6 Hz, 1H), 5.09 (s, 2H), 3.52 (t, <i>J</i> = 7.0 Hz, 2H), 3.30â3.29 (m, 2H), 1.97â1.91 (m, 2H), 1.88â1.82 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 172.9, 171.7, 171.2, 162.2, 159.7, 146.2, 139.4, 136.3, 134.3, 132.1, 130.1, 129.0, 128.8, 121.2, 114.0, 107.7, 103.7, 54.0, 50.9, 47.6, 27.3, 25.4, 23.9. LRMS (ESI) <i>m</i>/<i>z</i> 474 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>28</sub>N<sub>3</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 474.2029. Found: 474.2026.</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> General Procedure B</h5><div class="NLM_p last">Round flask A: To a solution of <b>16</b> (1.0 equiv) in dry MeOH (0.15 M) were added various aldehydes (1.2 equiv) and acetic acid (0.1 equiv). The reaction mixture was stirred at room temperature for 10 min and treated slowly with NaBH<sub>3</sub>CN (1.5 equiv). The reaction mixture was then stirred for 5 h at room temperature and diluted with H<sub>2</sub>O and NaHCO<sub>3</sub>. The aqueous layer was extracted with DCM. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Round flask B: To a solution of <b>10a</b> (2.0 equiv) in dry DCM (0.6 M) was added oxalyl chloride (10 equiv) and DMF (0.1 equiv) at 0 Â°C. The reaction mixture was stirred at room temperature for 2 h and concentrated under reduced pressure. Round flask A residue was transferred to round flask B with dry DMF (0.3 M). After cooling to 0 Â°C, the mixture was treated dropwise with DIPEA (3.0 equiv) and stirred at room temperature for 2 h. The mixture was diluted with H<sub>2</sub>O and extracted with EtOAc. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. To a solution of the resulting residue in MeOH (0.1 M) was added K<sub>2</sub>CO<sub>3</sub> (5.0 equiv). The reaction mixture was stirred at room temperature for 1 h, concentrated under reduced pressure, and diluted with EtOAc. The organic layer was washed with H<sub>2</sub>O, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was subjected to flash column chromatography on silica gel.</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>N</i>-Benzyl-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19a</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19a</b> (104.9 mg, 22%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 11.39 (bs, 1H), 8.04 (bs, 1H), 7.29â7.26 (m, 7H), 7.04 (d, <i>J</i> = 8.4 Hz, 2H), 6.51 (d, <i>J</i> = 8.9 Hz, 1H), 6.36 (d, <i>J</i> = 2.5 Hz, 1H), 5.82 (dd, <i>J</i> = 2.5, 8.9 Hz, 1H), 5.10 (s, 2H), 3.10 (s, 3H), 2.93 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 171.7, 171.2, 163.4, 161.3, 145.7, 136.9, 133.8, 132.2, 128.6, 128.4, 128.1, 127.5, 127.0, 107.6, 106.8, 103.6, 54.4, 39.7, 35.6. LRMS (ESI) <i>m</i>/<i>z</i> 391 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>: 391.1658. Found: 391.1653.</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-<i>N</i>-(4-fluorobenzyl)-2,4-dihydroxybenzamide (<b>19b</b>)</h5><div class="NLM_p last">Compound <b>16</b> (0.5 g, 2.10 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography on silica gel (35% THF/hexane to 70% THF/hexane) to afford <b>19b</b> (154.29 mg, 18%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.33 (dd, <i>J</i> = 5.4, 8.6 Hz, 2H), 7.25 (d, <i>J</i> = 8.4 Hz, 2H), 7.13 (d, <i>J</i> = 8.6 Hz, 2H), 6.99 (t, <i>J</i> = 8.9 Hz, 2H), 6.86 (d, <i>J</i> = 8.6 Hz, 1H), 6.13 (d, <i>J</i> = 2.3 Hz, 1H), 6.04 (dd, <i>J</i> = 2.3, 8.6 Hz, 1H), 5.12 (s, 2H), 3.04 (s, 3H), 2.87 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.1, 173.0, 163.7 (d, <i>J</i><sub>CâF</sub> = 242 Hz), 162.2, 159.7, 145.9, 135.7, 134.7 (d, <i>J</i><sub>CâF</sub> = 4 Hz), 132.1, 131.6 (d, <i>J</i><sub>CâF</sub> = 8 Hz), 129.0, 128.8, 116.2 (d, <i>J</i><sub>CâF</sub> = 22 Hz), 114.0, 107.7, 103.7, 53.7, 40.0, 35.7. LRMS (ESI) <i>m</i>/<i>z</i> 409 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>22</sub>FN<sub>2</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>: 409.1564. Found: 409.1553.</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>N</i>-(4-Chlorobenzyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19c</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19c</b> (140.0 mg, 27%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.33â7.31 (m, 2H), 7.28â7.24 (m, 4H), 7.15â7.13 (m, 2H), 6.87 (d, <i>J</i> = 8.6 Hz, 1H), 6.13 (d, <i>J</i> = 2.2 Hz, 1H), 6.05 (dd, <i>J</i> = 2.2, 8.5 Hz, 1H), 5.12 (s, 2H), 3.04 (s, 3H), 2.88 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.1, 173.0, 162.3, 159.6, 145.9, 137.5, 135.7, 134.4, 132.1, 131.2, 129.7, 129.0, 128.8, 114.0, 107.7, 103.7, 53.8, 40.0, 35.7. LRMS (ESI) <i>m</i>/<i>z</i> 425 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>: 425.1268. Found: 425.1263.</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-2,4-dihydroxy-<i>N</i>-(4-(trifluoromethyl)benzyl)benzamide (<b>19d</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19d</b> (106.4 mg, 19%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.55 (d, <i>J</i> = 8.1 Hz, 2H), 7.42 (d, <i>J</i> = 8.1 Hz, 2H), 7.32 (d, <i>J</i> = 8.4 Hz, 2H), 7.06 (d, <i>J</i> = 8.4 Hz, 2H), 6.54 (d, <i>J</i> = 8.8 Hz, 1H), 6.38 (d, <i>J</i> = 2.4 Hz, 1H), 5.85 (dd, <i>J</i> = 2.4, 8.9 Hz, 1H), 5.15 (s, 2H), 3.12 (s, 3H), 2.94 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.6, 159.9, 156.4, 143.9, 142.8, 134.0, 130.5, 128.3, 127.8 (q, <i>J</i><sub>CâF</sub> = 31 Hz), 127.4, 126.6, 125.3 (q, <i>J</i><sub>CâF</sub> = 4 Hz), 124.4 (q, <i>J</i><sub>CâF</sub> = 270 Hz), 114.1, 106.5, 102.4, 52.2, 34.8. LRMS (ESI) <i>m</i>/<i>z</i> 459 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>22</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>: 459.1532. Found: 459.1530.</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-2,4-dihydroxy-<i>N</i>-(4-nitrobenzyl)benzamide (<b>19e</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19e</b> (164.9 mg, 31%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.18 (d, <i>J</i> = 8.8 Hz, 2H), 7.62 (d, <i>J</i> = 8.8 Hz, 2H), 7.19 (d, <i>J</i> = 8.5 Hz, 2H), 7.11 (d, <i>J</i> = 8.5 Hz, 2H), 6.93 (d, <i>J</i> = 8.41 Hz, 1H), 6.09â6.06 (m, 2H), 5.20 (s, 2H), 2.91 (s, 3H), 2.77 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.1, 173.0, 162.4, 159.5, 148.8, 146.5, 145.9, 135.8, 132.2, 130.3, 128.9, 128.7, 124.7, 113.9, 107.8, 103.7, 54.0, 40.0, 35.7. LRMS (ESI) <i>m</i>/<i>z</i> 436 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>6</sub><sup>+</sup> [M + H]<sup>+</sup>: 436.1508. Found: 436.1508.</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>N</i>-(4-Cyanobenzyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19f</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19f</b> (142.1 mg, 28%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.66 (d, <i>J</i> = 8.4 Hz, 2H), 7.55 (d, <i>J</i> = 8.4 Hz, 2H), 7.26 (d, <i>J</i> = 8.6 Hz, 2H), 7.17 (d, <i>J</i> = 8.7 Hz, 2H), 6.91 (d, <i>J</i> = 8.6 Hz, 1H), 6.12 (d, <i>J</i> = 2.2 Hz, 1H), 6.07 (dd, <i>J</i> = 2.3, 8.5 Hz, 1H), 5.22 (s, 2H), 3.04 (s, 3H), 2.88 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.1, 173.0, 162.4, 159.5, 145.9, 144.6, 135.8, 133.5, 132.2, 130.3, 128.9, 128.7, 119.7, 113.9, 112.3, 107.8, 103.7, 54.3, 40.0, 35.7. LRMS (ESI) <i>m</i>/<i>z</i> 416 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>: 416.1610. Found: 416.1600.</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-2,4-dihydroxy-<i>N</i>-(4-hydroxybenzyl)benzamide (<b>19g</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19g</b> (89.4 mg, 18%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.23 (d, <i>J</i> = 8.6 Hz, 2H), 7.10 (d, <i>J</i> = 8.4 Hz, 4H), 6.83 (d, <i>J</i> = 8.6 Hz, 1H), 6.66 (d, <i>J</i> = 8.6 Hz, 2H), 6.13 (d, <i>J</i> = 2.3 Hz, 1H), 6.03 (dd, <i>J</i> = 2.3, 8.6 Hz, 1H), 5.02 (s, 2H), 3.04 (s, 3H), 2.87 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.2, 172.8, 162.1, 159.8, 158.0, 145.9, 135.5, 132.1, 131.1, 129.3, 129.2, 129.2, 128.6, 116.3, 114.0, 107.6, 103.7, 54.0, 40.0, 35.7. LRMS (ESI) <i>m</i>/<i>z</i> 407 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>23</sub>N<sub>2</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 407.1607. Found: 407.1603.</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-2,4-dihydroxy-<i>N</i>-(naphthalen-2-ylmethyl)benzamide (<b>19h</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19h</b> (161.4 mg, 30%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.86 (d, <i>J</i> = 8.4 Hz, 2H), 7.83â7.80 (m, 2H), 7.51â7.46 (m, 3H), 7.16 (d, <i>J</i> = 8.1 Hz, 2H), 7.12 (d, <i>J</i> = 8.3 Hz, 2H), 6.92 (d, <i>J</i> = 8.4 Hz, 1H), 6.11 (s, 1H), 6.06 (d, <i>J</i> = 8.3 Hz, 1H), 5.23 (s, 2H), 2.88 (s, 3H), 2.73 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.2, 173.1, 162.2, 159.5, 146.0, 136.1, 135.6, 134.9, 134.4, 132.1, 129.4, 129.1, 128.9, 128.8, 128.6, 128.4, 127.5, 127.3, 127.1, 114.3, 107.7, 103.7, 54.5, 40.0, 35.7. LRMS (ESI) <i>m</i>/<i>z</i> 441 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>: 441.1814. Found: 441.1803.</div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-2,4-dihydroxy-<i>N</i>-neopentylbenzamide (<b>19i</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19i</b> (117.7 mg, 26%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.31â7.26 (m, 4H), 6.76 (d, <i>J</i> = 8.4 Hz, 1H), 6.08 (d, <i>J</i> = 2.1 Hz, 1H), 6.06â6.03 (m, 1H), 3.93 (s, 2H), 3.06 (s, 3H), 2.89 (s, 3H), 0.90 (s, 9H); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>) Î´ 172.7, 170.7, 163.4, 162.1, 147.2, 135.9, 132.9, 129.1, 128.2, 110.4, 106.9, 103.9, 60.8, 34.9, 29.2. LRMS (ESI) <i>m</i>/<i>z</i> 371 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>: 371.1971. Found: 371.1972.</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>N</i>-(Cyclohexylmethyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19j</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19j</b> (67.5 mg, 17%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.33 (d, <i>J</i> = 8.6 Hz, 2H), 7.25 (d, <i>J</i> = 8.6 Hz, 2H), 6.78 (d, <i>J</i> = 8.4 Hz, 1H), 6.11 (d, <i>J</i> = 2.2 Hz, 1H), 6.03 (dd, <i>J</i> = 2.2, 8.6 Hz, 1H), 3.79 (d, <i>J</i> = 7.3 Hz, 2H), 3.07 (s, 3H), 2.93 (s, 3H), 1.79â1.71 (m, 4H), 1.64â1.54 (m, 2H), 1.20â1.12 (m, 3H), 1.07â0.99 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.2, 173.1, 161.8, 159.1, 146.5, 135.5, 131.8, 128.9, 128.9, 114.9, 107.6, 103.6, 56.9, 40.1, 37.9, 35.8, 32.2, 27.7, 27.1. LRMS (ESI) <i>m</i>/<i>z</i> 397 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>29</sub>N<sub>2</sub>O<sub>4</sub><sup>+</sup> [M + H]<sup>+</sup>: 397.2127. Found: 397.2127.</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-<i>N</i>-(furan-2-ylmethyl)-2,4-dihydroxybenzamide (<b>19k</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19k</b> (181.3 mg, 39%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.39 (s, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 7.17 (d, <i>J</i> = 8.3 Hz, 2H), 6.81 (d, <i>J</i> = 8.6 Hz, 1H), 6.30â6.25 (m, 2H), 6.14 (d, <i>J</i> = 2.2 Hz, 1H), 6.02 (dd, <i>J</i> = 2.2, 8.6 Hz, 1H), 5.07 (s, 2H), 3.05 (s, 3H), 2.90 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.2, 172.8, 162.3, 160.0, 152.1, 146.0, 143.6, 135.8, 132.2, 129.0, 128.8, 113.6, 111.5, 110.2, 107.6, 103.7, 47.6, 40.1, 35.8. LRMS (ESI) <i>m</i>/<i>z</i> 381 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>21</sub>N<sub>2</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 381.1451. Found: 381.1450.</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-2,4-dihydroxy-<i>N</i>-((5-methylfuran-2-yl)methyl)benzamide (<b>19l</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19l</b> (139.8 mg, 29%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.92 (bs, 1H), 9.57 (bs, 1H), 7.22 (d, <i>J</i> = 8.2 Hz, 2H), 7.10 (d, <i>J</i> = 8.2 Hz, 2H), 6.80 (d, <i>J</i> = 8.4 Hz, 1H), 6.09â6.08 (m, 2H), 6.03 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 5.94â5.93 (m, 1H), 4.93 (s, 2H), 2.93 (s, 3H), 2.80 (s, 3H), 2.18 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.5, 169.0, 159.7, 156.6, 150.8, 148.9, 143.6, 134.0, 130.2, 127.1, 126.8, 113.6, 109.0, 106.4, 106.2, 102.3, 45.7, 13.2. LRMS (ESI) <i>m</i>/<i>z</i> 395 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>23</sub>N<sub>2</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 395.1607. Found: 395.1604.</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> <i>N</i>-((5-Chlorofuran-2-yl)methyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19m</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19m</b> (212.6 mg, 42%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.27 (d, <i>J</i> = 8.1 Hz, 2H), 7.13 (m, <i>J</i> = 8.1 Hz, 2H), 6.47 (d, <i>J</i> = 9.1 Hz, 1H), 6.33 (s, 2H), 5.71 (s, 1H), 5.54 (d, <i>J</i> = 8.7 Hz, 1H), 4.94 (s, 2H), 2.93 (s, 3H), 2.84 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 170.9, 170.0, 151.9, 144.9, 134.2, 134.1, 131.0, 127.9, 126.9, 111.4, 108.0, 103.4, 46.3, 35.2. LRMS (ESI) <i>m</i>/<i>z</i> 415 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 415.1061. Found: 415.1058.</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> <i>N</i>-((5-Bromofuran-2-yl)methyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19n</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19n</b> (184.8 mg, 33%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.31 (d, <i>J</i> = 8.7 Hz, 2H), 7.19 (d, <i>J</i> = 8.7 Hz, 2H), 6.83 (d, <i>J</i> = 8.6 Hz, 1H), 6.31 (m, 1H), 6.28â6.27 (m, 1H), 6.12 (d, <i>J</i> = 2.2 Hz, 1H), 6.03 (dd, <i>J</i> = 2.3, 8.6 Hz, 1H), 5.05 (s, 2H), 3.06 (s, 3H), 2.91 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.1, 172.8, 162.4, 159.9, 159.9, 154.4, 145.8, 135.9, 132.2, 129.0, 128.8, 122.3, 113.4, 113.1, 107.7, 103.7, 47.5, 40.1, 35.8. LRMS (ESI) <i>m</i>/<i>z</i> 459 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>20</sub>BrN<sub>2</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 459.0556. Found: 459.0545.</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-2,4-dihydroxy-<i>N</i>-((5-iodofuran-2-yl)methyl)benzamide (<b>19o</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19o</b> (278.3 mg, 45%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.25 (d, <i>J</i> = 8.4 Hz, 2H), 7.12 (d, <i>J</i> = 8.3 Hz, 2H), 6.63 (d, <i>J</i> = 8.7 Hz, 1H), 6.34 (s, 2H), 5.92 (d, <i>J</i> = 1.8 Hz, 1H), 5.80â5.77 (m, 1H), 4.96 (s, 2H), 2.93 (s, 3H), 2.81 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.5, 169.0, 159.8, 156.4, 156.2, 143.4, 134.1, 130.3, 127.1, 126.7, 120.6, 113.7, 111.2, 106.3, 102.2, 90.3, 45.5. LRMS (ESI) <i>m</i>/<i>z</i> 507 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>20</sub>IN<sub>2</sub>O<sub>5</sub><sup>+</sup> [M + H]<sup>+</sup>: 507.0417. Found: 507.0416.</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> <i>N</i>-((5-Bromothiophen-2-yl)methyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19p</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19p</b> (249.2 mg, 43%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.35 (d, <i>J</i> = 8.6 Hz, 2H), 7.07 (d, <i>J</i> = 8.4 Hz, 2H), 6.80 (d, <i>J</i> = 3.8 Hz, 1H), 6.57 (d, <i>J</i> = 3.7 Hz, 1H), 6.51 (d, <i>J</i> = 8.9 Hz, 1H), 6.37 (d, <i>J</i> = 2.5 Hz, 1H), 5.84 (dd, <i>J</i> = 2.5, 8.9 Hz, 1H), 5.08 (s, 2H), 3.12 (s, 3H), 2.97 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.1, 173.0, 162.7, 160.5, 145.6, 142.8, 136.0, 132.5, 130.5, 129.3, 129.1, 129.0, 113.5, 112.8, 107.8, 103.7, 50.1, 40.1, 35.8. LRMS (ESI) <i>m</i>/<i>z</i> 475 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>20</sub>BrN<sub>2</sub>O<sub>4</sub>S<sup>+</sup> [M + H]<sup>+</sup>: 475.0327. Found: 475.0327.</div></div><div id="sec4_1_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> <i>N</i>-((5-Cyanothiophen-2-yl)methyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19q</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19q</b> (123.6 mg, 24%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.87 (bs, 1H), 9.67 (bs, 1H), 7.77 (d, <i>J</i> = 3.8 Hz, 1H), 7.23 (d, <i>J</i> = 8.4 Hz, 2H), 7.10â7.08 (m, 3H), 6.87 (d, <i>J</i> = 8.3 Hz, 1H), 6.08â6.04 (m, 2H), 5.23 (s, 2H), 2.92 (s, 3H), 2.79 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.9, 169.9, 160.6, 157.1, 149.6, 143.5, 139.0, 134.7, 131.0, 128.3, 127.8, 127.2, 114.9, 113.6, 108.3, 106.9, 102.7, 48.3, 35.1. LRMS (ESI) <i>m</i>/<i>z</i> 422 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>S<sup>+</sup> [M + H]<sup>+</sup>: 422.1175. Found: 422.1175.</div></div><div id="sec4_1_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> <i>N</i>-((2-Bromothiazol-5-yl)methyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19r</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19r</b> (220.7 mg, 38%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.90 (bs, 1H), 9.64 (bs, 1H), 7.47 (s, 1H), 7.24 (d, <i>J</i> = 8.2 Hz, 2H), 7.07 (d, <i>J</i> = 8.2 Hz, 2H), 6.85 (d, <i>J</i> = 8.3 Hz, 1H), 6.07â6.04 (m, 2H), 5.13 (s, 2H), 2.93 (s, 3H), 2.80 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.5, 169.4, 160.1, 156.7, 142.9, 142.0, 138.8, 136.4, 134.3, 130.6, 127.4, 126.8, 113.0, 106.4, 102.2, 54.9, 45.7, 34.7. LRMS (ESI) <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>19</sub>BrN<sub>3</sub>O<sub>4</sub>S<sup>+</sup> [M + H]<sup>+</sup>: 476.0280. Found: 476.0269.</div></div><div id="sec4_1_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> <i>N</i>-((5-Bromothiazol-2-yl)methyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19s</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19s</b> (110.3 mg, 19%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.79 (s, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 2H), 7.17 (d, <i>J</i> = 8.4 Hz, 2H), 6.87 (d, <i>J</i> = 8.2 Hz, 1H), 6.09â6.06 (m, 2H), 5.28 (s, 2H), 2.93 (s, 3H), 2.80 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.4, 169.4, 168.7, 160.1, 156.5, 143.3, 134.2, 130.4, 127.3, 126.5, 122.7, 119.2, 113.2, 106.4, 102.2, 50.8, 34.7. LRMS (ESI) <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>19</sub>BrN<sub>3</sub>O<sub>4</sub>S<sup>+</sup> [M + H]<sup>+</sup>: 476.0280. Found: 476.0274.</div></div><div id="sec4_1_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> <i>N</i>-((4-Bromothiophen-2-yl)methyl)-<i>N</i>-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxybenzamide (<b>19t</b>)</h5><div class="NLM_p last">Compound <b>16</b> (200 mg, 1.22 mmol) was converted to the target compound using general procedure B. The crude product was purified using flash column chromatography (30% THF/hexane to 70% THF/hexane) on silica gel to afford <b>19t</b> (127.5 mg, 22%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.91 (s, 1H), 9.61 (s, 1H), 7.53 (m, 1H), 7.23 (d, <i>J</i> = 8.3 Hz, 2H), 7.08 (d, <i>J</i> = 8.2 Hz, 2H), 6.92 (s, 1H), 6.84 (d, <i>J</i> = 8.4 Hz, 1H), 6.08 (d, <i>J</i> = 2.0 Hz, 1H), 6.05 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 5.15 (s, 2H), 2.93 (s, 3H), 2.80 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 169.4, 169.3, 160.0, 156.7, 143.2, 142.2, 134.1, 130.4, 128.7, 127.3, 126.7, 123.7, 113.3, 107.6, 106.3, 102.2, 47.5, 34.7. LRMS (ESI) <i>m</i>/<i>z</i> 475 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>20</sub>BrN<sub>2</sub>O<sub>4</sub>S<sup>+</sup> [M + H]<sup>+</sup>: 475.0327. Found: 475.0322.</div></div><div id="sec4_1_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-<i>N</i>-(4-fluorobenzyl)-4-hydroxybenzamide (<b>21a</b>)</h5><div class="NLM_p last">Compound <b>16</b> (0.5 g, 2.78 mmol) was converted to the target compound using general procedure B except using <b>10b</b> instead of <b>10a</b>. The crude product was purified using flash column chromatography on silica gel (35% THF/hexane to 70% THF/hexane) to afford <b>21a</b> (239.75 mg, 22%) as a solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 7.31 (dd, <i>J</i> = 5.4, 8.6 Hz, 2H), 7.26 (d, <i>J</i> = 8.4 Hz, 2H), 7.22 (d, <i>J</i> = 8.7 Hz, 2H), 7.08 (d, <i>J</i> = 8.4 Hz, 2H), 6.99 (t, <i>J</i> = 8.8 Hz, 2H), 6.58 (d, <i>J</i> = 8.7 Hz, 2H), 5.15 (s, 2H), 3.04 (s, 3H), 2.87 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.0, 163.7 (d, <i>J</i><sub>CâF</sub> = 244 Hz), 161.0, 146.2, 135.6, 134.7 (d, <i>J</i><sub>CâF</sub> = 3 Hz), 132.3, 131.6 (d, <i>J</i><sub>CâF</sub> = 8 Hz), 129.3, 129.1, 127.5, 116.3 (d, <i>J</i><sub>CâF</sub> = 22 Hz), 115.8, 53.9, 40.0, 35.7. LRMS (ESI) <i>m</i>/<i>z</i> 393 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>22</sub>FN<sub>2</sub>O<sub>3</sub><sup>+</sup> [M + H]<sup>+</sup>: 393.1614. Found: 393.1610.</div></div><div id="sec4_1_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> <i>N</i>-(4-(Dimethylcarbamoyl)phenyl)-<i>N</i>-(4-fluorobenzyl)-2-hydroxybenzamide (<b>21b</b>)</h5><div class="NLM_p last">Compound <b>16</b> (0.5 g, 2.78 mmol) was converted to the target compound using general procedure B except using <b>10c</b> instead of <b>10a</b>. The crude product was purified using flash column chromatography on silica gel (35% THF/hexane to 70% THF/hexane) to afford <b>21b</b> (272.44 mg, 25%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.36 (dd, <i>J</i> = 5.6, 8.4 Hz, 2H), 7.15â7.09 (m, 7H), 7.06â7.03 (m, 1H), 6.67â6.64 (m, 2H), 5.05 (s, 2H), 2.89 (s, 3H), 2.71 (s, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) Î´ 173.0, 172.3, 163.7 (d, <i>J</i><sub>CâF</sub> = 243 Hz), 155.6, 144.8, 136.1, 134.7 (d, <i>J</i><sub>CâF</sub> = 2 Hz), 132.1, 131.5 (d, <i>J</i><sub>CâF</sub> = 8 Hz), 129.9, 129.3, 128.5, 124.8, 120.1, 116.9, 116.3 (d, <i>J</i><sub>CâF</sub> = 22 Hz), 53.4, 39.9, 35.7. LRMS (ESI) <i>m</i>/<i>z</i> 393 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>22</sub>FN<sub>2</sub>O<sub>3</sub><sup>+</sup> [M + H]<sup>+</sup>: 393.1614. Found: 393.1603.</div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Molecular Docking Study</h4><div class="NLM_p last">Co-crystal structures of the PDHK1 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8G">2Q8G</a>), PDHK2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V26">4V26</a>), PDHK3 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8I">2Q8I</a>), and PDHK4 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E0A">2E0A</a>) were retrieved from the Protein Data Bank. Molecular docking studies and molecular dynamics (MD) simulation studies were carried out by methods previously reported.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Cell Culture and Maintenance</h4><div class="NLM_p last">H1299 and DU145 cells were obtained from Korean Cell Line Bank, Korean Cell Line Research Foundation, and incubated in RPMI supplied with 10% fetal bovine serum and 1% penicillin/streptomycin (Welgene, Seoul, Korea).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Antiproliferation Assay</h4><div class="NLM_p">The day before treatment with compounds, cells were seeded at a density of 3 Ã 10<sup>3</sup> in each well of a 96-well plate. A 3-fold serial dilution of each test compound in 1% DMSO (maximum concentration is 100 Î¼M, 10 points) was added to each well. After 72 h of incubation, the number of viable cells was determined using a conventional CellTiter glo assay (Promega, Fitchburg, WI, USA) and the GI<sub>50</sub> was calculated using GraphPad Prism 6.0 software (GraphPad). Each experiment was performed three times independently in duplicate mode. Sodium dichloroacetate (347795) was purchased from Sigma (St. Louis, MO, USA).</div><div class="NLM_p last">PDHKs siRNA (200 nM of each) (AccuTarget, Bioneer, Korea) were transfected into 1 Ã 10<sup>6</sup> H1299 cells using Lipofectamine RNAi max (Thermo No. 13778030) following the manufacturerâs instruction. After 24 h of transfection, the cells were transferred into 96-well plates and incubated with the indicated compounds for a further 48 h. Cell proliferation was measured using CellTiter-Glo Reagent (Promega, Fitchburg, WI, USA).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> PDH Assay</h4><div class="NLM_p last">PDC activity was determined in 96-well microplates at 33 Â°C with a total volume of 200 Î¼L. To the wells was added to 176 Î¼L of the reaction cocktail comprised of 100 mM TrisâHCl (pH 7.8), 0.5 mM EDTA, 1 mM MgCl<sub>2</sub>, 1 mM thiamine pyrophosphate, 5 mM Î²-mercaptoethanol, 0.5 mM NAD<sup>+</sup>, and 0.1 mM CoA. The assay was carried out using 50 mM potassium phosphate buffer (pH 7.8), 20 mM potassium fluoride, 1 mM MgCl<sub>2</sub>, PDC, and PDK4. The activity of PDH was measured using a VersaMax microplate reader (Molecular Devices, Sunnyvale, CA, USA) at 33 Â°C by the rate of NAD<sup>+</sup> reduction for 30 min.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Western Blot</h4><div class="NLM_p last">Cells (2 Ã 10<sup>5</sup> per well in a six-well plate) were incubated overnight for adherence. The culture medium was changed to serum free growth medium for 5 h. Thereafter, cells were treated with test compounds at the proper time and concentration. Cells were lysed with lysis buffer (1% NP40, 150 mM NaCl, 50 mM Tris (PH 7.5), and 1 mM EDTA), and equal amounts of proteins were separated by using 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were electrophoretically transferred to a 0.45 Î¼m polyvinylidene difluoride (PVDF) membrane (Millipore, Temecula, CA, USA). After blocking in 1Ã TBS/T containing 5% skim milk for 30 min, primary antibodies diluted 1:1000 in 0.05% TBS/T were incubated for 1 h and followed by washing three times. Thereafter, the blots were incubated with 1:2000 dilutions of horseradish peroxidase conjugated secondary antibodies (Santa Cruz Biotechnology) for 30 min. As the last step, enhanced chemiluminescence solution (Lugen, Seoul, Korea) was dropped on the membrane and exposed to X-ray film (Agfa, Japan). The following antibodies were used: Î²-actin (sc-47778), HRP-conjugated donkey antirabbit secondary antibody (sc-2305), and HRP-conjugated donkey antimouse secondary antibody (sc-2318) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); cleaved caspase3 (9661S) (Cell Signaling Technologies, Danvers, MA, USA); and phosphor-PDHE1a (S293) (abcam).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> DCF-DA Staining</h4><div class="NLM_p last">Cells were plated at 0.5 Ã 10<sup>6</sup> cells per well in a six-well plate. After cells were adherent, they were treated with the indicated concentrations of compounds for 5 h before staining with 10 Î¼M DCF-DA (sigma) for 30 min and washed with PBS twice. For the FACS analysis, compound treated cells were trypsinized. Thereafter, fluorescence was determined by using FACS.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> JC-1 Staining</h4><div class="NLM_p last">Cells were plated at 1 Ã 10<sup>5</sup> cells per well in a 35 mm confocal plate. After cells were adherent, they were treated with the indicated compounds for 5 h. Cells were then stained with 10 Î¼M JC-1 (Sigma) for 30 min and washed with PBS twice. Fluorescence was monitored by using fluorescence microscopy (Nikon).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Measuring Energy Metabolism by an XF-96 XF Analyzer</h4><div class="NLM_p last">The oxygen consumption rate (OCR) was measured using an XFe96 Extracellular Flux Analyzer (Seahorse Bioscience, Billerica, MA, USA) according to the manufacturerâs protocol. H1299 cells were seeded in XFe96 tissue culture plates at a density of 2 Ã 10<sup>4</sup> cells/well. The next day, the medium was replaced with XF base medium (pH 7.4, Seahorse Biosciences) supplemented with 25 mM <span class="smallcaps smallerCapital">d</span>-glucose (Sigma-Aldrich; G7528), 1 mM sodium pyruvate (Sigma-Aldrich; S8636), and 1Ã GlutaMAX (Gibco; 35050) and XF Base Media (pH 7.4, Seahorse Biosciences) with 1 mM glutamine (Sigma-Aldrich; G8540) followed by appropriate drug treatment, respectively. To measure the OCR, the inhibitors used in this study were as follows: oligomycin A (1 Î¼M, Sigma-Aldrich; 75351), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP; 2 Î¼M, Sigma-Aldrich; C2920), rotenone (1 Î¼M, Sigma-Aldrich; R8875), and antimycin A (1 Î¼M, Sigma-Aldrich; A8674). For the normalization, DAPI stained cells were counted by the microscopy automatically (BioTek Lionheart FX, The Netherlands).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Apoptosis Analysis</h4><div class="NLM_p last">Cells were plated on 60 mm<sup>2</sup> dishes and incubated overnight prior to addition of test compounds. The indicated concentration of compounds was exposed for 48 h. Trypsinized cells were costained with Alexafluor488 conjugated annexinV (A13201) and propidium iodide (P3560) followed by instruction (Thermo Fisher Scientific, Waltham, MA, USA). Thereafter, apoptotic cells were analyzed by FACS Canto II (Becton Dickinson, San Jose, CA, USA).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Anchorage-Independent Assay</h4><div class="NLM_p last">For preparing the 0.6% bottom layer, six-well plates were covered with a 1:1 mixture of 1.2% low melting agarose (50080, Lonza) and 2Ã growth media. After agar solidification, 3000 cells per well were included in 1 mL of 0.3% agarose (top layer). One day later, growth media containing DMSO or test compounds was added, and incubation was performed for 2 w. Spheroids were stained using 2 mg/mL of <i>p</i>-iodonitrotetrazolium violet (I8377) (Sigma, St. Louis, MO, USA). Colonies in each well were analyzed by using Image J software. All experiments were performed in triplicate.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00565" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00565" class="ext-link">10.1021/acs.jmedchem.9b00565</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00565/suppl_file/jm9b00565_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Ligand interaction diagrams of molecular dynamic simulations of <b>6</b> with PDHK isoforms, <i>in vitro</i> selectivity profiling of <b>19b</b> at 1 Î¼Î against 366 human kinase, <i>in vitro</i> selectivity profiling of <b>19t</b> at 1 Î¼Î against 366 human kinase, overall kinase selectivity profiling of <b>19b</b>, inhibitory activities of <b>19n</b> at three different ATP concentration against PDHK1/2/3, antiproliferation assay of compound <b>6</b> and <b>19n</b> in H1299 and DU145, knockdown of PDHK expression affects the antiproliferative activity of <b>19n</b> on H1299 cells, 1H, 13C NMR spectra and HPLC traces of all final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00565/suppl_file/jm9b00565_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00565/suppl_file/jm9b00565_si_001.csv">jm9b00565_si_001.csv (3.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00565/suppl_file/jm9b00565_si_002.pdf">jm9b00565_si_002.pdf (9.63 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00565" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taebo Sim</span> - <span class="hlFld-Affiliation affiliation">KU-KIST
Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea</span>;Â 
    <span class="hlFld-Affiliation affiliation">Chemical
Kinomics Research Center, Korea Institute
of Science and Technology (KIST), 5 Hwarangro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3015-2059" title="Orcid link">http://orcid.org/0000-0003-3015-2059</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#95e1f7e6fcf8d5fefce6e1bbe7f0bbfee7b5e1f7e6fcf8d5fefae7f0f4bbf4f6bbfee7"><span class="__cf_email__" data-cfemail="671305140e0a270c0e1413491502490c15">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="661204150f0b260d09140307480705480d14">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanna Cho</span> - <span class="hlFld-Affiliation affiliation">KU-KIST
Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Injae Shin</span> - <span class="hlFld-Affiliation affiliation">KU-KIST
Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyungseon Cho</span> - <span class="hlFld-Affiliation affiliation">Chemical
Kinomics Research Center, Korea Institute
of Science and Technology (KIST), 5 Hwarangro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hojong Yoon</span> - <span class="hlFld-Affiliation affiliation">Chemical
Kinomics Research Center, Korea Institute
of Science and Technology (KIST), 5 Hwarangro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9334-0252" title="Orcid link">http://orcid.org/0000-0002-9334-0252</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eun Kyung Yoo</span> - <span class="hlFld-Affiliation affiliation">Leading-Edge
Research Center for Drug Discovery and Development for Diabetes and
Metabolic Disease, Kyungpook National University
Hospital, Daegu 41404, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mi-Jin Kim</span> - <span class="hlFld-Affiliation affiliation">Leading-Edge
Research Center for Drug Discovery and Development for Diabetes and
Metabolic Disease, Kyungpook National University
Hospital, Daegu 41404, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sungmi Park</span> - <span class="hlFld-Affiliation affiliation">Leading-Edge
Research Center for Drug Discovery and Development for Diabetes and
Metabolic Disease, Kyungpook National University
Hospital, Daegu 41404, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">In-Kyu Lee</span> - <span class="hlFld-Affiliation affiliation">Leading-Edge
Research Center for Drug Discovery and Development for Diabetes and
Metabolic Disease, Kyungpook National University
Hospital, Daegu 41404, Republic of Korea</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nam Doo Kim</span> - <span class="hlFld-Affiliation affiliation">Daegu-Gyeongbuk
Medical Innovation Foundation, 2387 Dalgubeol-daero, Suseong-gu, Daegu 42019, Republic
of Korea</span>;Â 
    <span class="hlFld-Affiliation affiliation">NDBio Therapeutics
Inc., 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, Republic of Korea</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>H.C. and I.S. contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Korea Institute of Science and Technology (KIST); the KU-KIST Graduate School of Converging Science and Technology Program; Candidate Development Program [NRF-2016M3A9B5940991] of the National Research Foundation funded by the Ministry of Science and ICT, Republic of Korea; and the Korea Health Technology R&D Project [HI16C1501] of the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">PDHK</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase kinase</p></td></tr><tr><td class="NLM_term">RCC</td><td class="NLM_def"><p class="first last">renal cell carcinoma</p></td></tr><tr><td class="NLM_term">PDH</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase</p></td></tr><tr><td class="NLM_term">DCA</td><td class="NLM_def"><p class="first last">dichloroacetate</p></td></tr><tr><td class="NLM_term">OCR</td><td class="NLM_def"><p class="first last">oxygen consumption rate</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warburg, O.</span></span> <span> </span><span class="NLM_article-title">On the origin of cancer cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">309</span>â <span class="NLM_lpage">314</span>, <span class="refDoi">Â DOI: 10.1126/science.123.3191.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+origin+of+cancer+cells&doi=10.1126%2Fscience.123.3191.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2ebjE3OeWn9wcLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520origin%2520of%2520cancer%2520cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314%26doi%3D10.1126%2Fscience.123.3191.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span> <span> </span><span class="NLM_article-title">Targeting cellular metabolism to improve cancer therapeutics</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e532</span>, <span class="refDoi">Â DOI: 10.1038/cddis.2013.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fcddis.2013.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23470539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyku7%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e532&author=Y.+Zhaoauthor=E.+B.+Butlerauthor=M.+Tan&title=Targeting+cellular+metabolism+to+improve+cancer+therapeutics&doi=10.1038%2Fcddis.2013.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cellular metabolism to improve cancer therapeutics</span></div><div class="casAuthors">Zhao, Y.; Butler, E. B.; Tan, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">e532</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The metabolic properties of cancer cells diverge significantly from those of normal cells.  Energy prodn. in cancer cells is abnormally dependent on aerobic glycolysis.  In addn. to the dependency on glycolysis, cancer cells have other atypical metabolic characteristics such as increased fatty acid synthesis and increased rates of glutamine metab.  Emerging evidence shows that many features characteristic to cancer cells, such as dysregulated Warburg-like glucose metab., fatty acid synthesis and glutaminolysis are linked to therapeutic resistance in cancer treatment.  Therefore, targeting cellular metab. may improve the response to cancer therapeutics and the combination of chemotherapeutic drugs with cellular metab. inhibitors may represent a promising strategy to overcome drug resistance in cancer therapy.  Recently, several review articles have summarized the anticancer targets in the metabolic pathways and metabolic inhibitor-induced cell death pathways, however, the dysregulated metab. in therapeutic resistance, which is a highly clin. relevant area in cancer metab. research, has not been specifically addressed.  From this unique angle, this review article will discuss the relationship between dysregulated cellular metab. and cancer drug resistance and how targeting of metabolic enzymes, such as glucose transporters, hexokinase, pyruvate kinase M2, lactate dehydrogenase A, pyruvate dehydrogenase kinase, fatty acid synthase and glutaminase can enhance the efficacy of common therapeutic agents or overcome resistance to chemotherapy or radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMC5ekN6_UhbVg90H21EOLACvtfcHk0lhZSCza-0owLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyku7%252FJ&md5=fef8a7abec0d228e32fd03cfb85f3ca6</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.60%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DButler%26aufirst%3DE.%2BB.%26aulast%3DTan%26aufirst%3DM.%26atitle%3DTargeting%2520cellular%2520metabolism%2520to%2520improve%2520cancer%2520therapeutics%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De532%26doi%3D10.1038%2Fcddis.2013.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilda, P. J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial metabolism inhibitors for cancer therapy</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2731</span>â <span class="NLM_lpage">2744</span>, <span class="refDoi">Â DOI: 10.1007/s11095-011-0584-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1007%2Fs11095-011-0584-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=21918915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsbrL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=2731-2744&author=E.+E.+Ramsayauthor=P.+J.+Hoggauthor=P.+J.+Dilda&title=Mitochondrial+metabolism+inhibitors+for+cancer+therapy&doi=10.1007%2Fs11095-011-0584-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Metabolism Inhibitors for Cancer Therapy</span></div><div class="casAuthors">Ramsay, Emma E.; Hogg, Philip J.; Dilda, Pierre J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2731-2744</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cancer cells catabolize nutrients in a different way than healthy cells.  Healthy cells mainly rely on oxidative phosphorylation, while cancer cells employ aerobic glycolysis.  Glucose is the main nutrient catabolized by healthy cells, while cancer cells often depend on catabolism of both glucose and glutamine.  A key organelle involved in this altered metab. is mitochondria.  Mitochondria coordinate the catabolism of glucose and glutamine across the cancer cell.  Targeting mitochondrial metab. in cancer cells has potential for the treatment of this disease.  Perhaps the most promising target is the hexokinase-voltage dependent anion channel-adenine nucleotide translocase complex that spans the outer- and inner-mitochondrial membranes.  This complex links glycolysis, oxidative phosphorylation and mitochondrial-mediated apoptosis in cancer cells.  This review discusses cancer cell mitochondrial metab. and the small mol. inhibitors of this metab. that are in pre-clin. or clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7xMJ0QRGDo7Vg90H21EOLACvtfcHk0lhZSCza-0owLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsbrL&md5=a60df6faa02585df8699dd300f42986e</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1007%2Fs11095-011-0584-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-011-0584-5%26sid%3Dliteratum%253Aachs%26aulast%3DRamsay%26aufirst%3DE.%2BE.%26aulast%3DHogg%26aufirst%3DP.%2BJ.%26aulast%3DDilda%26aufirst%3DP.%2BJ.%26atitle%3DMitochondrial%2520metabolism%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DPharm.%2520Res.%26date%3D2011%26volume%3D28%26spage%3D2731%26epage%3D2744%26doi%3D10.1007%2Fs11095-011-0584-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tso, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernstedt-Asterholm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morlock, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherer, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span> <span> </span><span class="NLM_article-title">Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">4432</span>â <span class="NLM_lpage">4443</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M113.533885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1074%2Fjbc.M113.533885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=24356970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=4432-4443&author=S.+C.+Tsoauthor=X.+Qiauthor=W.+J.+Guiauthor=C.+Y.+Wuauthor=J.+L.+Chuangauthor=I.+Wernstedt-Asterholmauthor=L.+K.+Morlockauthor=K.+R.+Owensauthor=P.+E.+Schererauthor=N.+S.+Williams&title=Structure-guided+development+of+specific+pyruvate+dehydrogenase+kinase+inhibitors+targeting+the+ATP-binding+pocket&doi=10.1074%2Fjbc.M113.533885"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket</span></div><div class="casAuthors">Tso, Shih-Chia; Qi, Xiangbing; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Wernstedt-Asterholm, Ingrid; Morlock, Lorraine K.; Owens, Kyle R.; Scherer, Philipp E.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4432-4443</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase isoforms (PDKs 1-4) neg. regulate activity of the mitochondrial pyruvate dehydrogenase complex by reversible phosphorylation.  PDK isoforms are up-regulated in obesity, diabetes, heart failure, and cancer and are potential therapeutic targets for these important human diseases.  Here, the authors employed a structure-guided design to convert a known Hsp90 inhibitor to a series of highly specific PDK inhibitors, based on structural conservation in the ATP-binding pocket.  The key step involved the substitution of a carbonyl group in the parent compd. with a sulfonyl in the PDK inhibitors.  The final compd. of this series, 2-[(2,4-dihydroxyphenyl)sulfonyl]isoindoline-4,6-diol, designated PS10, inhibits all four PDK isoforms with IC50 = 0.8 Î¼m for PDK2.  The administration of PS10 (70 mg/kg) to diet-induced obese mice significantly augments pyruvate dehydrogenase complex activity with reduced phosphorylation in different tissues.  Prolonged PS10 treatments result in improved glucose tolerance and notably lessened hepatic steatosis in the mouse model.  The results support the pharmacol. approach of targeting PDK to control both glucose and fat levels in obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmYMKZrXKTrVg90H21EOLACvtfcHk0lhZSCza-0owLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D&md5=e3bd48326cc1ab39c76f7bd19734a361</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.533885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.533885%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DGui%26aufirst%3DW.%2BJ.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DWernstedt-Asterholm%26aufirst%3DI.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DOwens%26aufirst%3DK.%2BR.%26aulast%3DScherer%26aufirst%3DP.%2BE.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26atitle%3DStructure-guided%2520development%2520of%2520specific%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%2520targeting%2520the%2520ATP-binding%2520pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D4432%26epage%3D4443%26doi%3D10.1074%2Fjbc.M113.533885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hitosugi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lythgoe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakiewicz, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesel, J. L.</span></span> <span> </span><span class="NLM_article-title">Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">864</span>â <span class="NLM_lpage">877</span>, <span class="refDoi">Â DOI: 10.1016/j.molcel.2011.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.molcel.2011.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=22195962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=864-877&author=T.+Hitosugiauthor=J.+Fanauthor=T.+W.+Chungauthor=K.+Lythgoeauthor=X.+Wangauthor=J.+Xieauthor=Q.+Geauthor=T.+L.+Guauthor=R.+D.+Polakiewiczauthor=J.+L.+Roesel&title=Tyrosine+phosphorylation+of+mitochondrial+pyruvate+dehydrogenase+kinase+1+is+important+for+cancer+metabolism&doi=10.1016%2Fj.molcel.2011.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism</span></div><div class="casAuthors">Hitosugi, Taro; Fan, Jun; Chung, Tae-Wook; Lythgoe, Katherine; Wang, Xu; Xie, Jianxin; Ge, Qingyuan; Gu, Ting-Lei; Polakiewicz, Roberto D.; Roesel, Johannes L.; Chen, Georgia Z.; Boggon, Titus J.; Lonial, Sagar; Fu, Haian; Khuri, Fadlo R.; Kang, Sumin; Chen, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">864-877</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Many tumor cells rely on aerobic glycolysis instead of oxidative phosphorylation for their continued proliferation and survival.  Myc and HIF-1 are believed to promote such a metabolic switch by, in part, upregulating gene expression of pyruvate dehydrogenase (PDH) kinase 1 (PDHK1), which phosphorylates and inactivates mitochondrial PDH and consequently pyruvate dehydrogenase complex (PDC).  Here we report that tyrosine phosphorylation enhances PDHK1 kinase activity by promoting ATP and PDC binding.  Functional PDC can form in mitochondria outside of the matrix in some cancer cells and PDHK1 is commonly tyrosine phosphorylated in human cancers by diverse oncogenic tyrosine kinases localized to different mitochondrial compartments.  Expression of phosphorylation-deficient, catalytic hypomorph PDHK1 mutants in cancer cells leads to decreased cell proliferation under hypoxia and increased oxidative phosphorylation with enhanced mitochondrial utilization of pyruvate and reduced tumor growth in xenograft nude mice.  Together, tyrosine phosphorylation activates PDHK1 to promote the Warburg effect and tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt7BASuMHOGLVg90H21EOLACvtfcHk0ljHhZ8qcxnKuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL7L&md5=d022eae26590b3fed9009260a692d67c</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DHitosugi%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DLythgoe%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DT.%2BL.%26aulast%3DPolakiewicz%26aufirst%3DR.%2BD.%26aulast%3DRoesel%26aufirst%3DJ.%2BL.%26atitle%3DTyrosine%2520phosphorylation%2520of%2520mitochondrial%2520pyruvate%2520dehydrogenase%2520kinase%25201%2520is%2520important%2520for%2520cancer%2520metabolism%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26spage%3D864%26epage%3D877%26doi%3D10.1016%2Fj.molcel.2011.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Saunier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortoli, S.</span></span> <span> </span><span class="NLM_article-title">The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">809</span>â <span class="NLM_lpage">817</span>, <span class="refDoi">Â DOI: 10.1002/ijc.29564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1002%2Fijc.29564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=25868605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFCktr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=809-817&author=E.+Saunierauthor=C.+Benelliauthor=S.+Bortoli&title=The+pyruvate+dehydrogenase+complex+in+cancer%3A+an+old+metabolic+gatekeeper+regulated+by+new+pathways+and+pharmacological+agents&doi=10.1002%2Fijc.29564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents</span></div><div class="casAuthors">Saunier, Elise; Benelli, Chantal; Bortoli, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-817</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Cancer cells exhibit an altered metab. which is characterized by a preference for aerobic glycolysis more than mitochondrial oxidn. of pyruvate.  This provides anabolic support and selective growth advantage for cancer cells.  Recently, a new concept has arisen suggesting that these metabolic changes may be due, in part, to an attenuated mitochondrial function which results from the inhibition of the pyruvate dehydrogenase complex (PDC).  This mitochondrial complex links glycolysis to the Krebs cycle and the current understanding of its regulation involves the cyclic phosphorylation and dephosphorylation by specific pyruvate dehydrogenase kinases (PDKs) and pyruvate dehydrogenase phosphatases (PDPs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHoUftek7vjrVg90H21EOLACvtfcHk0ljHhZ8qcxnKuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFCktr0%253D&md5=5ed6990e7c6e5d4619149746338f5582</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1002%2Fijc.29564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29564%26sid%3Dliteratum%253Aachs%26aulast%3DSaunier%26aufirst%3DE.%26aulast%3DBenelli%26aufirst%3DC.%26aulast%3DBortoli%26aufirst%3DS.%26atitle%3DThe%2520pyruvate%2520dehydrogenase%2520complex%2520in%2520cancer%253A%2520an%2520old%2520metabolic%2520gatekeeper%2520regulated%2520by%2520new%2520pathways%2520and%2520pharmacological%2520agents%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2016%26volume%3D138%26spage%3D809%26epage%3D817%26doi%3D10.1002%2Fijc.29564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. U.</span></span> <span> </span><span class="NLM_article-title">Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">44</span>â <span class="NLM_lpage">54</span>, <span class="refDoi">Â DOI: 10.3892/ijo.2012.1687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.3892%2Fijo.2012.1687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23135628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWntr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=44-54&author=H.+Hurauthor=Y.+Xuanauthor=Y.+B.+Kimauthor=G.+Leeauthor=W.+Shimauthor=J.+Yunauthor=I.+H.+Hamauthor=S.+U.+Han&title=Expression+of+pyruvate+dehydrogenase+kinase-1+in+gastric+cancer+as+a+potential+therapeutic+target&doi=10.3892%2Fijo.2012.1687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target</span></div><div class="casAuthors">Hur, Hoon; Xuan, Yi; Kim, Young Bae; Lee, Gwang; Shim, Wooyoung; Yun, Jisoo; Ham, In-Hye; Han, Sang-Uk</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-54</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">In contrast to mitochondria in healthy cells, which utilize oxidative phosphorylation, malignant cells undergo elevated glycolysis for energy prodn. using glucose.  The objectives of this study were to evaluate whether the expression of various mols., including pyruvate dehydrogenase kinase-1 (PDK-1), is involved in the altered glucose metab. assocd. with gastric cancer prognosis and to assess the role of a therapeutic agent in targeting glucose metab. in gastric cancer.  Immunohistochem. was performed on gastric cancer tissues obtained from 152 patients who underwent curative resection to assess the expression of hypoxia-inducible factor-1Î± (HIF-1Î±), glucose transporter-1 (GLUT-1), hexokinase-2 (HK-2) and PDK-1.  In an in vitro anal., the lactate prodn. and glucose uptake levels, cellular viability and 5-fluorouracil (5-FU) responses were evaluated before and after treatment with dichloroacetate (DCA), a PDK-1 inhibitor, in the MKN45 and AGS gastric cancer cell lines and in the non-cancerous HEK293 cell line.  GLUT-1 and PDK-1 expression was significantly assocd. with tumor progression, although only PDK-1 expression was an independent prognostic factor for patients who received 5-FU adjuvant treatment.  There was no significant difference in cell viability between the HEK293 and gastric cancer cell lines following DCA treatment.  However, DCA treatment reduced lactate prodn. and increased responsiveness to 5-FU in MKN45 cells, which expressed high levels of PDK-1 in comparison to the other cell lines.  Thus, PDK-1 may serve as a biomarker of poor prognosis in patients with gastric cancer.  In addn., PDK-1 inhibitors such as DCA may be considered an addnl. treatment option for patients with PDK-1-expressing gastric cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgDvVgrWla2LVg90H21EOLACvtfcHk0ljHhZ8qcxnKuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWntr8%253D&md5=f9e2602bfd973bec91d910b604fba7f4</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.3892%2Fijo.2012.1687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2012.1687%26sid%3Dliteratum%253Aachs%26aulast%3DHur%26aufirst%3DH.%26aulast%3DXuan%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DY.%2BB.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DShim%26aufirst%3DW.%26aulast%3DYun%26aufirst%3DJ.%26aulast%3DHam%26aufirst%3DI.%2BH.%26aulast%3DHan%26aufirst%3DS.%2BU.%26atitle%3DExpression%2520of%2520pyruvate%2520dehydrogenase%2520kinase-1%2520in%2520gastric%2520cancer%2520as%2520a%2520potential%2520therapeutic%2520target%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2013%26volume%3D42%26spage%3D44%26epage%3D54%26doi%3D10.3892%2Fijo.2012.1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, H.</span></span> <span> </span><span class="NLM_article-title">PDK1 inhibition is a novel therapeutic target in multiple myeloma</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">170</span>â <span class="NLM_lpage">178</span>, <span class="refDoi">Â DOI: 10.1038/bjc.2012.527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fbjc.2012.527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23321518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCmtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2013&pages=170-178&author=S.+Fujiwaraauthor=Y.+Kawanoauthor=H.+Yukiauthor=Y.+Okunoauthor=K.+Nosakaauthor=H.+Mitsuyaauthor=H.+Hata&title=PDK1+inhibition+is+a+novel+therapeutic+target+in+multiple+myeloma&doi=10.1038%2Fbjc.2012.527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PDK1 inhibition is a novel therapeutic target in multiple myeloma</span></div><div class="casAuthors">Fujiwara, S.; Kawano, Y.; Yuki, H.; Okuno, Y.; Nosaka, K.; Mitsuya, H.; Hata, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-178</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells utilize the glycolytic pathway even when adequate oxygen is present, a phenomenon known as the Warburg effect.  We examd. whether this system is operative in multiple myeloma (MM) cells and whether glycolysis inhibition is a potential therapeutic modality.  The MM cells were purified from 59 patients using CD138-immunomagnetic beads.  The expression levels of genes assocd. with glycolysis, c-MYC, GLUT1, LDHA, HIF1A and pyruvate dehydrogenase kinase-1 (PDK1) were detd. by real-time PCR.  Glucose consumption and lactate prodn. by MM cell lines were analyzed.  Oxamate, an LDH inhibitor, and dichloroacetate (DCA), a PDK1 inhibitor, were employed.  Inhibition of PDK1 expression was achieved using a siRNA.  High LDHA expression was found to be an indicator of poor prognosis.  It was also pos. correlated with the expression of PDK1, c-MYC and GLUT1.  Greater glucose consumption and lactate prodn. in MM cells was assocd. with higher LDHA expression.  All the glycolysis inhibitors (oxamate, DCA and PDK1 siRNA) induced apoptosis in MM cells.  DCA combined with bortezomib showed additive cytotoxic effects.  The present data suggest that the Warburg effect is operative in MM cells.  As PDK1 is not overexpressed in normal tissues, PDK1 inhibition could serve as a novel therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR94YLXWvLtbVg90H21EOLACvtfcHk0lhocnQu39XjtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCmtro%253D&md5=b3e7af9d01088a9d28da69ad416c3e21</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.527%26sid%3Dliteratum%253Aachs%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DY.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DNosaka%26aufirst%3DK.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DHata%26aufirst%3DH.%26atitle%3DPDK1%2520inhibition%2520is%2520a%2520novel%2520therapeutic%2520target%2520in%2520multiple%2520myeloma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2013%26volume%3D108%26spage%3D170%26epage%3D178%26doi%3D10.1038%2Fbjc.2012.527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baumunk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichelt, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrandt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebbing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cash, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schostak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weikert, S.</span></span> <span> </span><span class="NLM_article-title">Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC)</span>. <i>World J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1191</span>â <span class="NLM_lpage">1196</span>, <span class="refDoi">Â DOI: 10.1007/s00345-012-0874-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1007%2Fs00345-012-0874-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=22544372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKqs7vM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=1191-1196&author=D.+Baumunkauthor=U.+Reicheltauthor=J.+Hildebrandtauthor=H.+Krauseauthor=J.+Ebbingauthor=H.+Cashauthor=K.+Millerauthor=M.+Schostakauthor=S.+Weikert&title=Expression+parameters+of+the+metabolic+pathway+genes+pyruvate+dehydrogenase+kinase-1+%28PDK-1%29+and+DJ-1%2FPARK7+in+renal+cell+carcinoma+%28RCC%29&doi=10.1007%2Fs00345-012-0874-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC)</span></div><div class="casAuthors">Baumunk, Daniel; Reichelt, Uta; Hildebrandt, Jannis; Krause, Hans; Ebbing, Jan; Cash, Hannes; Miller, Kurt; Schostak, Martin; Weikert, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Urology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1191-1196</span>CODEN:
                <span class="NLM_cas:coden">WJURDJ</span>;
        ISSN:<span class="NLM_cas:issn">0724-4983</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose Metabolic adaptations, such as increases in glucose and energy metab., play a pivotal role in the biol. of RCC.  PDK-1 and DJ-1/PARK7 are thought to control metabolic pathways in cancer.  We investigated the expression of PDK-1 and DJ-1/PARK7 in RCC and their prognostic relevance.  Methods RCC tumor tissue and corresponding normal parenchyma samples were obtained from 91 patients with clear cell RCC.  Expression of PDK-1 and DJ-1/PARK7 was detd. on the mRNA and protein levels using quant. RT-PCR and immunohistochem.  Expression ratios tumor/normal were analyzed for assocns. with pathol. stage and grade (Kruskal-Wallis ANOVA, chi-square test).  Potential assocns. with progression-free and overall survival were analyzed using Cox regression models.  Results PDK-1 mRNA expression was up-regulated as compared to normal tissue (p < 0.001).  Differences were obsd. by tumor stage (p < 0.05) with a trend toward lower expression with increasing stage (p > 0.01).  Expression ratio tumor/normal also showed differences by tumor stage with the lowest ratio obsd. in advanced (pT3) disease.  MRNA expression data were confirmed on the protein level with the lowest protein expression in pT3 tumors.  PDK-1 expression ratio tumor/normal was inversely assocd. with outcome after adjustment for stage and grade (HR, 0.54; 95 % CI, 0.31-0.94).  No assocns. obsd. for DJ-1/PARK7 expression.  Conclusions PDK is up-regulated in RCC, but down-regulation may be assocd. with progression toward a metastasizing behavior.  Given the role of PDK-1 in the control of glucose metab., aerobic glycolysis via up-regulation of PDK-1 may be an early event in RCC development, but less relevant for the progression toward an aggressive phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe8UV9vRe-b7Vg90H21EOLACvtfcHk0lhocnQu39XjtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKqs7vM&md5=240989dc2b53f10fc9b1ce9fecada74f</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1007%2Fs00345-012-0874-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00345-012-0874-5%26sid%3Dliteratum%253Aachs%26aulast%3DBaumunk%26aufirst%3DD.%26aulast%3DReichelt%26aufirst%3DU.%26aulast%3DHildebrandt%26aufirst%3DJ.%26aulast%3DKrause%26aufirst%3DH.%26aulast%3DEbbing%26aufirst%3DJ.%26aulast%3DCash%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DSchostak%26aufirst%3DM.%26aulast%3DWeikert%26aufirst%3DS.%26atitle%3DExpression%2520parameters%2520of%2520the%2520metabolic%2520pathway%2520genes%2520pyruvate%2520dehydrogenase%2520kinase-1%2520%2528PDK-1%2529%2520and%2520DJ-1%252FPARK7%2520in%2520renal%2520cell%2520carcinoma%2520%2528RCC%2529%26jtitle%3DWorld%2520J.%2520Urol.%26date%3D2013%26volume%3D31%26spage%3D1191%26epage%3D1196%26doi%3D10.1007%2Fs00345-012-0874-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">193</span>â <span class="NLM_lpage">200</span>, <span class="refDoi">Â DOI: 10.3892/or.2016.5253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.3892%2For.2016.5253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=27878287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A280%3ADC%252BC2snpsFajtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=193-200&author=T.+Liuauthor=H.+Yin&title=PDK1+promotes+tumor+cell+proliferation+and+migration+by+enhancing+the+Warburg+effect+in+non-small+cell+lung+cancer&doi=10.3892%2For.2016.5253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer</span></div><div class="casAuthors">Liu Tao; Yin Honglei</div><div class="citationInfo"><span class="NLM_cas:title">Oncology reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-200</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumor cells prefer glycolysis (Warburg effect) during the proliferation and metastasis.  The precise mechanism remains largely unknown.  Here, we demonstrated that pyruvate dehydrogenase kinase 1 (PDK1) was a critical enzyme that functioned as an oncogene to promote non-small cell lung cancer (NSCLC) growth and metastasis.  We discovered that PDK1 expression was significantly upregulated in NSCLC tissues and correlated with advanced T stage.  Moreover, high expression of PDK1 was an independent prognostic factor of NSCLC.  Ectopic overexpression of PDK1 promoted cell proliferation and inhibited apoptosis.  Also it was shown that PDK1 increased the cell mobility when Transwell assay was performed.  Further experiments indicated that PDK1 had a central role in metabolic reprogramming by phosphorylating pyruvate dehydrogenase, leading to enhanced Warburg effect.  Collectively, our data reveal a new function for PDK1, which could be used to indicate the prognosis of NSCLC, and provide targeted therapeutic strategy for clinical treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxnJ8WA5DjZFMGsG_HTXYFfW6udTcc2eZT-xhSZgna3Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snpsFajtA%253D%253D&md5=c0970c18f900c9fc25b664ff6e2aebcd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3892%2For.2016.5253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2016.5253%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DPDK1%2520promotes%2520tumor%2520cell%2520proliferation%2520and%2520migration%2520by%2520enhancing%2520the%2520Warburg%2520effect%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D37%26spage%3D193%26epage%3D200%26doi%3D10.3892%2For.2016.5253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sutendra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dromparis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinnaird, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haromy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurtry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelakis, E.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1638</span>â <span class="NLM_lpage">1650</span>, <span class="refDoi">Â DOI: 10.1038/onc.2012.198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fonc.2012.198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=22614004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Cmsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1638-1650&author=G.+Sutendraauthor=P.+Dromparisauthor=A.+Kinnairdauthor=T.+Stensonauthor=A.+Haromyauthor=J.+Parkerauthor=M.+McMurtryauthor=E.+Michelakis&title=Mitochondrial+activation+by+inhibition+of+PDKII+suppresses+HIF1a+signaling+and+angiogenesis+in+cancer&doi=10.1038%2Fonc.2012.198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial activation by inhibition of PDKII suppresses HIF-1Î± signaling and angiogenesis in cancer</span></div><div class="casAuthors">Sutendra, G.; Dromparis, P.; Kinnaird, A.; Stenson, T. H.; Haromy, A.; Parker, J. M. R.; McMurtry, M. S.; Michelakis, E. D.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1638-1650</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Most solid tumors are characterized by a metabolic shift from glucose oxidn. to glycolysis, in part due to actively suppressed mitochondrial function, a state that favors resistance to apoptosis.  Suppressed mitochondrial function may also contribute to the activation of hypoxia-inducible factor 1Î± (HIF1Î±) and angiogenesis.  We have previously shown that the inhibitor of pyruvate dehydrogenase kinase (PDK) dichloroacetate (DCA) activates glucose oxidn. and induces apoptosis in cancer cells in vitro and in vivo.  We hypothesized that DCA will also reverse the pseudohypoxic' mitochondrial signals that lead to HIF1Î± activation in cancer, even in the absence of hypoxia and inhibit cancer angiogenesis.  We show that inhibition of PDKII inhibits HIF1Î± in cancer cells using several techniques, including HIF1Î± luciferase reporter assays.  Using pharmacol. and mol. approaches that suppress the prolyl-hydroxylase (PHD)-mediated inhibition of HIF1Î±, we show that DCA inhibits HIF1Î± by both a PHD-dependent mechanism (that involves a DCA-induced increase in the prodn. of mitochondria-derived Î±-ketoglutarate) and a PHD-independent mechanism, involving activation of p53 via mitochondrial-derived H2O2, as well as activation of GSK3Î².  Effective inhibition of HIF1Î± is shown by a decrease in the expression of several HIF1Î± regulated gene products as well as inhibition of angiogenesis in vitro in matrigel assays.  More importantly, in rat Xenotransplant models of non-small cell lung cancer and breast cancer, we show effective inhibition of angiogenesis and tumor perfusion in vivo, assessed by contrast-enhanced ultrasonog., nuclear imaging techniques and histol.  This work suggests that mitochondria-targeting metabolic modulators that increase pyruvate dehydrogenase activity, in addn. to the recently described pro-apoptotic and anti-proliferative effects, suppress angiogenesis as well, normalizing the pseudo-hypoxic signals that lead to normoxic HIF1Î± activation in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwpRW4kQDlOLVg90H21EOLACvtfcHk0ljGu4oCkEwu0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Cmsrg%253D&md5=8a5ea78b008f38044951a718e620ef70</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.198%26sid%3Dliteratum%253Aachs%26aulast%3DSutendra%26aufirst%3DG.%26aulast%3DDromparis%26aufirst%3DP.%26aulast%3DKinnaird%26aufirst%3DA.%26aulast%3DStenson%26aufirst%3DT.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DJ.%26aulast%3DMcMurtry%26aufirst%3DM.%26aulast%3DMichelakis%26aufirst%3DE.%26atitle%3DMitochondrial%2520activation%2520by%2520inhibition%2520of%2520PDKII%2520suppresses%2520HIF1a%2520signaling%2520and%2520angiogenesis%2520in%2520cancer%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D1638%26epage%3D1650%26doi%3D10.1038%2Fonc.2012.198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S. J.</span></span> <span> </span><span class="NLM_article-title">Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">1405</span>â <span class="NLM_lpage">1414</span>, <span class="refDoi">Â DOI: 10.1016/j.ajpath.2011.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.ajpath.2011.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=21763680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsb%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=1405-1414&author=C.+W.+Luauthor=S.+C.+Linauthor=C.+W.+Chienauthor=S.+C.+Linauthor=C.+T.+Leeauthor=B.+W.+Linauthor=J.+C.+Leeauthor=S.+J.+Tsai&title=Overexpression+of+pyruvate+dehydrogenase+kinase+3+increases+drug+resistance+and+early+recurrence+in+colon+cancer&doi=10.1016%2Fj.ajpath.2011.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of pyruvate dehydrpgenase kinase 3 increases drug resistance and early recurrence in colon cancer</span></div><div class="casAuthors">Lu, Chun-Wun; Lin, Shau-Chieh; Chien, Chun-Wei; Lin, Shih-Chieh; Lee, Chung-Ta; Lin, Bo-Wen; Lee, Jenq-Chang; Tsai, Shaw-Jenq</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1405-1414</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The switch of cellular metab. from mitochondrial respiration to glycolysis is the hallmark of cancer cells and is assocd. with tumor malignancy.  Pyruvate dehydrogenase kinase-1 (PDK1) and PDK3 participate in the metabolic switch of cancer cells; however, the medical significance of PDK1 and PDK3 in cancer progression is not known.  Here, we assessed the expression profiles of PDK1 and PDK3 in colorectal cancer.  Western blot anal. (n = 74) demonstrated that PDK3 was markedly increased in colon cancer compared to that in adjacent normal tissues, whereas PDK1 was decreased in cancer cells.  In addn., PDK3 expression was pos. correlated with that of hypoxia inducible factor-1Î± (HIF-1Î±) in cancer cells.  Further anal. using immunohistochem. staining revealed that PDK3 levels were pos. assocd. with severity of cancer and neg. assocd. with disease-free survival.  In vitro studies using several colon cancer cell lines showed that PDK3 expression was controlled by HIF-1Î± and contributed to hypoxia-induced increased drug resistance, perhaps explaining why patients with PDK3 overexpression have a greater incidence of treatment failure.  Taken together, our findings suggest that PDK3 plays an important role in the metabolic switch and drug resistance of colon cancer and is potentially a novel target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQmjhmaIUuIrVg90H21EOLACvtfcHk0ljGu4oCkEwu0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsb%252FI&md5=44cb57fc1b370446524ecaa0a5a0fa05</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%2BW.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DChien%26aufirst%3DC.%2BW.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DLin%26aufirst%3DB.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DTsai%26aufirst%3DS.%2BJ.%26atitle%3DOverexpression%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25203%2520increases%2520drug%2520resistance%2520and%2520early%2520recurrence%2520in%2520colon%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26spage%3D1405%26epage%3D1414%26doi%3D10.1016%2Fj.ajpath.2011.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koukourakis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giatromanolaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivridis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatter, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">6</span>, <span class="refDoi">Â DOI: 10.1593/neo.04373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1593%2Fneo.04373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=15736311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Gnsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1-6&author=M.+I.+Koukourakisauthor=A.+Giatromanolakiauthor=E.+Sivridisauthor=K.+C.+Gatterauthor=A.+L.+Harris&title=Pyruvate+dehydrogenase+and+pyruvate+dehydrogenase+kinase+expression+in+non+small+cell+lung+cancer+and+tumor-associated+stroma&doi=10.1593%2Fneo.04373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma</span></div><div class="casAuthors">Koukourakis, Michael I.; Giatromanolaki, Alexandra; Sivridis, Efthimios; Gatter, Kevin C.; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase (PDH) catalyzes the conversion of pyruvate to acetyl-CoA, which enters into the Krebs cycle, providing ATP (ATP) to the cell.  PDH activity is under the control of pyruvate dehydrogenase kinases (PDKs).  Under hypoxic conditions, conversion of pyruvate to lactate occurs, a reaction catalyzed by lactate dehydrogenase 5 (LDH5).  In cancer cells, however, pyruvate is transformed to lactate occurs, regardless of the presence of oxygen (aerobic glycolysis/Warburg effect).  Although hypoxic intratumoral conditions account for HIF1Î± stabilization and induction of anaerobic metab., recent data suggest that high pyruvate concns. also result in HIF1Î± stabilization independently of hypoxia.  In the present immunohistochem. study, we provide evidence that the PDH/PDK pathway is repressed in 73% of non small cell lung carcinomas, which may be a key reason for HIF1Î± stabilization and "aerobic glycolysis.".  However, about half of PDH-deficient carcinomas are not able to switch on the HIF pathway, and patients harboring these tumors have an excellent postoperative outcome.  A small subgroup of clin. aggressive tumors maintains a coherent PDH and HIF/LDH5 expression.  In contrast to cancer cells, fibroblasts in the tumor-supporting stroma exhibit an intense PDH but reduced PDK1 expression favoring max. PDH activity.  This means that stroma may use lactic acid produced by tumor cells, preventing the creation of an intolerable intratumoral acidic environment at the same time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV1TgkNQIoR7Vg90H21EOLACvtfcHk0ljGu4oCkEwu0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Gnsb4%253D&md5=59d95598203762a351627ce808b5b32f</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1593%2Fneo.04373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.04373%26sid%3Dliteratum%253Aachs%26aulast%3DKoukourakis%26aufirst%3DM.%2BI.%26aulast%3DGiatromanolaki%26aufirst%3DA.%26aulast%3DSivridis%26aufirst%3DE.%26aulast%3DGatter%26aufirst%3DK.%2BC.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DPyruvate%2520dehydrogenase%2520and%2520pyruvate%2520dehydrogenase%2520kinase%2520expression%2520in%2520non%2520small%2520cell%2520lung%2520cancer%2520and%2520tumor-associated%2520stroma%26jtitle%3DNeoplasia%26date%3D2005%26volume%3D7%26spage%3D1%26epage%3D6%26doi%3D10.1593%2Fneo.04373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radenkovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papandreou, I.</span></span> <span> </span><span class="NLM_article-title">Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">674</span>â <span class="NLM_lpage">686</span>, <span class="refDoi">Â DOI: 10.1002/ijc.31812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1002%2Fijc.31812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=30121950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVCqtLjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=674-686&author=T.+Goliasauthor=M.+Keryauthor=S.+Radenkovicauthor=I.+Papandreou&title=Microenvironmental+control+of+glucose+metabolism+in+tumors+by+regulation+of+pyruvate+dehydrogenase&doi=10.1002%2Fijc.31812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase</span></div><div class="casAuthors">Golias, Tereza; Kery, Martin; Radenkovic, Silvia; Papandreou, Ioanna</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">674-686</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">During malignant progression cancer cells undergo a series of changes, which promote their survival, invasiveness and metastatic process.  One of them is a change in glucose metab.  Unlike normal cells, which mostly rely on the tricarboxylic acid cycle (TCA), many cancer types rely on glycolysis.  Pyruvate dehydrogenase complex (PDC) is the gatekeeper enzyme between these two pathways and is responsible for converting pyruvate to acetyl-CoA, which can then be processed further in the TCA cycle.  Its activity is regulated by PDP (pyruvate dehydrogenase phosphatases) and PDHK (pyruvate dehydrogenase kinases).  Pyruvate dehydrogenase kinase exists in 4 tissue specific isoforms (PDHK1-4), the activities of which are regulated by different factors, including hormones, hypoxia and nutrients.  PDHK1 and PDHK3 are active in the hypoxic tumor microenvironment and inhibit PDC, resulting in a decrease of mitochondrial function and activation of the glycolytic pathway.  High PDHK1/3 expression is assocd. with worse prognosis in patients, which makes them a promising target for cancer therapy.  However, a better understanding of PDC's enzymic regulation in vivo and of the mechanisms of PDHK-mediated malignant progression is necessary for the design of better PDHK inhibitors and the selection of patients most likely to benefit from such inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsoidTi7vIWrVg90H21EOLACvtfcHk0lgahjlIk-tcOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVCqtLjJ&md5=bcbdeb03b8a018d45bb647b635b5575e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fijc.31812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.31812%26sid%3Dliteratum%253Aachs%26aulast%3DGolias%26aufirst%3DT.%26aulast%3DKery%26aufirst%3DM.%26aulast%3DRadenkovic%26aufirst%3DS.%26aulast%3DPapandreou%26aufirst%3DI.%26atitle%3DMicroenvironmental%2520control%2520of%2520glucose%2520metabolism%2520in%2520tumors%2520by%2520regulation%2520of%2520pyruvate%2520dehydrogenase%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2019%26volume%3D144%26spage%3D674%26epage%3D686%26doi%3D10.1002%2Fijc.31812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truongcao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foulkes, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapienza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozen, R.</span></span> <span> </span><span class="NLM_article-title">Oncogenic role of PDK4 in human colon cancer cells</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">930</span>â <span class="NLM_lpage">936</span>, <span class="refDoi">Â DOI: 10.1038/bjc.2017.38</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fbjc.2017.38" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=28208156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVyktL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=930-936&author=D.+Leclercauthor=D.+Phamauthor=N.+Levesqueauthor=M.+Truongcaoauthor=W.+Foulkesauthor=C.+Sapienzaauthor=R.+Rozen&title=Oncogenic+role+of+PDK4+in+human+colon+cancer+cells&doi=10.1038%2Fbjc.2017.38"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic role of PDK4 in human colon cancer cells</span></div><div class="casAuthors">Leclerc, D.; Pham, D. N. T.; Levesque, N.; Truongcao, M.; Foulkes, W. D.; Sapienza, C.; Rozen, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">930-936</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Cancer cells maintain high rates of glycolysis.  Pyruvate dehydrogenase kinases (PDK) contribute to this phenomenon, which favors apoptosis resistance and cellular transformation.  We previously reported upregulation of PDK4 in normal mucosa of colorectal cancer (CRC) patients compared with controls and in preneoplastic intestine of our mouse model.  Decreased methylation of four consecutive PDK4 CpGs was obsd. in normal mucosa of patients.  Although other members of the PDK family have been investigated for transformation potential, PDK4 has not been extensively studied.  Methods: PDK4 methylation in blood of CRC patients and controls was evaluated by pyrosequencing.  PDK4 expression in human colon carcinoma cells was down-regulated by RNAi.  Cellular migration and invasion, apoptosis and qRT-PCR of key genes were assessed.  Results: Pyrosequencing revealed decreased methylation of the same four consecutive CpGs in the blood of patients compared with controls.  Cellular migration and invasion were reduced and apoptosis was increased following transient or stable inhibition of PDK4.  Expression of vimentin, HIF-1 and VEGFA was reduced.  Conclusions: These studies demonstrate the involvement of PDK4 in transformation.  Methylation assessment of PDK4 in the blood may be useful for non-invasive CRC detection.  PDK4 should be considered as a target for development of anticancer strategies and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-CUeJfoOW47Vg90H21EOLACvtfcHk0lgahjlIk-tcOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVyktL4%253D&md5=9f1e136b96e59e3c5f6227b2150c7d75</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2017.38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2017.38%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DD.%26aulast%3DPham%26aufirst%3DD.%26aulast%3DLevesque%26aufirst%3DN.%26aulast%3DTruongcao%26aufirst%3DM.%26aulast%3DFoulkes%26aufirst%3DW.%26aulast%3DSapienza%26aufirst%3DC.%26aulast%3DRozen%26aufirst%3DR.%26atitle%3DOncogenic%2520role%2520of%2520PDK4%2520in%2520human%2520colon%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D116%26spage%3D930%26epage%3D936%26doi%3D10.1038%2Fbjc.2017.38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woolbright, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhary, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikhalyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trammel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilbeam, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. A.</span></span> <span> </span><span class="NLM_article-title">The role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in bladder cancer and chemoresistance</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2004</span>â <span class="NLM_lpage">2012</span>, <span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-18-0063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1158%2F1535-7163.MCT-18-0063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=29907593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit12qtLjK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=2004-2012&author=B.+L.+Woolbrightauthor=D.+Choudharyauthor=A.+Mikhalyukauthor=C.+Trammelauthor=S.+Shanmugamauthor=E.+Abbottauthor=C.+C.+Pilbeamauthor=J.+A.+Taylor&title=The+role+of+Pyruvate+Dehydrogenase+Kinase-4+%28PDK4%29+in+bladder+cancer+and+chemoresistance&doi=10.1158%2F1535-7163.MCT-18-0063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The role of pyruvate dehydrogenase kinase-4 (PDK4) in bladder cancer and chemoresistance</span></div><div class="casAuthors">Woolbright, Benjamin L.; Choudhary, Dharamainder; Mikhalyuk, Andrew; Trammel, Cassandra; Shanmugam, Sambantham; Abbott, Erika; Pilbeam, Carol C.; Taylor, John A., III.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2004-2012</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Advanced bladder cancer remains a major source of mortality, with poor treatment options.  Cisplatin-based chemotherapy is the std. treatment, however many patients are or become resistant.  One potential cause of chemoresistance is the Warburg effect, a metabolic switch to aerobic glycolysis that occurs in many cancers.  Upregulation of the pyruvate dehydrogenase kinase family (PDK1-PDK4) is assocd. with aerobic glycolysis and chemoresistance through inhibition of the pyruvate dehydrogenase complex (PDH).  We have previously obsd. upregulation of PDK4 in high-grade compared with low-grade bladder cancers.  We initiated this study to det. if inhibition of PDK4 could reduce tumor growth rates or sensitize bladder cancer cells to cisplatin.  Upregulation of PDK4 in malignant bladder cancer cell lines as compared with benign transformed urothelial cells was confirmed using qPCR.  Inhibition of PDK4 with dichloroacetate (DCA) resulted in increased PDH activity, reduced cell growth, and G0-G1 phase arrest in bladder cancer cells.  Similarly, siRNA knockdown of PDK4 inhibited bladder cancer cell proliferation.  Cotreatment of bladder cancer cells with cisplatin and DCA did not increase caspase-3 activity but did enhance overall cell death in vitro.  Although daily treatment with 200 mg/kg DCA alone did not reduce tumor vols. in a xenograft model, combination treatment with cisplatin resulted in dramatically reduced tumor vols. as compared with either DCA or cisplatin alone.  This was attributed to substantial intratumoral necrosis.  These findings indicate inhibition of PDK4 may potentiate cisplatin-induced cell death and warrant further studies investigating the mechanism through which this occurs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC7yypSx8LTbVg90H21EOLACvtfcHk0lgahjlIk-tcOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit12qtLjK&md5=6fecb75e56961e5f14f76b77e5659fb4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-18-0063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-18-0063%26sid%3Dliteratum%253Aachs%26aulast%3DWoolbright%26aufirst%3DB.%2BL.%26aulast%3DChoudhary%26aufirst%3DD.%26aulast%3DMikhalyuk%26aufirst%3DA.%26aulast%3DTrammel%26aufirst%3DC.%26aulast%3DShanmugam%26aufirst%3DS.%26aulast%3DAbbott%26aufirst%3DE.%26aulast%3DPilbeam%26aufirst%3DC.%2BC.%26aulast%3DTaylor%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520role%2520of%2520Pyruvate%2520Dehydrogenase%2520Kinase-4%2520%2528PDK4%2529%2520in%2520bladder%2520cancer%2520and%2520chemoresistance%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D2004%26epage%3D2012%26doi%3D10.1158%2F1535-7163.MCT-18-0063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Targeting tumor metabolism for cancer treatment: is Pyruvate Dehydrogenase Kinases (PDKs) a viable anticancer target?</span>. <i>Int. J. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1390</span>â <span class="NLM_lpage">1400</span>, <span class="refDoi">Â DOI: 10.7150/ijbs.13325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.7150%2Fijbs.13325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=26681918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1ejsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=1390-1400&author=W.+Zhangauthor=S.+L.+Zhangauthor=X.+Huauthor=K.+Y.+Tam&title=Targeting+tumor+metabolism+for+cancer+treatment%3A+is+Pyruvate+Dehydrogenase+Kinases+%28PDKs%29+a+viable+anticancer+target%3F&doi=10.7150%2Fijbs.13325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumor metabolism for cancer treatment: is pyruvate dehydrogenase kinases (PDKs) a viable anticancer target?</span></div><div class="casAuthors">Zhang, Wen; Zhang, Shao-Lin; Hu, Xiaohui; Tam, Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1390-1400</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Cancer remains a lethal threat to global lives.  Development of novel anticancer therapeutics is still a challenge to scientists in the field of biomedicine.  In cancer cells, the metabolic features are significantly different from those of normal ones, which are hallmarks of several malignancies.  Recent studies brought atypical cellular metab., such as aerobic glycolysis or the Warburg effect, into the scientific limelight.  Targeting these altered metabolic pathways in cancer cells presents a promising therapeutic strategy.  Pyruvate dehydrogenase kinases (PDKs), key enzymes in the pathway of glucose metab., could inactivate the pyruvate dehydrogenase complex (PDC) by phosphorylating it and preserving the substrates pyruvate, lactate and alanine for gluconeogenesis.  Overexpression of PDKs could block the oxidative decarboxylation of pyruvate to satisfy high oxygen demand in cancer cells, while inhibition of PDKs could upregulate the activity of PDC and rectify the balance between the demand and supply of oxygen, which could lead to cancer cell death.  Thus, inhibitors targeting PDKs represent a promising strategy for cancer treatment by acting on glycolytic tumors while showing minimal side effects on the oxidative healthy organs.  This review considers the role of PDKs as regulator of PDC that catalyzes the oxidative decarboxylation of pyruvate in mitochondrion.  It is concluded that PDKs are solid therapeutic targets.  Inhibition of PDKs could be an attractive therapeutic approach for the development of anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWBd1-X2WBlbVg90H21EOLACvtfcHk0lgeM-D6vOHY7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1ejsLo%253D&md5=897a9100a5400807ae4043598d592aff</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7150%2Fijbs.13325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.13325%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DTargeting%2520tumor%2520metabolism%2520for%2520cancer%2520treatment%253A%2520is%2520Pyruvate%2520Dehydrogenase%2520Kinases%2520%2528PDKs%2529%2520a%2520viable%2520anticancer%2520target%253F%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2015%26volume%3D11%26spage%3D1390%26epage%3D1400%26doi%3D10.7150%2Fijbs.13325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Knoechel, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungay, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasten, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span> <span> </span><span class="NLM_article-title">Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">402</span>â <span class="NLM_lpage">415</span>, <span class="refDoi">Â DOI: 10.1021/bi051402s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051402s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=402-415&author=T.+R.+Knoechelauthor=A.+D.+Tuckerauthor=C.+M.+Robinsonauthor=C.+Phillipsauthor=W.+Taylorauthor=P.+J.+Bungayauthor=S.+A.+Kastenauthor=T.+E.+Rocheauthor=D.+G.+Brown&title=Regulatory+roles+of+the+N-terminal+domain+based+on+crystal+structures+of+human+pyruvate+dehydrogenase+kinase+2+containing+physiological+and+synthetic+ligands&doi=10.1021%2Fbi051402s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands</span></div><div class="casAuthors">Knoechel, Thorsten R.; Tucker, Alec D.; Robinson, Colin M.; Phillips, Chris; Taylor, Wendy; Bungay, Peter J.; Kasten, Shane A.; Roche, Thomas E.; Brown, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-415</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDHK) regulates the activity of the pyruvate dehydrogenase multienzyme complex.  PDHK inhibition provides a route for therapeutic intervention in diabetes and cardiovascular disorders.  We report crystal structures of human PDHK isoenzyme 2 (PDHK2) complexed with physiol. and synthetic ligands.  Several of the PDHK2 structures disclosed have C-terminal cross arms that span a large trough region between the N-terminal regulatory (R) domains of the PDHK2 dimers.  The structures contg. bound ATP and ADP demonstrate variation in the conformation of the active site lid, residues 316-321, which enclose the nucleotide Î² and Î³ phosphates at the active site in the C-terminal catalytic domain.  We have identified three novel ligand binding sites located in the R domain of PDHK2.  Dichloroacetate (DCA) binds at the pyruvate binding site in the center of the R domain, which together with ADP, induces significant changes at the active site.  Nov3r and AZ12 inhibitors bind at the lipoamide binding site that is located at one end of the R domain.  Pfz3 (an allosteric inhibitor) binds in an extended site at the other end of the R domain.  We conclude that the N-terminal domain of PDHK has a key regulatory function and propose that the different inhibitor classes act by discrete mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0BAYhcMgn7Vg90H21EOLACvtfcHk0lgeM-D6vOHY7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L&md5=62e6162ff1191e7b5ae88014dcb71830</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fbi051402s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051402s%26sid%3Dliteratum%253Aachs%26aulast%3DKnoechel%26aufirst%3DT.%2BR.%26aulast%3DTucker%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DW.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DKasten%26aufirst%3DS.%2BA.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26atitle%3DRegulatory%2520roles%2520of%2520the%2520N-terminal%2520domain%2520based%2520on%2520crystal%2520structures%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520containing%2520physiological%2520and%2520synthetic%2520ligands%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D402%26epage%3D415%26doi%3D10.1021%2Fbi051402s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allalunis-Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haromy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopaschuk, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puttagunta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">37</span>â <span class="NLM_lpage">51</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2006.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.ccr.2006.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=17222789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=37-51&author=S.+Bonnetauthor=S.+L.+Archerauthor=J.+Allalunis-Turnerauthor=A.+Haromyauthor=C.+Beaulieuauthor=R.+Thompsonauthor=C.+T.+Leeauthor=G.+D.+Lopaschukauthor=L.+Puttaguntaauthor=S.+Bonnet&title=A+mitochondria-K%2B+channel+axis+is+suppressed+in+cancer+and+its+normalization+promotes+apoptosis+and+inhibits+cancer+growth&doi=10.1016%2Fj.ccr.2006.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span></div><div class="casAuthors">Bonnet, Sebastien; Archer, Stephen L.; Allalunis-Turner, Joan; Haromy, Alois; Beaulieu, Christian; Thompson, Richard; Lee, Christopher T.; Lopaschuk, Gary D.; Puttagunta, Lakshmi; Bonnet, Sandra; Harry, Gwyneth; Hashimoto, Kyoko; Porter, Christopher J.; Andrade, Miguel A.; Thebaud, Bernard; Michelakis, Evangelos D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-51</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The unique metabolic profile of cancer (aerobic glycolysis) might confer apoptosis resistance and be therapeutically targeted.  Compared to normal cells, several human cancers have high mitochondrial membrane potential (ÎÎ¨m) and low expression of the K+ channel Kv1.5, both contributing to apoptosis resistance.  Dichloroacetate (DCA) inhibits mitochondrial pyruvate dehydrogenase kinase (PDK), shifts metab. from glycolysis to glucose oxidn., decreases ÎÎ¨m, increases mitochondrial H2O2, and activates Kv channels in all cancer, but not normal, cells; DCA upregulates Kv1.5 by an NFAT1-dependent mechanism.  DCA induces apoptosis, decreases proliferation, and inhibits tumor growth, without apparent toxicity.  Mol. inhibition of PDK2 by siRNA mimics DCA.  The mitochondria-NFAT-Kv axis and PDK are important therapeutic targets in cancer; the orally available DCA is a promising selective anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocAukkjsEmZLVg90H21EOLACvtfcHk0lj6H1kIYX9LTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D&md5=ce8b45e3292469a3ce1af91803785bee</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DArcher%26aufirst%3DS.%2BL.%26aulast%3DAllalunis-Turner%26aufirst%3DJ.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DLopaschuk%26aufirst%3DG.%2BD.%26aulast%3DPuttagunta%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DS.%26atitle%3DA%2520mitochondria-K%252B%2520channel%2520axis%2520is%2520suppressed%2520in%2520cancer%2520and%2520its%2520normalization%2520promotes%2520apoptosis%2520and%2520inhibits%2520cancer%2520growth%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D11%26spage%3D37%26epage%3D51%26doi%3D10.1016%2Fj.ccr.2006.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of N-arylphenyl-2,2-dichloroacetamide analogues as anti-cancer agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">7268</span>â <span class="NLM_lpage">7271</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2012.07.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.bmcl.2012.07.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23067553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFWhsrjO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7268-7271&author=T.+Liauthor=Y.+Yangauthor=C.+Chengauthor=A.+K.+Tiwariauthor=K.+Sodaniauthor=Y.+Zhaoauthor=I.+Abrahamauthor=Z.+S.+Chen&title=Design%2C+synthesis+and+biological+evaluation+of+N-arylphenyl-2%2C2-dichloroacetamide+analogues+as+anti-cancer+agents&doi=10.1016%2Fj.bmcl.2012.07.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of N-arylphenyl-2,2-dichloroacetamide analogues as anti-cancer agents</span></div><div class="casAuthors">Li, Tianwen; Yang, Yongchong; Cheng, Changmei; Tiwari, Amit K.; Sodani, Kamlesh; Zhao, Yufen; Abraham, Ioana; Chen, Zhe-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7268-7271</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our earlier research has shown that N-phenyl-2,2-dichloroacetamide analogs had much higher anti-cancer activity than the lead compd. sodium dichloroacetate (DCA).  In this current study, a variety of N-arylphenyl-2,2-dichloroacetamide analogs were synthesized via Suzuki coupling reaction and their anti-cancer activity was evaluated.  The results showed that N-terphenyl-2,2-dichloroacetamide analogs had satisfactory anti-cancer activity.  Among them, N-(3,5-bis(benzo[d][1,3]dioxol-5-yl)phenyl)-2,2-dichloroacetamide had an IC50 of 2.40 Î¼M against KB-3-1 cells, 1.04 Î¼M against H460 cells and 1.73 Î¼M against A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGyQg9q24gdrVg90H21EOLACvtfcHk0lj6H1kIYX9LTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFWhsrjO&md5=5c4537ff62f29610e70b2905a1a253d4</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.057%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DTiwari%26aufirst%3DA.%2BK.%26aulast%3DSodani%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAbraham%26aufirst%3DI.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520N-arylphenyl-2%252C2-dichloroacetamide%2520analogues%2520as%2520anti-cancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7268%26epage%3D7271%26doi%3D10.1016%2Fj.bmcl.2012.07.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: design, synthesis and biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4300</span>â <span class="NLM_lpage">4306</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2010.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.ejmech.2010.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=20663593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4300-4306&author=Y.+Yangauthor=P.+Shangauthor=C.+Chengauthor=D.+Wangauthor=P.+Yangauthor=F.+Zhangauthor=T.+Liauthor=A.+Luauthor=Y.+Zhao&title=Novel+N-phenyl+dichloroacetamide+derivatives+as+anticancer+reagents%3A+design%2C+synthesis+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2010.06.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: Design, synthesis and biological evaluation</span></div><div class="casAuthors">Yang, Yongchong; Shang, Peihua; Cheng, Changmei; Wang, Dongchun; Yang, Ping; Zhang, Feng; Li, Tianwen; Lu, Aijun; Zhao, Yufen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4300-4306</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A current study shows that sodium dichloroacetate (DCA) can induce cancer cell apoptosis and inhibit tumor growth, but its cytotoxic activity is low (IC50 > 1000 Î¼M for A549).  In this paper, a variety of DCA derivs. were synthesized, and their cytotoxic activities were evaluated.  The result showed that the N-phenyl-2,2-dichloroacetamide analogs had satisfactory potencies.  Among them, N-(3-iodophenyl)-2,2-dichloroacetamide, an optimized lead compd., has an IC50 against A549 as low as 4.76 Î¼M.  Furthermore, it can induce cancer cell apoptosis and has a low toxicity in mice (LD50 = 1117 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvkHzJq8OK77Vg90H21EOLACvtfcHk0lj6H1kIYX9LTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLY%253D&md5=a3eef328bc5c3ff3fdc8b2ebd81e73ff</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DShang%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DNovel%2520N-phenyl%2520dichloroacetamide%2520derivatives%2520as%2520anticancer%2520reagents%253A%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4300%26epage%3D4306%26doi%3D10.1016%2Fj.ejmech.2010.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrache, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harn, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span> <span> </span><span class="NLM_article-title">Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1178</span>â <span class="NLM_lpage">1187</span>, <span class="refDoi">Â DOI: 10.1021/cb400944y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400944y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1178-1187&author=R.+K.+Pathakauthor=S.+Marracheauthor=D.+A.+Harnauthor=S.+Dhar&title=Mito-DCA%3A+a+mitochondria+targeted+molecular+scaffold+for+efficacious+delivery+of+metabolic+modulator+dichloroacetate&doi=10.1021%2Fcb400944y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate</span></div><div class="casAuthors">Pathak, Rakesh K.; Marrache, Sean; Harn, Donald A.; Dhar, Shanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1178-1187</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor growth is fueled by the use of glycolysis, which normal cells use only in the scarcity of oxygen.  Glycolysis makes tumor cells resistant to normal death processes.  Targeting this unique tumor metab. can provide an alternative strategy to selectively destroy the tumor, leaving normal tissue unharmed.  The orphan drug dichloroacetate (DCA) is a mitochondrial kinase inhibitor that has the ability to show such characteristics.  However, its mol. form shows poor uptake and bioavailability and limited ability to reach its target mitochondria.  Here, we describe a targeted mol. scaffold for construction of a multiple DCA loaded compd., Mito-DCA, with three orders of magnitude enhanced potency and cancer cell specificity compared to DCA.  Incorporation of a lipophilic triphenylphosphonium cation through a biodegradable linker in Mito-DCA allowed for mitochondria targeting.  Mito-DCA did not show any significant metabolic effects toward normal cells but tumor cells with dysfunctional mitochondria were affected by Mito-DCA, which caused a switch from glycolysis to glucose oxidn. and subsequent cell death via apoptosis.  Effective delivery of DCA to the mitochondria resulted in significant redn. in lactate levels and played important roles in modulating dendritic cell (DC) phenotype evidenced by secretion of interleukin-12 from DCs upon activation with tumor antigens from Mito-DCA treated cancer cells.  Targeting mitochondrial metabolic inhibitors to the mitochondria could lead to induction of an efficient antitumor immune response, thus introducing the concept of combining glycolysis inhibition with immune system to destroy tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_tg-468e5JrVg90H21EOLACvtfcHk0lhvxJNdJMYjmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D&md5=d9a7041a1c8f3417e5bf290e00b092d4</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fcb400944y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400944y%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DR.%2BK.%26aulast%3DMarrache%26aufirst%3DS.%26aulast%3DHarn%26aufirst%3DD.%2BA.%26aulast%3DDhar%26aufirst%3DS.%26atitle%3DMito-DCA%253A%2520a%2520mitochondria%2520targeted%2520molecular%2520scaffold%2520for%2520efficacious%2520delivery%2520of%2520metabolic%2520modulator%2520dichloroacetate%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1178%26epage%3D1187%26doi%3D10.1021%2Fcb400944y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Unexpected discovery of Dichloroacetate derived adenosine triphosphate competitors targeting pyruvate dehydrogenase kinase to inhibit cancer proliferation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3562</span>â <span class="NLM_lpage">3568</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eis7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3562-3568&author=S.+L.+Zhangauthor=X.+Huauthor=W.+Zhangauthor=K.+Y.+Tam&title=Unexpected+discovery+of+Dichloroacetate+derived+adenosine+triphosphate+competitors+targeting+pyruvate+dehydrogenase+kinase+to+inhibit+cancer+proliferation&doi=10.1021%2Facs.jmedchem.5b01828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12dR"><div class="casContent"><span class="casTitleNuber">12d</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation</span></div><div class="casAuthors">Zhang, Shao-Lin; Hu, Xiaohui; Zhang, Wen; Tam, Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3562-3568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinases (PDKs) have recently emerged as an attractive target for cancer therapy.  Herein, the authors prepd. a series of compds. derived from dichloroacetate (DCA) which inhibited cancer cells proliferation.  For the first time, the authors have successfully developed DCA derived inhibitors that preferentially bind to the ATP pocket of PDK isoform 1 (PDK1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmY3Q84QJe_bVg90H21EOLACvtfcHk0lhvxJNdJMYjmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eis7k%253D&md5=fa825a672c4c481c0cc55f59da38b43f</span></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01828%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DUnexpected%2520discovery%2520of%2520Dichloroacetate%2520derived%2520adenosine%2520triphosphate%2520competitors%2520targeting%2520pyruvate%2520dehydrogenase%2520kinase%2520to%2520inhibit%2520cancer%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3562%26epage%3D3568%26doi%3D10.1021%2Facs.jmedchem.5b01828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butlin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgour, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myatt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, B. R.</span></span> <span> </span><span class="NLM_article-title">AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1165</span>â <span class="NLM_lpage">1167</span>, <span class="refDoi">Â DOI: 10.1042/bst0311165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1042%2Fbst0311165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=14641018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1165-1167&author=R.+M.+Mayersauthor=R.+J.+Butlinauthor=E.+Kilgourauthor=B.+Leightonauthor=D.+Martinauthor=J.+Myattauthor=J.+P.+Ormeauthor=B.+R.+Holloway&title=AZD7545%2C+a+novel+inhibitor+of+pyruvate+dehydrogenase+kinase+2+%28PDHK2%29%2C+activates+pyruvate+dehydrogenase+in+vivo+and+improves+blood+glucose+control+in+obese+%28fa%2Ffa%29+Zucker+rats&doi=10.1042%2Fbst0311165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats</span></div><div class="casAuthors">Mayers, R. M.; Butlin, R. J.; Kilgour, E.; Leighton, B.; Martin, D.; Myatt, J.; Orme, J. P.; Holloway, B. R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-1167</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">PDH (pyruvate dehydrogenase) is a key enzyme controlling the rate of glucose oxidn., and the availability of gluconeogenic precursors.  Activation of PDH in skeletal muscle and liver may increase glucose uptake and reduce glucose prodn.  This study describes the properties of AZD7545, a novel, small-mol. inhibitor of PDHK (PDH kinase).  In the presence of PDHK2, AZD7545 increased PDH activity with an EC50 value of 5.2 nM.  In rat hepatocytes, the rate of pyruvate oxidn. was stimulated 2-fold (EC50 105 nM).  A single dose of AZD7545 to Wistar rats increased the proportion of liver PDH in its active, dephosphorylated form in a dose-related manner from 24.7 to 70.3% at 30 mg/kg; and in skeletal muscle from 21.1 to 53.3%.  A single dose of 10 mg/kg also significantly elevated muscle PDH activity in obese Zucker (fa / fa) rats.  Obese, insulin-resistant, Zucker rats show elevated postprandial glucose levels compared with their lean counterparts (8.7 vs. 6.1 mM at 12 wk old).  AZD7545 (10 mg/kg) twice daily for 7 days markedly improved the 24-h glucose profile, by eliminating the postprandial elevation in blood glucose.  These results suggest that PDHK inhibitors may be beneficial agents for improving glucose control in the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3Q4M5QmmjLVg90H21EOLACvtfcHk0lhvxJNdJMYjmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsr4%253D&md5=409b3a21f3cd550e2c04311446e5d0a0</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1042%2Fbst0311165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311165%26sid%3Dliteratum%253Aachs%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DKilgour%26aufirst%3DE.%26aulast%3DLeighton%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DMyatt%26aufirst%3DJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DB.%2BR.%26atitle%3DAZD7545%252C%2520a%2520novel%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520%2528PDHK2%2529%252C%2520activates%2520pyruvate%2520dehydrogenase%2520in%2520vivo%2520and%2520improves%2520blood%2520glucose%2520control%2520in%2520obese%2520%2528fa%252Ffa%2529%2520Zucker%2520rats%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1165%26epage%3D1167%26doi%3D10.1042%2Fbst0311165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butlin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgour, E.</span></span> <span> </span><span class="NLM_article-title">AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1168</span>â <span class="NLM_lpage">1170</span>, <span class="refDoi">Â DOI: 10.1042/bst0311168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1042%2Fbst0311168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=14641019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1168-1170&author=J.+A.+Morrellauthor=J.+Ormeauthor=R.+J.+Butlinauthor=T.+E.+Rocheauthor=R.+M.+Mayersauthor=E.+Kilgour&title=AZD7545+is+a+selective+inhibitor+of+pyruvate+dehydrogenase+kinase+2&doi=10.1042%2Fbst0311168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2</span></div><div class="casAuthors">Morrell, J. A.; Orme, J.; Butlin, R. J.; Roche, T. E.; Mayers, R. M.; Kilgour, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1168-1170</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The PDH (pyruvate dehydrogenase) multi-enzyme complex catalyzes a key regulatory step in oxidative glycolysis.  Phosphorylation of the E1 subunit of the complex on serine residues results in the inactivation of enzyme activity.  A family of four dedicated PDH kinase isoenzymes exists, each of which displays a distinct tissue-specific expression profile.  AZD7545 is one of a series of PDH kinase inhibitors developed for the treatment of type 2 diabetes.  The isoenzyme-selectivity profile of AZD7545 and related compds. is described and the consequences for their in vivo mode of action are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRKIXN95mX-bVg90H21EOLACvtfcHk0ljGAl3NbciKwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsr8%253D&md5=86c9fe03c05f86792c14953c381d3beb</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1042%2Fbst0311168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311168%26sid%3Dliteratum%253Aachs%26aulast%3DMorrell%26aufirst%3DJ.%2BA.%26aulast%3DOrme%26aufirst%3DJ.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DKilgour%26aufirst%3DE.%26atitle%3DAZD7545%2520is%2520a%2520selective%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25202%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1168%26epage%3D1170%26doi%3D10.1042%2Fbst0311168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hiromasa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, T. E.</span></span> <span> </span><span class="NLM_article-title">Specific ion influences on self-association of pyruvate dehydrogenase kinase isoform 2 (PDHK2), binding of PDHK2 to the L2 lipoyl domain, and effects of the lipoyl group-binding site inhibitor, Nov3r</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2312</span>â <span class="NLM_lpage">2324</span>, <span class="refDoi">Â DOI: 10.1021/bi7014772</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi7014772" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyitbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=2312-2324&author=Y.+Hiromasaauthor=X.+Yanauthor=T.+E.+Roche&title=Specific+ion+influences+on+self-association+of+pyruvate+dehydrogenase+kinase+isoform+2+%28PDHK2%29%2C+binding+of+PDHK2+to+the+L2+lipoyl+domain%2C+and+effects+of+the+lipoyl+group-binding+site+inhibitor%2C+Nov3r&doi=10.1021%2Fbi7014772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Ion Influences on Self-Association of Pyruvate Dehydrogenase Kinase Isoform 2 (PDHK2), Binding of PDHK2 to the L2 Lipoyl Domain, and Effects of the Lipoyl Group-Binding Site Inhibitor, Nov3r</span></div><div class="casAuthors">Hiromasa, Yasuaki; Yan, Xiaohua; Roche, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2312-2324</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Assocn. of the PDHK2 and GST-L2 (glutathione-S-transferase fused to the inner lipoyl domain (L2) of dihydrolipoyl acetyltransferase (E2)) dimers was enhanced by K+ with higher affinity K+ binding than occurs at the PDHK2 active site.  Supporting a distinct K+ binding site, the NH4+ ion did not effectively replace K+ in aiding GST-L2 binding.  With 50 mM K+, Pi enhanced interference by ADP, ATP, or pyruvate of PDHK2 binding to GST-L2.  The inclusion of Pi with ADP or ATP plus pyruvate greatly hindered PDHK2 binding to GST-L2 and promoted PDHK2 forming a tetramer.  Reciprocally, GST-L2 interference with ATP/ADP binding also required elevated K+ and was increased by Pi.  Potent inhibition by Nov3r of E2-activated PDHK2 activity (IC50 of â¼7.8 nM) required elevated K+ and Pi.  Nov3r only modestly inhibited the low activity of PDHK2 without E2.  By binding at the lipoyl group binding site, Nov3r prevented PDHK2 binding to E2 and GST-L2.  Nov3r interfered with high-affinity binding of ADP and pyruvate via a Pi-dependent mechanism.  Thus, GST-L2 binding to PDHK2 is supported by K+ binding at a site distinct from the active site.  Pi makes major contributions to ligands interfering with PDHK2 binding to GST-L2, the conversion of PDHK2 dimer to a tetramer, and Nov3r (an acetyl-lipoate analog) interfering with binding of ADP and pyruvate.  Pi is suggested to facilitate transmission within PDHK2 of the stimulatory signal of acetylation from the distal lipoyl-group binding site to the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4vmP7rusb0bVg90H21EOLACvtfcHk0ljGAl3NbciKwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyitbw%253D&md5=92d9b85afe55be2b4baacb4178f08ed7</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fbi7014772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7014772%26sid%3Dliteratum%253Aachs%26aulast%3DHiromasa%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26atitle%3DSpecific%2520ion%2520influences%2520on%2520self-association%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520isoform%25202%2520%2528PDHK2%2529%252C%2520binding%2520of%2520PDHK2%2520to%2520the%2520L2%2520lipoyl%2520domain%252C%2520and%2520effects%2520of%2520the%2520lipoyl%2520group-binding%2520site%2520inhibitor%252C%2520Nov3r%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D2312%26epage%3D2324%26doi%3D10.1021%2Fbi7014772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">92</span>, <span class="refDoi">Â DOI: 10.1016/j.ejps.2017.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.ejps.2017.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=28347773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOqtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2017&pages=87-92&author=S.+L.+Zhangauthor=W.+Zhangauthor=Z.+Yangauthor=X.+Huauthor=K.+Y.+Tam&title=Synthesis+and+biological+evaluation+of+%28R%29-3%2C3%2C3-trifluoro-2-hydroxy-2-methylpropionamides+as+pyruvate+dehydrogenase+kinase+1+%28PDK1%29+inhibitors+to+reduce+the+growth+of+cancer+cells&doi=10.1016%2Fj.ejps.2017.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells</span></div><div class="casAuthors">Zhang, Shao-Lin; Zhang, Wen; Yang, Zheng; Hu, Xiaohui; Tam, Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Most cancer cells exhibit a high rate of glycolysis and reduced capacity in mitochondrial oxidative phosphorylation.  The expression of pyruvate dehydrogenase kinases (PDKs) was found to be increased in many cancer cells.  Inhibition of PDKs increases the oxidative phosphorylation of glucose, which may disrupt the balance between the demand and supply of oxygen in cancer cell, thus leading to cell death.  Several reports suggested that compds. contg. (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide group could inhibit PDKs in pyruvate dehydrogenase primary enzymic assay.  However, none of them were capable of reducing the growth of cancer cells.  Herein, we report the synthesis and biol. evaluation of some novel PDK1 inhibitors contg. the (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide warhead.  Excitingly, these novel PDK1 inhibitors exhibited good potency to reduce the growth of cancer cells.  We have demonstrated that these compds. could phys. assoc. with PDK1 and activate pyruvate dehydrogenase in low micromolar levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxXedalvtbQ7Vg90H21EOLACvtfcHk0ljGAl3NbciKwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOqtLk%253D&md5=7383daf75ee4cfcb3bf5d489b70dfa0d</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2017.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2017.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520%2528R%2529-3%252C3%252C3-trifluoro-2-hydroxy-2-methylpropionamides%2520as%2520pyruvate%2520dehydrogenase%2520kinase%25201%2520%2528PDK1%2529%2520inhibitors%2520to%2520reduce%2520the%2520growth%2520of%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D110%26spage%3D87%26epage%3D92%26doi%3D10.1016%2Fj.ejps.2017.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dijk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hekelaar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwisscha
van Scheltinga, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moman, E.</span></span> <span> </span><span class="NLM_article-title">Furoates and thenoates inhibit pyruvate dehydrogenase kinase 2 allosterically by binding to its pyruvate regulatory site</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">170</span>â <span class="NLM_lpage">175</span>, <span class="refDoi">Â DOI: 10.1080/14756366.2016.1201812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1080%2F14756366.2016.1201812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=27435185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktbbK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=170-175&author=T.+Masiniauthor=B.+Birkayaauthor=S.+van+Dijkauthor=M.+Mondalauthor=J.+Hekelaarauthor=M.+Jagerauthor=A.+C.+Terwisscha%0Avan+Scheltingaauthor=M.+S.+Patelauthor=A.+K.+Hirschauthor=E.+Moman&title=Furoates+and+thenoates+inhibit+pyruvate+dehydrogenase+kinase+2+allosterically+by+binding+to+its+pyruvate+regulatory+site&doi=10.1080%2F14756366.2016.1201812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Furoates and thenoates inhibit pyruvate dehydrogenase kinase 2 allosterically by binding to its pyruvate regulatory site</span></div><div class="casAuthors">Masini, Tiziana; Birkaya, Barbara; van Dijk, Simon; Mondal, Milon; Hekelaar, Johan; Jaeger, Manuel; Terwisscha van Scheltinga, Anke C.; Patel, Mulchand S.; Hirsch, Anna K. H.; Moman, Edelmiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup4</span>),
    <span class="NLM_cas:pages">170-175</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The last decade has witnessed the reawakening of cancer metab. as a therapeutic target.  In particular, inhibition of pyruvate dehydrogenase kinase (PDK) holds remarkable promise.  Dichloroacetic acid (DCA), currently undergoing clin. trials, is a unique PDK inhibitor in which it binds to the allosteric pyruvate site of the enzyme.  However, the safety of DCA as a drug is compromised by its neurotoxicity, whereas its usefulness as an investigative tool is limited by the high concns. required to exert observable effects in cell culture.  Herein, we report the identification - by making use of satn.-transfer difference NMR spectroscopy, enzymic assays and computational methods - of furoate and thenoate derivs. as allosteric pyruvatesite-binding PDK2 inhibitors.  This work substantiates the pyruvate regulatory pocket as a druggable target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJOOvduZ3b67Vg90H21EOLACvtfcHk0ljg8OxLaicwOA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktbbK&md5=710eeccceb190c6041c92c790e8aa691</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1201812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1201812%26sid%3Dliteratum%253Aachs%26aulast%3DMasini%26aufirst%3DT.%26aulast%3DBirkaya%26aufirst%3DB.%26aulast%3Dvan%2BDijk%26aufirst%3DS.%26aulast%3DMondal%26aufirst%3DM.%26aulast%3DHekelaar%26aufirst%3DJ.%26aulast%3DJager%26aufirst%3DM.%26aulast%3DTerwisscha%2Bvan%2BScheltinga%26aufirst%3DA.%2BC.%26aulast%3DPatel%26aufirst%3DM.%2BS.%26aulast%3DHirsch%26aufirst%3DA.%2BK.%26aulast%3DMoman%26aufirst%3DE.%26atitle%3DFuroates%2520and%2520thenoates%2520inhibit%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520allosterically%2520by%2520binding%2520to%2520its%2520pyruvate%2520regulatory%2520site%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D170%26epage%3D175%26doi%3D10.1080%2F14756366.2016.1201812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gahlot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakkar, R.</span></span> <span> </span><span class="NLM_article-title">Docking modes of Pfz3 and its analogues into the lipoamide binding site on PDHK2</span>. <i>Int. Res. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">33</span>â <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKlt7jN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=33-41&author=P.+Gahlotauthor=R.+Kakkar&title=Docking+modes+of+Pfz3+and+its+analogues+into+the+lipoamide+binding+site+on+PDHK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Docking modes of Pfz3 and its analogues into the lipoamide binding site on PDHK2</span></div><div class="casAuthors">Gahlot, Pragya; Kakkar, Rita</div><div class="citationInfo"><span class="NLM_cas:title">International Research Journal of Pharmaceuticals</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-41</span>CODEN:
                <span class="NLM_cas:coden">IRJPCT</span>;
        ISSN:<span class="NLM_cas:issn">2048-4143</span>.
    
            (<span class="NLM_cas:orgname">Scientific Journals</span>)
        </div><div class="casAbstract">Inhibitors based on the PDHK2 synthetic inhibitor Pfz3 have been docked into the lipoamide binding site of PDHK2.  It is found that all analogs bind at the same site and most of the proposed structural modifications lead to better binding.  This suggests that homologous inhibitors have similar binding patterns in and modes of interaction with PDHK2 and have a similar inhibitory mechanism.  In particular, replacement of the iso-Pr group docking in the hydrophobic region by its fluoro analog leads to better docking.  Another potential improvement can be brought out by replacement of chlorine by bromine.  Replacement of the carbonyl oxygen by sulfur, however, has a deleterious effect, as it reduces the hydrogen bond energy.  Most of the considered modifications improve the score and all but one of the new compds. score higher than Pfz3 itself.  Further, ADME screening provided a peer anal. for the final selection of potential candidates from the compd. library generated.  This approach promises to suggest future leads for rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqleuIf1S4KrrVg90H21EOLACvtfcHk0lgzbBHxUznhCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKlt7jN&md5=d0588af18be4f77d1497bbcd65977804</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGahlot%26aufirst%3DP.%26aulast%3DKakkar%26aufirst%3DR.%26atitle%3DDocking%2520modes%2520of%2520Pfz3%2520and%2520its%2520analogues%2520into%2520the%2520lipoamide%2520binding%2520site%2520on%2520PDHK2%26jtitle%3DInt.%2520Res.%2520J.%2520Pharm.%26date%3D2011%26volume%3D1%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, D. T.</span></span> <span> </span><span class="NLM_article-title">Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">992</span>â <span class="NLM_lpage">1004</span>, <span class="refDoi">Â DOI: 10.1016/j.str.2007.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.str.2007.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=17683942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=992-1004&author=M.+Katoauthor=J.+Liauthor=J.+L.+Chuangauthor=D.+T.+Chuang&title=Distinct+structural+mechanisms+for+inhibition+of+pyruvate+dehydrogenase+kinase+isoforms+by+AZD7545%2C+dichloroacetate%2C+and+radicicol&doi=10.1016%2Fj.str.2007.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Structural Mechanisms for Inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545, Dichloroacetate, and Radicicol</span></div><div class="casAuthors">Kato, Masato; Li, Jun; Chuang, Jacinta L.; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">992-1004</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) isoforms are mol. switches that downregulate the pyruvate dehydrogenase complex (PDC) by reversible phosphorylation in mitochondria.  We have detd. structures of human PDK1 or PDK3 bound to the inhibitors AZD7545, dichloroacetate (DCA), and radicicol.  We show that the trifluoromethylpropanamide end of AZD7545 projects into the lipoyl-binding pocket of PDK1.  This interaction results in inhibition of PDK1 and PDK3 activities by aborting kinase binding to the PDC scaffold.  Paradoxically, AZD7545 at satg. concns. robustly increases scaffold-free PDK3 activity, similar to the inner lipoyl domain.  Good DCA d. is present in the helix bundle in the N-terminal domain of PDK1.  Bound DCA promotes local conformational changes that are communicated to both nucleotide-binding and lipoyl-binding pockets of PDK1, leading to the inactivation of kinase activity. Finally, radicicol inhibits kinase activity by binding directly to the ATP-binding pocket of PDK3, similar to Hsp90 and Topo VI from the same ATPase/kinase superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCpzfnlsNVarVg90H21EOLACvtfcHk0lgzbBHxUznhCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D&md5=3efc7e8b434566932ef28ca3486c401a</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DDistinct%2520structural%2520mechanisms%2520for%2520inhibition%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520isoforms%2520by%2520AZD7545%252C%2520dichloroacetate%252C%2520and%2520radicicol%26jtitle%3DStructure%26date%3D2007%26volume%3D15%26spage%3D992%26epage%3D1004%26doi%3D10.1016%2Fj.str.2007.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regenass, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of 4, 5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9832</span>â <span class="NLM_lpage">9843</span>, <span class="refDoi">Â DOI: 10.1021/jm5010144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9832-9843&author=T.+Mengauthor=D.+Zhangauthor=Z.+Xieauthor=T.+Yuauthor=S.+Wuauthor=L.+Wyderauthor=U.+Regenassauthor=K.+Hilpertauthor=M.+Huangauthor=M.+Geng&title=Discovery+and+optimization+of+4%2C+5-diarylisoxazoles+as+potent+dual+inhibitors+of+pyruvate+dehydrogenase+kinase+and+heat+shock+protein+90&doi=10.1021%2Fjm5010144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span></div><div class="casAuthors">Meng, Tao; Zhang, Dadong; Xie, Zuoquan; Yu, Ting; Wu, Shuchao; Regenass, Urs; Hilpert, Kurt; Huang, Min; Geng, Meiyu; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9832-9843</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Upregulation of pyruvate dehydrogenase kinase (PDHK) has been obsd. in a variety of cancers.  Inhibition of PDHK offers an attractive opportunity for the development of novel cancer therapies.  To obtain novel PDHK inhibitors, the authors took advantage of the homol. of the ATP-binding pocket between Heat Shock Protein 90 (HSP90) and PDHK, and utilized 4,5-diarylisoxazole based HSP90 inhibitor for structural design.  The efforts led to the identification of I that inhibited PDHK1 with an IC50 value of 17 nM, which, however, showed marginal cellular activity.  Further structural optimization resulted in compd. II with improved cellular activity which could effectively modulate the metabolic profile of cancer cells and lead to the inhibition of cancer cell proliferation, evidenced by the increased oxidative phosphorylation and decreased glycolysis and assocd. oxidative stress.  The results suggested II as an excellent lead compd. and a favorable biol. tool to further evaluate the therapeutic potential of PDHK and HSP90 dual inhibitors in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpX1cvlKuuz7Vg90H21EOLACvtfcHk0lgu_OuJNFFVNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK&md5=ab2f08b46344868b81247a228b149755</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm5010144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010144%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWyder%26aufirst%3DL.%26aulast%3DRegenass%26aufirst%3DU.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25204%252C%25205-diarylisoxazoles%2520as%2520potent%2520dual%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520and%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9832%26epage%3D9843%26doi%3D10.1021%2Fjm5010144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâAlessandro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, P. C.</span></span> <span> </span><span class="NLM_article-title">VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12862</span>â <span class="NLM_lpage">12876</span>, <span class="refDoi">Â DOI: 10.18632/oncotarget.2656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.18632%2Foncotarget.2656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=25404640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ovVyjtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=12862-12876&author=J.+D.+Mooreauthor=A.+Staniszewskaauthor=T.+Shawauthor=J.+D%E2%80%99Alessandroauthor=B.+Davisauthor=A.+Surgenorauthor=L.+Bakerauthor=N.+Matassovaauthor=J.+Murrayauthor=A.+Maciasauthor=P.+Broughauthor=M.+Woodauthor=P.+C.+Mahon&title=VER-246608%2C+a+novel+pan-isoform+ATP+competitive+inhibitor+of+pyruvate+dehydrogenase+kinase%2C+disrupts+Warburg+metabolism+and+induces+context-dependent+cytostasis+in+cancer+cells&doi=10.18632%2Foncotarget.2656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells</span></div><div class="casAuthors">Moore Jonathan D; Staniszewska Anna; Shaw Terence; D'Alessandro Jalanie; Davis Ben; Surgenor Alan; Baker Lisa; Matassova Natalia; Murray James; Macias Alba; Brough Paul; Wood Mike; Mahon Patrick C</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">12862-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) is a pivotal enzyme in cellular energy metabolism that has previously been implicated in cancer through both RNAi based studies and clinical correlations with poor prognosis in several cancer types.  Here, we report the discovery of a novel and selective ATP competitive pan-isoform inhibitor of PDK, VER-246608.  Consistent with a PDK mediated MOA, VER-246608 increased pyruvate dehydrogenase complex (PDC) activity, oxygen consumption and attenuated glycolytic activity.  However, these effects were only observed under D-glucose-depleted conditions and required almost complete ablation of PDC E1Î± subunit phosphorylation.  VER-246608 was weakly anti-proliferative to cancer cells in standard culture media; however, depletion of either serum or combined D-glucose/L-glutamine resulted in enhanced cellular potency.  Furthermore, this condition-selective cytostatic effect correlated with reduced intracellular pyruvate levels and an attenuated compensatory response involving deamination of L-alanine.  In addition, VER-246608 was found to potentiate the activity of doxorubicin.  In contrast, the lipoamide site inhibitor, Nov3r, demonstrated sub-maximal inhibition of PDK activity and no evidence of cellular activity.  These studies suggest that PDK inhibition may be effective under the nutrient-depleted conditions found in the tumour microenvironment and that combination treatments should be explored to reveal the full potential of this therapeutic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQq_Bxi2o-MqOxsqfvU0ziafW6udTcc2eZKKtK7aImimrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ovVyjtQ%253D%253D&md5=6480086dc38b2ebcbfa93b2e611d40f1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2656%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DStaniszewska%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMacias%26aufirst%3DA.%26aulast%3DBrough%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DMahon%26aufirst%3DP.%2BC.%26atitle%3DVER-246608%252C%2520a%2520novel%2520pan-isoform%2520ATP%2520competitive%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%252C%2520disrupts%2520Warburg%2520metabolism%2520and%2520induces%2520context-dependent%2520cytostasis%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D12862%26epage%3D12876%26doi%3D10.18632%2Foncotarget.2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knorr, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperbeck, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinluan, C. C.</span></span> <span> </span><span class="NLM_article-title">Secondary amides of (R)-3, 3, 3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">236</span>â <span class="NLM_lpage">249</span>, <span class="refDoi">Â DOI: 10.1021/jm990358+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990358%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVWktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=236-249&author=T.+D.+Aicherauthor=R.+C.+Andersonauthor=J.+Gaoauthor=S.+S.+Shettyauthor=G.+M.+Coppolaauthor=J.+L.+Stantonauthor=D.+C.+Knorrauthor=D.+M.+Sperbeckauthor=L.+J.+Brandauthor=C.+C.+Vinluan&title=Secondary+amides+of+%28R%29-3%2C+3%2C+3-trifluoro-2-hydroxy-2-methylpropionic+acid+as+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm990358%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Secondary Amides of (R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase</span></div><div class="casAuthors">Aicher, Thomas D.; Anderson, Robert C.; Gao, Jiaping; Shetty, Suraj S.; Coppola, Gary M.; Stanton, James L.; Knorr, Douglas C.; Sperbeck, Donald M.; Brand, Leonard J.; Vinluan, Christine C.; Kaplan, Emma L.; Dragland, Carol J.; Tomaselli, Hollis C.; Islam, Amin; Lozito, Robert J.; Liu, Xilin; Maniara, Wieslawa M.; Fillers, William S.; DelGrande, Dominick; Walter, R. Eric; Mann, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-249</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N'-Methyl-N-(4-tert-butyl-1,2,5,6-tetrahydropyridine)thiourea, SDZ048-619, is a modest inhibitor (IC50 = 180 Î¼M) of pyruvate dehydrogenase kinase (PDHK).  In an optimization of the N-methylcarbothioamide moiety of SDZ048-619, it was discovered that amides with a small acyl group, in particular appropriately substituted amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, are inhibitors of PDHK.  Utilizing this acyl moiety, herein is reported the rationale leading to the optimization of a series of acylated piperazine derivs.  Me substitution of the piperazine at the 2- and 5-positions (with S and R abs. stereochem.) markedly increased the potency of the lead compd. (>1000-fold).  Oral bioavailability of the compds. in this series is good and is optimal (as measured by AUC) when the 4-position of the piperazine is substituted with an electron-poor benzoyl moiety.  (+)-1-N-[2,5-(S,R)-Dimethyl-4-N-(4-cyanobenzoyl)piperazine]-(R)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide inhibits PDHK in the primary enzymic assay with an IC50 of 16 nM, enhances the oxidn. of [14C]lactate into 14CO2 in human fibroblasts with an EC50 of 57 nM, diminishes lactate significantly 2.5 h post-oral-dose at doses as low as 1 Î¼mol/kg, and increases the ex vivo activity of pyruvate dehydrogenase in muscle, liver, and fat tissues in normal Sprague-Dawley rats.  These PDHK inhibitors, however, do not lower glucose in diabetic animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIKZ8HyLQA-LVg90H21EOLACvtfcHk0lgNw0DLyy7oog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVWktQ%253D%253D&md5=fc326e00ff7db4addc99eee6073620fb</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm990358%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990358%252B%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BC.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DSperbeck%26aufirst%3DD.%2BM.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DVinluan%26aufirst%3DC.%2BC.%26atitle%3DSecondary%2520amides%2520of%2520%2528R%2529-3%252C%25203%252C%25203-trifluoro-2-hydroxy-2-methylpropionic%2520acid%2520as%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D236%26epage%3D249%26doi%3D10.1021%2Fjm990358%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, L. W.</span></span> <span> </span><span class="NLM_article-title">Anemone rivularis inhibits pyruvate dehydrogenase kinase activity and tumor growth</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">47</span>â <span class="NLM_lpage">54</span>, <span class="refDoi">Â DOI: 10.1016/j.jep.2017.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.jep.2017.03.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=28341246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFens78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2017&pages=47-54&author=T.+W.+Chungauthor=J.+H.+Leeauthor=H.+J.+Choiauthor=M.+J.+Parkauthor=E.+Y.+Kimauthor=S.+Jangauthor=S.+O.+Leeauthor=S.+W.+Leeauthor=J.+Hangauthor=L.+W.+Yi&title=Anemone+rivularis+inhibits+pyruvate+dehydrogenase+kinase+activity+and+tumor+growth&doi=10.1016%2Fj.jep.2017.03.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Anemone rivularis inhibits pyruvate dehydrogenase kinase activity and tumor growth</span></div><div class="casAuthors">Chung, Tae-Wook; Lee, Jung Hee; Choi, Hee-Jung; Park, Mi-Ju; Kim, Eun-Yeong; Han, Jung Ho; Jang, Sebok; Lee, Syng-Ook; Lee, Sang Woo; Hang, Jin; Yi, Li Wan; Ha, Ki-Tae</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Anemone rivularis Buch.-Ham. ex DC. (Ranunculaceae) have been used as a traditional remedy for treatment of inflammation and cancer.  However, there is no report demonstrating exptl. evidence on anti-tumor action of A. rivularis.  The Warburg's effect, preference of aerobic glycolysis rather than oxidative phosphorylation (OXPHOS) even in oxygen rich condition, is focused as one of major characteristics of malignant tumor.  Thus, we investigated the effect of A. rivularis on the Pyruvate dehydrogenase (PDH) kinases (PDHKs), a major mol. targets for reducing aerobic glycolysis.  The ethanol ext. of whole plant of A. rivularis (ARE), fingerprinted by high performance liq. chromatog. (HPLC), was applied to in vitro and cell-based PDHK activity assays.  The effect of ARE on cell viabilities of several tumor cells was estd. by MTT assay.  The expression of phosphor-PDH, PDH and PDHK1 were measured by Western blot anal.  The prodn. of reactive oxygen species (ROS) and apoptosis was measured by fluorescence-activated cell sorting anal., using 5-(and-6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) and Annexin V/propidium iodide (PI) staining, resp.  Mitochondrial membrane potential was examd. by tetramethylrhodamine Me ester (TMRM) staining.  In vivo anti-tumor efficacy of ARE was estd. by means of tumor vol. and wt. using allograft injection of murine Lewis lung carcinoma (LLC) cells to dorsa of C57BL/6 mice.  ARE inhibited the viabilities of several cancer cells, including MDA-MB321, K562, HT29, Hep3B, DLD-1, and LLC.  ARE suppressed PDHK activity in in vitro kinase assay, and also inhibited aerobic glycolysis by reducing phosphorylation of PDHA in human DLD-1 colon cancer and murine LLC cells.  The expression of PDHK1, a major isoform of PDHKs in cancer, was not affected by ARE treatment.  Moreover, ARE increased the both ROS prodn. and mitochondrial damage.  In addn., ARE suppressed the in vitro tumor growth through mitochondria-mediated apoptosis.  The growth rates of allograft LLC cells were also reduced by ARE treatment.  Here, we firstly report that ARE inhibits PDHK activity and growth of tumor in both in vitro and in vivo expts.  Therefore, we suggest ARE as a potential candidate for developing anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6kewK8V5fbrVg90H21EOLACvtfcHk0lgNw0DLyy7oog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFens78%253D&md5=4e6530d04102ee1631fb16116c494542</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2017.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2017.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DE.%2BY.%26aulast%3DJang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BO.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DHang%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DL.%2BW.%26atitle%3DAnemone%2520rivularis%2520inhibits%2520pyruvate%2520dehydrogenase%2520kinase%2520activity%2520and%2520tumor%2520growth%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2017%26volume%3D203%26spage%3D47%26epage%3D54%26doi%3D10.1016%2Fj.jep.2017.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bebernitz, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knorr, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohschein, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span> <span> </span><span class="NLM_article-title">Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2248</span>â <span class="NLM_lpage">2257</span>, <span class="refDoi">Â DOI: 10.1021/jm0000923</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0000923" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVGqt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2248-2257&author=G.+R.+Bebernitzauthor=T.+D.+Aicherauthor=J.+L.+Stantonauthor=J.+Gaoauthor=S.+S.+Shettyauthor=D.+C.+Knorrauthor=R.+J.+Strohscheinauthor=J.+Tanauthor=L.+J.+Brandauthor=C.+Liu&title=Anilides+of+%28R%29-trifluoro-2-hydroxy-2-methylpropionic+acid+as+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm0000923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Anilides of (R)-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase</span></div><div class="casAuthors">Bebernitz, Gregory R.; Aicher, Thomas D.; Stanton, James L.; Gao, Jiaping; Shetty, Suraj S.; Knorr, Douglas C.; Strohschein, Robert J.; Tan, Jennifer; Brand, Leonard J.; Liu, Charles; Wang, Wei H.; Vinluan, Christine C.; Kaplan, Emma L.; Dragland, Carol J.; DelGrande, Dominick; Islam, Amin; Lozito, Robert J.; Liu, Xilin; Maniara, Wieslawa M.; Mann, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2248-2257</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The optimization of a series of anilide derivs. of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase (PDHK) is described that started from N-phenyl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide 1 (IC50 = 35 Â± 1.4 Î¼M).  It was found that small electron-withdrawing groups on the ortho position of the anilide, i.e., chloro, acetyl, or bromo, increased potency 20-40-fold.  The oral bioavailability of the compds. in this series is optimal (as measured by AUC) when the anilide is substituted at the 4-position with an electron-withdrawing group (i.e., carboxyl, carboxyamide, and sulfoxyamide). N-(2-Chloro-4-isobutylsulfamoylphenyl)-(R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide inhibits PDHK in the primary enzymic assay with an IC50 of 13 Â± 1.5 nM, enhances the oxidn. of [14C]lactate into 14CO2 in human fibroblasts, lowers blood lactate levels significantly 2.5 and 5 h after oral doses as low as 30 Î¼mol/kg, and increases the ex vivo activity of PDH in muscle, kidney, liver, and heart tissues. However, in contrast to sodium dichloroacetate, these PDHK inhibitors did not lower blood glucose levels. Nevertheless, they are effective at increasing the utilization and disposal of lactate and could be of utility to ameliorate conditions of inappropriate blood lactate elevation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMhDErIEuIjrVg90H21EOLACvtfcHk0lgb6LiCX1zXiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVGqt7Y%253D&md5=39c46f8cea151e8d159487f57f0b15d4</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fjm0000923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0000923%26sid%3Dliteratum%253Aachs%26aulast%3DBebernitz%26aufirst%3DG.%2BR.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DStrohschein%26aufirst%3DR.%2BJ.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DAnilides%2520of%2520%2528R%2529-trifluoro-2-hydroxy-2-methylpropionic%2520acid%2520as%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2248%26epage%3D2257%26doi%3D10.1021%2Fjm0000923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagire, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagire, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dighe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaladi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gim, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Y. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel pyruvate dehydrogenase kinase 4 inhibitors for potential oral treatment of metabolic diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">575</span>â <span class="NLM_lpage">588</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01168</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01168" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFakuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=575-588&author=D.+Leeauthor=H.+S.+Pagireauthor=S.+H.+Pagireauthor=E.+J.+Baeauthor=M.+Digheauthor=M.+Kimauthor=K.+M.+Leeauthor=Y.+K.+Jangauthor=A.+K.+Jaladiauthor=K.+Y.+Jungauthor=E.+K.+Yooauthor=H.+E.+Gimauthor=S.+Leeauthor=W.+I.+Choiauthor=Y.+I.+Chiauthor=J.+S.+Songauthor=M.+A.+Baeauthor=Y.+H.+Jeonauthor=G.+H.+Leeauthor=K.+H.+Liuauthor=T.+Leeauthor=S.+Parkauthor=J.+H.+Jeonauthor=I.+K.+Leeauthor=J.+H.+Ahn&title=Discovery+of+novel+pyruvate+dehydrogenase+kinase+4+inhibitors+for+potential+oral+treatment+of+metabolic+diseases&doi=10.1021%2Facs.jmedchem.8b01168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases</span></div><div class="casAuthors">Lee, Dahye; Pagire, Haushabhau S.; Pagire, Suvarna H.; Bae, Eun Jung; Dighe, Mahesh; Kim, Minhee; Lee, Kyu Myung; Jang, Yoon Kyung; Jaladi, Ashok Kumar; Jung, Kwan-Young; Yoo, Eun Kyung; Gim, Hee Eon; Lee, Seungmi; Choi, Won-Il; Chi, Young-In; Song, Jin Sook; Bae, Myung Ae; Jeon, Yong Hyun; Lee, Ga-Hyun; Liu, Kwang-Hyeon; Lee, Taeho; Park, Sungmi; Jeon, Jae-Han; Lee, In-Kyu; Ahn, Jin Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">575-588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase 4 (PDK4) activation is assocd. with metabolic diseases including hyperglycemia, insulin resistance, allergies, and cancer.  Structural modifications of hit anthraquinone led to the identification of a new series of allosteric PDK4 inhibitors.  Among this series, compd. 8c showed promising in vitro activity with an IC50 value of 84 nM.  Good metabolic stability, pharmacokinetic profiles, and possible metabolites were suggested.  Compd. 8c improved glucose tolerance in diet-induced obese mice and ameliorated allergic reactions in a passive cutaneous anaphylaxis mouse model.  Addnl., compd. 8c exhibited anticancer activity by controlling cell proliferation, transformation, and apoptosis.  From the mol. docking studies, compd. 8c displayed optimal fitting in the lipoamide binding site (allosteric) with a full fitness, providing a new scaffold for drug development toward PDK4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodAERNQ0GcMLVg90H21EOLACvtfcHk0lhZpOVqhzCI1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFakuw%253D%253D&md5=31b365c1d241ac0d121d6a4a7bc13a54</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01168%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%26aulast%3DPagire%26aufirst%3DH.%2BS.%26aulast%3DPagire%26aufirst%3DS.%2BH.%26aulast%3DBae%26aufirst%3DE.%2BJ.%26aulast%3DDighe%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%2BM.%26aulast%3DJang%26aufirst%3DY.%2BK.%26aulast%3DJaladi%26aufirst%3DA.%2BK.%26aulast%3DJung%26aufirst%3DK.%2BY.%26aulast%3DYoo%26aufirst%3DE.%2BK.%26aulast%3DGim%26aufirst%3DH.%2BE.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BI.%26aulast%3DChi%26aufirst%3DY.%2BI.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DBae%26aufirst%3DM.%2BA.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DLiu%26aufirst%3DK.%2BH.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DJeon%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26atitle%3DDiscovery%2520of%2520novel%2520pyruvate%2520dehydrogenase%2520kinase%25204%2520inhibitors%2520for%2520potential%2520oral%2520treatment%2520of%2520metabolic%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D575%26epage%3D588%26doi%3D10.1021%2Facs.jmedchem.8b01168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tso, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morlock, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, D. T.</span></span> <span> </span><span class="NLM_article-title">Development of dihydroxyphenyl sulfonylisoindoline derivatives as liver-targeting pyruvate dehydrogenase Kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1142</span>â <span class="NLM_lpage">1150</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01540</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01540" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKisrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1142-1150&author=S.+C.+Tsoauthor=M.+Louauthor=C.+Y.+Wuauthor=W.+J.+Guiauthor=J.+L.+Chuangauthor=L.+K.+Morlockauthor=N.+S.+Williamsauthor=R.+M.+Wynnauthor=X.+Qiauthor=D.+T.+Chuang&title=Development+of+dihydroxyphenyl+sulfonylisoindoline+derivatives+as+liver-targeting+pyruvate+dehydrogenase+Kinase+inhibitors&doi=10.1021%2Facs.jmedchem.6b01540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors</span></div><div class="casAuthors">Tso, Shih-Chia; Lou, Mingliang; Wu, Cheng-Yang; Gui, Wen-Jun; Chuang, Jacinta L.; Morlock, Lorraine K.; Williams, Noelle S.; Wynn, R. Max; Qi, Xiangbing; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1142-1150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinases 1-4 (PDK1-4) neg. control activity of the pyruvate dehydrogenase complex (PDC) and are up-regulated in obesity, diabetes, heart failure and cancer.  The authors reported earlier two novel pan-PDK inhibitors PS8 [4-((5-hydroxyisoindolin-2-yl)sulfonyl)benzene-1,3-diol] and PS10 [2-((2,4-dihydroxyphenyl)sulfonyl)isoindoline-4,6-diol] that targeted the ATP-binding pocket in PDKs.  Here, the authors developed a new generation of PDK inhibitors by extending the dihydroxyphenyl sulfonylisoindoline scaffold in PS8 and PS10 to the entrance region of the ATP-binding pocket in PDK2.  The lead inhibitor PS46 [(S)-3-amino-4-(4-((2-((2,4-dihydroxyphenyl)sulfonyl)isoindolin-5-yl)amino)piperidin-1-yl)-4-oxobutanamide] (17) shows a â¼8-fold lower IC50 (58 nM) than 2 (456 nM).  In the crystal structure, the asparagine moiety in 17 provides addnl. interactions with Glu 262 from PDK2.  Treatment of diet-induced obese mice with 17 resulted in significant liver-specific augmentation of PDC activity, accompanied by improved glucose tolerance and drastically reduced hepatic steatosis.  These findings support 17 as a potential glucose-lowering therapeutic targeting liver for obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKDNbLY3_4KrVg90H21EOLACvtfcHk0lhZpOVqhzCI1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKisrs%253D&md5=70c22064b3920f8ff871e0265818a201</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01540%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DLou%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DGui%26aufirst%3DW.%2BJ.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DWynn%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DDevelopment%2520of%2520dihydroxyphenyl%2520sulfonylisoindoline%2520derivatives%2520as%2520liver-targeting%2520pyruvate%2520dehydrogenase%2520Kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1142%26epage%3D1150%26doi%3D10.1021%2Facs.jmedchem.6b01540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Development of the first generation of disulfide-based subtype-selective and potent covalent pyruvate dehydrogenase kinase 1 (PDK1) Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2227</span>â <span class="NLM_lpage">2244</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlyjtr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2227-2244&author=Y.+Liuauthor=Z.+Xieauthor=D.+Zhaoauthor=J.+Zhuauthor=F.+Maoauthor=S.+Tangauthor=H.+Xuauthor=C.+Luoauthor=M.+Gengauthor=M.+Huangauthor=J.+Li&title=Development+of+the+first+generation+of+disulfide-based+subtype-selective+and+potent+covalent+pyruvate+dehydrogenase+kinase+1+%28PDK1%29+Inhibitors&doi=10.1021%2Facs.jmedchem.6b01245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors</span></div><div class="casAuthors">Liu, Yifu; Xie, Zuoquan; Zhao, Dan; Zhu, Jin; Mao, Fei; Tang, Shuai; Xu, Hui; Luo, Cheng; Geng, Meiyu; Huang, Min; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2227-2244</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinases (PDKs) are overexpressed in most cancer cells and are responsible for aberrant glucose metab.  The authors previously described Bis(4-morpholinyl thiocarbonyl)-disulfide (JX06, 16) as the first covalent inhibitor of PDK1.  Here, based on the scaffold of JX06, the authors identify two novel types of disulfide-based PDK1 inhibitors.  The most potent analog, bis(1,4-oxazepan-4-yl-thiocarbonyl)disulfide (3a), effectively inhibits PDK1 both at the mol. (kinact/Ki = 4.17 Ã 103 M-1s-1) and the cellular level (down to 0.1 Î¼M).  In contrast to JX06, 3a is a potent and subtype-selective inhibitor of PDK1 with >40-fold selectivity for PDK2-4.  Compd. 3a also significantly alters glucose metabolic pathways in A549 cells by decreasing ECAR and increasing ROS.  Moreover, in the xenograft models, 3a shows significant antitumor activity with no neg. effect to the mice wt.  Collectively, these data demonstrate that 3a may be an excellent lead compd. for the treatment of cancer as a first-generation subtype-selective and covalent PDK1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEpZNCUKK6MrVg90H21EOLACvtfcHk0ljb3Rk0-tVhtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlyjtr0%253D&md5=7529ce2fc9d1a138a8d1405a23f7e4e8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01245%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520the%2520first%2520generation%2520of%2520disulfide-based%2520subtype-selective%2520and%2520potent%2520covalent%2520pyruvate%2520dehydrogenase%2520kinase%25201%2520%2528PDK1%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2227%26epage%3D2244%26doi%3D10.1021%2Facs.jmedchem.6b01245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chell, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâAlessandro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Strat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macias, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmonite, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span> <span> </span><span class="NLM_article-title">Application of off-rate screening in the identification of novel pan-isoform inhibitors of pyruvate dehydrogenase kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2271</span>â <span class="NLM_lpage">2286</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01478</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01478" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1agt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2271-2286&author=P.+A.+Broughauthor=L.+Bakerauthor=S.+Bedfordauthor=K.+Brownauthor=S.+Chavdaauthor=V.+Chellauthor=J.+D%E2%80%99Alessandroauthor=N.+G.+Daviesauthor=B.+Davisauthor=L.+Le+Stratauthor=A.+T.+Maciasauthor=D.+Maddoxauthor=P.+C.+Mahonauthor=A.+J.+Masseyauthor=N.+Matassovaauthor=S.+McKennaauthor=J.+W.+Meissnerauthor=J.+D.+Mooreauthor=J.+B.+Murrayauthor=C.+J.+Northfieldauthor=C.+Parryauthor=R.+Parsonsauthor=S.+D.+Roughleyauthor=T.+Shawauthor=H.+Simmoniteauthor=S.+Stokesauthor=A.+Surgenorauthor=E.+Stefaniakauthor=A.+Robertsonauthor=Y.+Wangauthor=P.+Webbauthor=N.+Whiteheadauthor=M.+Wood&title=Application+of+off-rate+screening+in+the+identification+of+novel+pan-isoform+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Facs.jmedchem.6b01478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase</span></div><div class="casAuthors">Brough, Paul A.; Baker, Lisa; Bedford, Simon; Brown, Kirsten; Chavda, Seema; Chell, Victoria; D'Alessandro, Jalanie; Davies, Nicholas G. M.; Davis, Ben; Le Strat, Loic; Macias, Alba T.; Maddox, Daniel; Mahon, Patrick C.; Massey, Andrew J.; Matassova, Natalia; McKenna, Sean; Moore, Jonathan D.; Murray, James B.; Northfield, Christopher J.; Parry, Charles; Parsons, Rachel; Roughley, Stephen D.; Shaw, Terry; Simmonite, Heather; Stokes, Stephen; Surgenor, Allan; Stefaniak, Emma; Robertson, Alan; Wang, Yikang; Webb, Paul; Whitehead, Neil; Wood, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2271-2286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Libraries of non-purified resorcinol amide derivs. were screened by surface plasmon resonance (SPR) to det. the binding dissocn. const. (off-rate, kd) for compds. binding to the pyruvate dehydrogenase kinase (PDHK) enzyme.  Parallel off-rate measurements against HSP90 and application of structure-based drug design enabled rapid hit to lead progression in a program to identify pan-isoform ATP-competitive inhibitors of PDHK.  Lead optimization identified selective sub-100-nM inhibitors of the enzyme which significantly reduced phosphorylation of the E1Î± subunit in the PC3 cancer cell line in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAus8qHW4d3bVg90H21EOLACvtfcHk0ljQr903bX364g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1agt7o%253D&md5=9727ca9e73096f63bbbb604c534155d8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01478%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DBedford%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DChavda%26aufirst%3DS.%26aulast%3DChell%26aufirst%3DV.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DLe%2BStrat%26aufirst%3DL.%26aulast%3DMacias%26aufirst%3DA.%2BT.%26aulast%3DMaddox%26aufirst%3DD.%26aulast%3DMahon%26aufirst%3DP.%2BC.%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DMcKenna%26aufirst%3DS.%26aulast%3DMeissner%26aufirst%3DJ.%2BW.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DParry%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DStefaniak%26aufirst%3DE.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWhitehead%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DApplication%2520of%2520off-rate%2520screening%2520in%2520the%2520identification%2520of%2520novel%2520pan-isoform%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2271%26epage%3D2286%26doi%3D10.1021%2Facs.jmedchem.6b01478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korotchkina, L. G.</span></span> <span> </span><span class="NLM_article-title">Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">191</span>â <span class="NLM_lpage">197</span>, <span class="refDoi">Â DOI: 10.1038/emm.2001.32</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Femm.2001.32" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=11795479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFehsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=191-197&author=M.+S.+Patelauthor=L.+G.+Korotchkina&title=Regulation+of+mammalian+pyruvate+dehydrogenase+complex+by+phosphorylation%3A+complexity+of+multiple+phosphorylation+sites+and+kinases&doi=10.1038%2Femm.2001.32"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: Complexity of multiple phosphorylation sites and kinases</span></div><div class="casAuthors">Patel, Mulchand S.; Korotchkina, Lioubov G.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">191-197</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1226-3613</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Medical Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review with 39 refs., summarizing recent developments in the regulation of the human pyruvate dehydrogenase complex (PDC) by site-specific phosphorylation with 4 kinases.  Mutagenic anal. of the 3 phosphorylation sites of human pyruvate dehydrogenase (E1) shows the site-independent mechanism of phosphorylation as well as site-independent dephosphorylation of the 3 phosphorylation sites and the importance of each phosphorylation site for the inactivation of E1.  Both the neg. charge and size of the group introduced at site 1 are involved in human E1 inactivation.  The mechanism of inactivation of E1 has been suggested to be site-specific.  Phosphorylation of site 1 affects E1 interaction with the lipoyl domain of dihydrolipoamide acetyltransferase, whereas phosphorylation site 3 appears to be closer to the thiamin pyrophosphate-binding region affecting coenzyme interaction with human E1.  Four isoenzymes of pyruvate dehydrogenase kinase (PDK) show different specificities for the 3 phosphorylation sites of E1.  All 4 PDKs phosphorylate sites 1 and 2 in PDC with different rates, and only PDK1 phosphorylates site 3.  PDK2 is maximally stimulated by the redn./acetylation of the lipoyl groups of E2.  The presence of the multiple phosphorylation sites and isoenzymes of PDK is important for the tissue-specific regulation of PDC under different physiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDcX-BoOs-J7Vg90H21EOLACvtfcHk0liMWDvAsh7fyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFehsA%253D%253D&md5=90879723a72a13f353c1af1c67d282ce</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Femm.2001.32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femm.2001.32%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BS.%26aulast%3DKorotchkina%26aufirst%3DL.%2BG.%26atitle%3DRegulation%2520of%2520mammalian%2520pyruvate%2520dehydrogenase%2520complex%2520by%2520phosphorylation%253A%2520complexity%2520of%2520multiple%2520phosphorylation%2520sites%2520and%2520kinases%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2001%26volume%3D33%26spage%3D191%26epage%3D197%26doi%3D10.1038%2Femm.2001.32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">621</span>â <span class="NLM_lpage">637</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2005.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors&doi=10.1016%2Fj.chembiol.2005.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0liMWDvAsh7fyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637%26doi%3D10.1016%2Fj.chembiol.2005.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alkarakooly, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilaparty, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Anbaky, Q. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, N.</span></span> <span> </span><span class="NLM_article-title">Dichloroacetic acid (DCA)-induced cytotoxicity in human breast cancer cells accompanies changes in mitochondrial membrane permeability and production of reactive oxygen species</span>. <i>J. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1234</span>â <span class="NLM_lpage">1248</span>, <span class="refDoi">Â DOI: 10.4236/jct.2014.513125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.4236%2Fjct.2014.513125" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1234-1248&author=Z.+Alkarakoolyauthor=S.+P.+Kilapartyauthor=Q.+A.+Al-Anbakyauthor=M.+S.+Khanauthor=N.+Ali&title=Dichloroacetic+acid+%28DCA%29-induced+cytotoxicity+in+human+breast+cancer+cells+accompanies+changes+in+mitochondrial+membrane+permeability+and+production+of+reactive+oxygen+species&doi=10.4236%2Fjct.2014.513125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4236%2Fjct.2014.513125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fjct.2014.513125%26sid%3Dliteratum%253Aachs%26aulast%3DAlkarakooly%26aufirst%3DZ.%26aulast%3DKilaparty%26aufirst%3DS.%2BP.%26aulast%3DAl-Anbaky%26aufirst%3DQ.%2BA.%26aulast%3DKhan%26aufirst%3DM.%2BS.%26aulast%3DAli%26aufirst%3DN.%26atitle%3DDichloroacetic%2520acid%2520%2528DCA%2529-induced%2520cytotoxicity%2520in%2520human%2520breast%2520cancer%2520cells%2520accompanies%2520changes%2520in%2520mitochondrial%2520membrane%2520permeability%2520and%2520production%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DJ.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D5%26spage%3D1234%26epage%3D1248%26doi%3D10.4236%2Fjct.2014.513125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachtel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haupt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzur, A.</span></span> <span> </span><span class="NLM_article-title">JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e430</span>, <span class="refDoi">Â DOI: 10.1038/cddis.2012.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fcddis.2012.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23171850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsV2ntA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e430&author=A.+Perelmanauthor=C.+Wachtelauthor=M.+Cohenauthor=S.+Hauptauthor=H.+Shapiroauthor=A.+Tzur&title=JC-1%3A+alternative+excitation+wavelengths+facilitate+mitochondrial+membrane+potential+cytometry&doi=10.1038%2Fcddis.2012.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry</span></div><div class="casAuthors">Perelman, A.; Wachtel, C.; Cohen, M.; Haupt, S.; Shapiro, H.; Tzur, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">e430, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mitochondrial membrane potential provides a valuable indicator of cells' health and functional status.  Cytometry- and microscopy-based analyses, in combination with fluorescent probes, are widely used to study mitochondrial behavior related to cellular pathways, most notably - apoptosis.  The cyanine dye JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide) facilitates discrimination of energized and deenergized mitochondria because the normally green fluorescent dye forms red fluorescent aggregates when concd. in energized mitochondria in response to their higher membrane potential.  JC-1 fluorescence is usually excited by the 488 nm laser wavelength common in flow cytometers.  In this study, we show that in practice this approach is not optimal for monitoring mitochondrial behavior.  Investigation of fluorescence of JC-1 in soln. and in cells using spectrofluorimetry, microscopy and flow cytometry reveals that excitation at 405 nm wavelength, now available on std. instruments, produces signals from aggregate fluorescence with considerably less spillover from dye monomer fluorescence than can be obtained using 488 nm excitation.  The improved data are more accurate and eliminate the necessity for fluorescence compensation, making the use of the alternative excitation wavelengths beneficial for mitochondria-related biol. and biomedial research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsyFk_xkRMyrVg90H21EOLACvtfcHk0lhyMLYMkjX-wQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsV2ntA%253D%253D&md5=9e281700eb1c4053b628761f49b3077c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.171%26sid%3Dliteratum%253Aachs%26aulast%3DPerelman%26aufirst%3DA.%26aulast%3DWachtel%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DM.%26aulast%3DHaupt%26aufirst%3DS.%26aulast%3DShapiro%26aufirst%3DH.%26aulast%3DTzur%26aufirst%3DA.%26atitle%3DJC-1%253A%2520alternative%2520excitation%2520wavelengths%2520facilitate%2520mitochondrial%2520membrane%2520potential%2520cytometry%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De430%26doi%3D10.1038%2Fcddis.2012.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubb, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawen, A.</span></span> <span> </span><span class="NLM_article-title">The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">115</span>â <span class="NLM_lpage">128</span>, <span class="refDoi">Â DOI: 10.1023/A:1022945107762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1023%2FA%3A1022945107762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=12766472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12ksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=115-128&author=J.+D.+Lyauthor=D.+R.+Grubbauthor=A.+Lawen&title=The+mitochondrial+membrane+potential+%28deltapsi%28m%29%29+in+apoptosis%3B+an+update&doi=10.1023%2FA%3A1022945107762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The mitochondrial membrane potential (ÎÏm) in apoptosis; an update</span></div><div class="casAuthors">Ly, J. D.; Grubb, D. R.; Lawen, A.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-128</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Mitochondrial dysfunction has been shown to participate in the induction of apoptosis and has even been suggested to be central to the apoptotic pathway.  Indeed, opening of the mitochondrial permeability transition pore has been demonstrated to induce depolarization of the transmembrane potential (ÎÏm), release of apoptogenic factors, and loss of oxidative phosphorylation.  In some apoptotic systems, loss of ÎÏm may be an early event in the apoptotic process.  However, there are emerging data suggesting that, depending on the model of apoptosis, the loss of ÎÏm may not be an early requirement for apoptosis, but on the contrary may be a consequence of the apoptotic-signaling pathway.  Furthermore, to add to these conflicting data, loss of ÎÏm has been demonstrated to not be required for cytochrome c release, whereas release of apoptosis-inducing factor AIF is dependent upon disruption of ÎÏm early in the apoptotic pathway.  Together, the existing literature suggests that depending on the cell system under investigation and the apoptotic stimuli used, dissipation of ÎÏm may or may not be an early event in the apoptotic pathway.  Discrepancies in this area of apoptosis research may be attributed to the fluorochromes used to detect ÎÏm.  Differential degrees of sensitivity of these fluorochromes exist, and there are also important factors that contribute to their ability to accurately discriminate changes in ÎÏm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOzp4dhnT9xLVg90H21EOLACvtfcHk0lhITfGboScWNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12ksb4%253D&md5=f1369780028cb13a045faf2a3db73c87</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022945107762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022945107762%26sid%3Dliteratum%253Aachs%26aulast%3DLy%26aufirst%3DJ.%2BD.%26aulast%3DGrubb%26aufirst%3DD.%2BR.%26aulast%3DLawen%26aufirst%3DA.%26atitle%3DThe%2520mitochondrial%2520membrane%2520potential%2520%2528deltapsi%2528m%2529%2529%2520in%2520apoptosis%253B%2520an%2520update%26jtitle%3DApoptosis%26date%3D2003%26volume%3D8%26spage%3D115%26epage%3D128%26doi%3D10.1023%2FA%3A1022945107762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Cytochrome C-mediated apoptosis</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1146/annurev.biochem.73.011303.073706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1146%2Fannurev.biochem.73.011303.073706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=15189137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=87-106&author=X.+Jiangauthor=X.+Wang&title=Cytochrome+C-mediated+apoptosis&doi=10.1146%2Fannurev.biochem.73.011303.073706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome C-mediated apoptosis</span></div><div class="casAuthors">Jiang, Xuejun; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-106</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Apoptosis, or programmed cell death, is involved in development, elimination of damaged cells, and maintenance of cell homeostasis.  Deregulation of apoptosis may cause diseases, such as cancers, immune diseases, and neurodegenerative disorders.  Apoptosis is executed by a subfamily of cysteine proteases known as caspases.  In mammalian cells, a major caspase activation pathway is the cytochrome c-initiated pathway.  In this pathway, a variety of apoptotic stimuli cause cytochrome c release from mitochondria, which in turn induces a series of biochem. reactions that result in caspase activation and subsequent cell death.  This review focused on the recent progress in understanding the biochem. mechanisms and regulation of the pathway, the roles of the pathway in physiol. and disease, and their potential therapeutic values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaXd15zPESYLVg90H21EOLACvtfcHk0lhITfGboScWNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D&md5=a8e668a41a4b4d0994a128019967f28d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.73.011303.073706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.73.011303.073706%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DCytochrome%2520C-mediated%2520apoptosis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2004%26volume%3D73%26spage%3D87%26epage%3D106%26doi%3D10.1146%2Fannurev.biochem.73.011303.073706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olszewski, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulsperger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G.</span></span> <span> </span><span class="NLM_article-title">In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds</span>. <i>Clin. Pharmacol.: Adv. Appl.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">177</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.2147/CPAA.S11795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.2147%2FCPAA.S11795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=22291503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVGgt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=177-183&author=U.+Olszewskiauthor=T.+T.+Poulsenauthor=E.+Ulspergerauthor=H.+S.+Poulsenauthor=K.+Geisslerauthor=G.+Hamilton&title=In+vitro+cytotoxicity+of+combinations+of+dichloroacetate+with+anticancer+platinum+compounds&doi=10.2147%2FCPAA.S11795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds</span></div><div class="casAuthors">Olszewski, Ulrike; Poulsen, Thomas Tuxen; Ulsperger, Ernst; Poulsen, Hans Skovgard; Geissler, Klaus; Hamilton, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology: Advances and Applications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-183</span>CODEN:
                <span class="NLM_cas:coden">CPAAGX</span>;
        ISSN:<span class="NLM_cas:issn">1179-1438</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Purpose: Dichloroacetate (DCA) inhibits pyruvate dehydrogenase kinase (PDK), and thus promotes glucose oxidn. over glycolysis and induces apoptotic death of tumor cells.  The present study investigated the potential of DCA to increase the antitumor effects of platinum-based compds. against a panel of permanent cell lines, including small cell lung cancer (SCLC), ovarian cancer, and Ewing's sarcoma in vitro.  Methods: DCA at a concn. of 10 mM was combined with cisplatin, carboplatin, satraplatin, the satraplatin metabolite JM118, oxaliplatin, oxoplatin, and picoplatin, and the cytotoxic activity was evaluated in proliferation tests employing a panel of different cell lines.  Addnl., cells were pretreated with DCA and then exposed to the platinum drugs and etoposide, or incubated with cisplatin or etoposide followed by application of DCA, resp.  Results: DCA 10 mM significantly increased the cytotoxicity of the platinum-based drugs carboplatin, satraplatin, JM118, and oxoplatin, but not cisplatin, picoplatin, and oxaliplatin in vitro.  Preincubation of cell lines with DCA 10 mM for three days reduced the antiproliferative activity of platinum-based agents in sequential application, but exposure of cells pretreated with cisplatin or etoposide to DCA resulted in minor sensitization.  The inhibitory effect of DCA showed no correlation with sensitization to the platinum compds.  Conclusion: DCA alone in a concn. that shows low antiproliferative activity is capable of increasing the cytotoxicity of selected platinum compds. upon coincubation, and such combinations may be interesting for clin. application in tumors like SCLC, Ewing's sarcoma, and ovarian cancer refractory to cisplatin chemotherapy as std. care.  The mechanism of this synergistic effect of DCA in combination with specific platinum species remains to be investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Cv9w1q-NPrVg90H21EOLACvtfcHk0lg7wwoePv9s6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitVGgt7s%253D&md5=006821ec90e9b077f56cb8f06a5569b9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2147%2FCPAA.S11795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCPAA.S11795%26sid%3Dliteratum%253Aachs%26aulast%3DOlszewski%26aufirst%3DU.%26aulast%3DPoulsen%26aufirst%3DT.%2BT.%26aulast%3DUlsperger%26aufirst%3DE.%26aulast%3DPoulsen%26aufirst%3DH.%2BS.%26aulast%3DGeissler%26aufirst%3DK.%26aulast%3DHamilton%26aufirst%3DG.%26atitle%3DIn%2520vitro%2520cytotoxicity%2520of%2520combinations%2520of%2520dichloroacetate%2520with%2520anticancer%2520platinum%2520compounds%26jtitle%3DClin.%2520Pharmacol.%253A%2520Adv.%2520Appl.%26date%3D2010%26volume%3D2%26spage%3D177%26epage%3D183%26doi%3D10.2147%2FCPAA.S11795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span> <span> </span><span class="NLM_article-title">The role of pyruvate dehydrogenase kinase in diabetes and obesity</span>. <i>Diabetes Metab</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">181</span>â <span class="NLM_lpage">186</span>, <span class="refDoi">Â DOI: 10.4093/dmj.2014.38.3.181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.4093%2Fdmj.2014.38.3.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A280%3ADC%252BC2cbgt12iuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=181-186&author=I.+K.+Lee&title=The+role+of+pyruvate+dehydrogenase+kinase+in+diabetes+and+obesity&doi=10.4093%2Fdmj.2014.38.3.181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The role of pyruvate dehydrogenase kinase in diabetes and obesity</span></div><div class="casAuthors">Lee In-Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes & metabolism journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-6</span>
        ISSN:<span class="NLM_cas:issn">2233-6079</span>.
    </div><div class="casAbstract">The pyruvate dehydrogenase complex (PDC) is an emerging target for the treatment of metabolic syndrome.  To maintain a steady-state concentration of adenosine triphosphate during the feed-fast cycle, cells require efficient utilization of fatty acid and glucose, which is controlled by the PDC.  The PDC converts pyruvate, coenzyme A (CoA), and oxidized nicotinamide adenine dinucleotide (NAD(+)) into acetyl-CoA, reduced form of nicotinamide adenine dinucleotide (NADH), and carbon dioxide.  The activity of the PDC is up- and down-regulated by pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase, respectively.  In addition, pyruvate is a key intermediate of glucose oxidation and an important precursor for the synthesis of glucose, glycerol, fatty acids, and nonessential amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNxZINmSrmWsrRqEXsZufAfW6udTcc2eZM1c15p7qfRrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbgt12iuw%253D%253D&md5=651dc166587d0757d8ae5bbb6e24dd90</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4093%2Fdmj.2014.38.3.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4093%252Fdmj.2014.38.3.181%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DI.%2BK.%26atitle%3DThe%2520role%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520in%2520diabetes%2520and%2520obesity%26jtitle%3DDiabetes%2520Metab%26date%3D2014%26volume%3D38%26spage%3D181%26epage%3D186%26doi%3D10.4093%2Fdmj.2014.38.3.181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgour, E.</span></span> <span> </span><span class="NLM_article-title">PDH kinase inhibitors: a novel therapy for Type II diabetes?</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">367</span>â <span class="NLM_lpage">370</span>, <span class="refDoi">Â DOI: 10.1042/BST0330367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1042%2FBST0330367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=15787608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFWjsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=367-370&author=R.+M.+Mayersauthor=B.+Leightonauthor=E.+Kilgour&title=PDH+kinase+inhibitors%3A+a+novel+therapy+for+Type+II+diabetes%3F&doi=10.1042%2FBST0330367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PDH kinase inhibitors: a novel therapy for Type II diabetes?</span></div><div class="casAuthors">Mayers, R. M.; Leighton, B.; Kilgour, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">367-370</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The pyruvate dehydrogenase multienzyme complex catalyzes the oxidative decarboxylation of pyruvate, which is an important regulatory step in oxidative metab.  Phosphorylation of the E1 (pyruvate decarboxylase) subunit on one of 3 specific serine residues results in loss of enzyme activity.  Four dedicated PDHK (pyruvate dehydrogenase kinase) isoenzymes were identified, each of which display a distinct tissue-specific expression profile, and have differential regulatory properties.  Thus PDHK play a key role in controlling the balance between glucose and lipid oxidn. according to substrate supply.  Increasing glucose oxidn. by inhibiting PDHK may be an effective mechanism to increase glucose utilization; addnl., increasing pyruvate oxidn. may further contribute to lowering of glucose level by decreasing the supply of gluconeogenic substrates.  A no. of PDHK inhibitors are now available to enable this mechanism to be evaluated as a therapy for diabetes.  The isoenzyme selectivity profile of AZD7545 and related compds. will be described and evidence for their non-ATP-competitive mode of action presented.  These compds. increase PDH activity in vivo, and when dosed chronically, improve glycemic control in Zucker rats.  Furthermore, glucose lowering was demonstrated in the hyperglycemic Zucker diabetic fatty rat.  This result supports the hypothesis that inhibition of PDHK may be an effective therapy for Type II diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGposPHvIBu3p7Vg90H21EOLACvtfcHk0ljD0Dwa4rqDrg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFWjsbw%253D&md5=881054109c4efa8fcea12a5979190cf4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1042%2FBST0330367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0330367%26sid%3Dliteratum%253Aachs%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DLeighton%26aufirst%3DB.%26aulast%3DKilgour%26aufirst%3DE.%26atitle%3DPDH%2520kinase%2520inhibitors%253A%2520a%2520novel%2520therapy%2520for%2520Type%2520II%2520diabetes%253F%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2005%26volume%3D33%26spage%3D367%26epage%3D370%26doi%3D10.1042%2FBST0330367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahcall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paweletz, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alden, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacher, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lydon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaklitsch, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sholl, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oxnard, G. R.</span></span> <span> </span><span class="NLM_article-title">Acquired METD1228V mutation and resistance to MET inhibition in lung cancer</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1334</span>â <span class="NLM_lpage">1341</span>, <span class="refDoi">Â DOI: 10.1158/2159-8290.CD-16-0686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1158%2F2159-8290.CD-16-0686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=27694386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGnt7zE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1334-1341&author=M.+Bahcallauthor=T.+Simauthor=C.+P.+Paweletzauthor=J.+D.+Patelauthor=R.+S.+Aldenauthor=Y.+Kuangauthor=A.+G.+Sacherauthor=N.+D.+Kimauthor=C.+A.+Lydonauthor=M.+M.+Awadauthor=M.+T.+Jaklitschauthor=L.+M.+Shollauthor=P.+A.+Janneauthor=G.+R.+Oxnard&title=Acquired+METD1228V+mutation+and+resistance+to+MET+inhibition+in+lung+cancer&doi=10.1158%2F2159-8290.CD-16-0686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer</span></div><div class="casAuthors">Bahcall, Magda; Sim, Taebo; Paweletz, Cloud P.; Patel, Jyoti D.; Alden, Ryan S.; Kuang, Yanan; Sacher, Adrian G.; Kim, Nam Doo; Lydon, Christine A.; Awad, Mark M.; Jaklitsch, Michael T.; Sholl, Lynette M.; Janne, Pasi A.; Oxnard, Geoffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1334-1341</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Amplified and/or mutated MET can act as both a primary oncogenic driver and as a promoter of tyrosine kinase inhibitor (TKI) resistance in non-small cell lung cancer (NSCLC).  However, the landscape of MET-specific targeting agents remains underdeveloped, and understanding of mechanisms of resistance to MET TKIs is limited.  Here, it present a case of a patient with lung adenocarcinoma harboring both a mutation in EGFR and an amplification of MET, who after progression on erlotinib responded dramatically to combined MET and EGFR inhibition with savolitinib and osimertinib.  When resistance developed to this combination, a new MET kinase domain mutation, D1228V, was detected.  Thus in vitro findings demonstrate that METD1228V induces resistance to type I MET TKIs through impaired drug binding, while sensitivity to type II MET TKIs is maintained.  Based on these findings, the patient was treated with erlotinib combined with cabozantinib, a type II MET inhibitor, and exhibited a response.  With several structurally distinct MET inhibitors undergoing development for treatment of NSCLC, it is crit. to identify mechanism-based therapies for drug resistance.  It demonstrate that an acquired METD1228V mutation mediates resistance to type I, but not type II, MET inhibitors, having therapeutic implications for the clin. use of sequential MET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowh81IU_F_VLVg90H21EOLACvtfcHk0ljODzQ8n2f6MA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGnt7zE&md5=b1e34064a7fb314b7e35538b5c305015</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-16-0686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-16-0686%26sid%3Dliteratum%253Aachs%26aulast%3DBahcall%26aufirst%3DM.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DPaweletz%26aufirst%3DC.%2BP.%26aulast%3DPatel%26aufirst%3DJ.%2BD.%26aulast%3DAlden%26aufirst%3DR.%2BS.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSacher%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DLydon%26aufirst%3DC.%2BA.%26aulast%3DAwad%26aufirst%3DM.%2BM.%26aulast%3DJaklitsch%26aufirst%3DM.%2BT.%26aulast%3DSholl%26aufirst%3DL.%2BM.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DOxnard%26aufirst%3DG.%2BR.%26atitle%3DAcquired%2520METD1228V%2520mutation%2520and%2520resistance%2520to%2520MET%2520inhibition%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2016%26volume%3D6%26spage%3D1334%26epage%3D1341%26doi%3D10.1158%2F2159-8290.CD-16-0686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b','cit12c','cit12d'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c','cit18d'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saleha  Anwar</span>, <span class="hlFld-ContribAuthor ">Anas  Shamsi</span>, <span class="hlFld-ContribAuthor ">Taj  Mohammad</span>, <span class="hlFld-ContribAuthor ">Asimul  Islam</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2021,</strong> <em>1876 </em>
                                    (1)
                                     , 188568. <a href="https://doi.org/10.1016/j.bbcan.2021.188568" title="DOI URL">https://doi.org/10.1016/j.bbcan.2021.188568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2021.188568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2021.188568%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DTargeting%252Bpyruvate%252Bdehydrogenase%252Bkinase%252Bsignaling%252Bin%252Bthe%252Bdevelopment%252Bof%252Beffective%252Bcancer%252Btherapy%26aulast%3DAnwar%26aufirst%3DSaleha%26date%3D2021%26volume%3D1876%26issue%3D1%26spage%3D188568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Choong-Hwan  Kwak</span>, <span class="hlFld-ContribAuthor ">Ling  Jin</span>, <span class="hlFld-ContribAuthor ">Jung Ho  Han</span>, <span class="hlFld-ContribAuthor ">Chang Woo  Han</span>, <span class="hlFld-ContribAuthor ">Eonmi  Kim</span>, <span class="hlFld-ContribAuthor ">MyoungLae  Cho</span>, <span class="hlFld-ContribAuthor ">Tae-Wook  Chung</span>, <span class="hlFld-ContribAuthor ">Sung-Jin  Bae</span>, <span class="hlFld-ContribAuthor ">Se Bok  Jang</span>, <span class="hlFld-ContribAuthor ">Ki-Tae  Ha</span>. </span><span class="cited-content_cbyCitation_article-title">Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (17)
                                     , 6021. <a href="https://doi.org/10.3390/ijms21176021" title="DOI URL">https://doi.org/10.3390/ijms21176021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21176021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21176021%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIlimaquinone%252BInduces%252Bthe%252BApoptotic%252BCell%252BDeath%252Bof%252BCancer%252BCells%252Bby%252BReducing%252BPyruvate%252BDehydrogenase%252BKinase%252B1%252BActivity%26aulast%3DKwak%26aufirst%3DChoong-Hwan%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D17%26spage%3D6021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alina  Ghinet</span>, <span class="hlFld-ContribAuthor ">Xavier  Thuru</span>, <span class="hlFld-ContribAuthor ">Emilie  Floquet</span>, <span class="hlFld-ContribAuthor ">JoÃ«lle  Dubois</span>, <span class="hlFld-ContribAuthor ">Amaury  Farce</span>, <span class="hlFld-ContribAuthor ">BenoÃ®t  Rigo</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>96 </em>, 103643. <a href="https://doi.org/10.1016/j.bioorg.2020.103643" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103643%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DEnhanced%252Bantitumor%252Bpotential%252Binduced%252Bby%252Bchloroacetate-loaded%252Bbenzophenones%252Bacting%252Bas%252Bfused%252Btubulin-pyruvate%252Bdehydrogenase%252Bkinase%252B1%252B%252528PDHK1%252529%252Bligands%26aulast%3DGhinet%26aufirst%3DAlina%26date%3D2020%26volume%3D96%26spage%3D103643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative PDHK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>14</b> and <b>15a</b>â<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4-nitrobenzaldehyde, acetic acid, NaBH<sub>3</sub>CN, MeOH, rt, 5 h, 81%; (b) (i) <b>10a</b>, oxalyl chloride, <i>cat</i>. DMF, DCM, rt, 2 h, (ii) <b>9</b>, DIPEA, DMF, 0 Â°C to rt, 2 h, 49% over two steps; (c) Pd/C, H<sub>2</sub>, MeOH, rt, 12 h; (d) acetic anhydride, TEA, DCM, 0 Â°C to rt, 2 h, 71% over two steps; (e) NaOH, MeOH/H<sub><i>2</i></sub>O, 80 Â°C, 2 h, 79%; (f) HATU, various amines, <i>N</i>-methylmorpholine, DMF, rt, 3 h, 21â58%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>19a</b>â<b>t</b> and <b>21a</b>,<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) various aldehydes, acetic acid, NaBH<sub>3</sub>CN, MeOH, rt, 5 h; (b) (i) <b>10a</b>â<b>c</b>, oxalyl chloride, <i>cat</i>. DMF, DCM, rt, 2 h, (ii) <b>17a</b>â<b>t</b>, DIPEA, DMF, 0 Â°C to rt, 2 h; (c) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, 1 h, 17â45%, over four steps.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Ligand interaction diagrams and interaction profile analysis of molecular dynamics simulations of <b>19n</b> within PDHK isoforms (a) PDHK1, (b) PDHK2, (c) PDHK3, and (d) PDHK4. The dotted arrows indicate H-bonds to side chains of the PDHKs, and the full arrows indicate H-bonds to backbones of the PDHKs. Red connectors denote cationâpi stacking interactions. Green, H-bonds; pink, ionic interactions; purple, hydrophobic interactions; blue, water bridges.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking structures of <b>19n</b> with the ATP binding sites of the PDHKs: (a) PDHK1, (b) PDHK2, (c) PDHK3, and (d) PDHK4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ligand interaction diagrams of molecular dynamic simulations of <b>19t</b> with PDHK isoforms: (a) PDHK1, (b) PDHK2, (c) PDHK3, and (d) PDHK4. The dotted arrows indicate H-bonds to side chains of the PDHKs, and the full arrows indicate H-bonds to backbones of PDHKs. The red connector denotes cationâpi stacking interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Overall kinase selectivity profiling of <b>19t</b>. Kinases showing >50% inhibition are clustered on the kinome tree. PDHK1/2/3/4 out of 366 kinases are inhibited more than 90% by 1 Î¼M <b>19t</b>. This illustration was reproduced courtesy of Cell Signaling Technology, Inc. (<a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>). (B) The percent inhibition of PDHK activities in the presence of <b>19t</b> and <b>19b</b> (1 Î¼M). (C) Inhibitory activities of selected compounds against PDHK1/2/3/4 and HSP90. Compounds were tested in 10 doses with a 3-fold serial dilution starting at 10 Î¼M.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PDH assay results. (A) Schematic diagram depicting the principle of the reconstituted PDC-reaction system. NAD<sup>+</sup> reduction simultaneously occurs when the PDH complex (E1, E2, and E3) converts pyruvate to acetyl-CoA. Phosphorylation of E1 by PDHKs suppresses the activity of the PDC complex; thus, NAD<sup>+</sup> reduction is decreased. The activity of the PDH complex (E1, E2, and E3) was evaluated by measuring the rate of NAD<sup>+</sup> reduction for 30 min in the presence of <b>19g</b>, <b>19k</b>, and <b>19n</b>, respectively. (B) The result of PDH assays of <b>19g</b>, <b>19k</b>, and <b>19n</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>19n</b> blocks PDHE1a phosphorylation in H1299 cells and DU145 cells. (A) Western blot analysis of H1299 cells treated with the selected compounds at 10 Î¼M for 2 h (110 mM) and a graph of the results (right panel). <b>19n</b> attenuated pPDHE1a phosphorylation 70â80%, while the other substances show only moderate inhibitory activities. (B) Phosphorylation of PDHE1a (S293) is attenuated by <b>19n</b> and <b>6</b> in a dose-dependent manner. (C) Western blot analysis of DU145 cells treated with the indicated concentration of <b>19n</b> for 2 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of <b>19n</b> on mitochondrial respiration, ROS production, and mitochondrial membrane potential. (A) <b>19n</b> enhances mitochondrial respiration in H1299 cells. OCRs were measured in H1299 cells in the presence or absence of DCA (10 mM) and <b>19n</b> (10 Î¼M) for 1 h, and oligomycin A (1 Î¼M), FCCP (2 Î¼M), and rotenone/antimycin A (1 Î¼M) were sequentially delivered to the XFe96 assay medium through injection ports in the sensor cartridge (<i>n</i> = 6, Â±SD, <i>t</i> test, â < 0.05 vs control). (B) <b>19n</b> promotes strong generation of ROS in a dose-dependent manner (left panel, H1299; right panel, DU145). Fluorescence of DCF was detected by using FACS (<i>n</i> = 3, Â±SD, one-way ANOVA; ââââ <i>p</i> < 0.0001, âââ <i>p</i> < 0.0009, â < 0.05). (C) DU145 cells were treated with increasing concentrations of <b>19n</b> for 5 h and stained with JC-1 for 30 min. <b>19n</b> dose-dependently reduces the red/green fluorescence ratio. Scale bar = 25 Î¼m. The intensity of fluorescence was automatically measured by Image J (<i>n</i> = 3, Â±SD, one-way ANOVA; âââ <i>p</i> < 0.0007, ââ < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <b>19n</b> induces apoptosis of H1299 and DU145, and <b>19n</b> inhibits anchorage-independent growth in H1299. (A) The numbers of apoptotic cells after treatment of <b>19n</b> for 48 h were determined by using Annexin V/PI staining. <b>19n</b> causes a dose-dependent increase in apoptotic cells (left panel, H1299; right panel, DU145). (B) Caspase 3 cleavage or PARP cleavage is increased by dose-dependent treatment with <b>19n</b> (left panel, H1299; right panel, DU145). (C) Anchorage-independent growth inhibition of H1299 cells promoted by <b>19n</b>. Average numbers of colonies per well were automatically counted using Image J software and are shown in the bar-graph (<i>n</i> = 3, Â±SD, one-way ANOVA; ââââ <i>p</i> < 0.0001, ââ <i>p</i> < 0.01, â <i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/medium/jm9b00565_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. <b>19n</b> increases the cytotoxicity of satraplatin. (A) The antiproliferative activity of <b>19n</b> was determined by using the CellTiter-Glo assay. A combination of satraplatin and <b>19n</b> (10 Î¼M) promotes an increase in the antiproliferation effect of satraplatin alone. (B, C) A combination of satraplatin and <b>19n</b> has a synergistic effect in promoting apoptosis in H1299 cells (<i>n</i> = 3, one-way ANOVA; ââââ <i>p</i> < 0.0001, âââ <i>p</i> < 0.0005, ââ <i>p</i> < 0.005).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00565/20190920/images/large/jm9b00565_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00565&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warburg, O.</span></span> <span> </span><span class="NLM_article-title">On the origin of cancer cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">309</span>â <span class="NLM_lpage">314</span>, <span class="refDoi">Â DOI: 10.1126/science.123.3191.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1126%2Fscience.123.3191.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=13298683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1956&pages=309-314&author=O.+Warburg&title=On+the+origin+of+cancer+cells&doi=10.1126%2Fscience.123.3191.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">On the origin of cancer cells</span></div><div class="casAuthors">WARBURG O</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3191</span>),
    <span class="NLM_cas:pages">309-14</span>
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDsp1coYpQW669lAbTj9rGfW6udTcc2eYaipiNpXUYn7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG28%252FltV2ktQ%253D%253D&md5=860d5ce9456831968fcc897b37d6d9c2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.123.3191.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.123.3191.309%26sid%3Dliteratum%253Aachs%26aulast%3DWarburg%26aufirst%3DO.%26atitle%3DOn%2520the%2520origin%2520of%2520cancer%2520cells%26jtitle%3DScience%26date%3D1956%26volume%3D123%26spage%3D309%26epage%3D314%26doi%3D10.1126%2Fscience.123.3191.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span> <span> </span><span class="NLM_article-title">Targeting cellular metabolism to improve cancer therapeutics</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e532</span>, <span class="refDoi">Â DOI: 10.1038/cddis.2013.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fcddis.2013.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23470539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyku7%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e532&author=Y.+Zhaoauthor=E.+B.+Butlerauthor=M.+Tan&title=Targeting+cellular+metabolism+to+improve+cancer+therapeutics&doi=10.1038%2Fcddis.2013.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cellular metabolism to improve cancer therapeutics</span></div><div class="casAuthors">Zhao, Y.; Butler, E. B.; Tan, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">March</span>),
    <span class="NLM_cas:pages">e532</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The metabolic properties of cancer cells diverge significantly from those of normal cells.  Energy prodn. in cancer cells is abnormally dependent on aerobic glycolysis.  In addn. to the dependency on glycolysis, cancer cells have other atypical metabolic characteristics such as increased fatty acid synthesis and increased rates of glutamine metab.  Emerging evidence shows that many features characteristic to cancer cells, such as dysregulated Warburg-like glucose metab., fatty acid synthesis and glutaminolysis are linked to therapeutic resistance in cancer treatment.  Therefore, targeting cellular metab. may improve the response to cancer therapeutics and the combination of chemotherapeutic drugs with cellular metab. inhibitors may represent a promising strategy to overcome drug resistance in cancer therapy.  Recently, several review articles have summarized the anticancer targets in the metabolic pathways and metabolic inhibitor-induced cell death pathways, however, the dysregulated metab. in therapeutic resistance, which is a highly clin. relevant area in cancer metab. research, has not been specifically addressed.  From this unique angle, this review article will discuss the relationship between dysregulated cellular metab. and cancer drug resistance and how targeting of metabolic enzymes, such as glucose transporters, hexokinase, pyruvate kinase M2, lactate dehydrogenase A, pyruvate dehydrogenase kinase, fatty acid synthase and glutaminase can enhance the efficacy of common therapeutic agents or overcome resistance to chemotherapy or radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMC5ekN6_UhbVg90H21EOLACvtfcHk0liykGjWh_FUHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyku7%252FJ&md5=fef8a7abec0d228e32fd03cfb85f3ca6</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.60%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DButler%26aufirst%3DE.%2BB.%26aulast%3DTan%26aufirst%3DM.%26atitle%3DTargeting%2520cellular%2520metabolism%2520to%2520improve%2520cancer%2520therapeutics%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De532%26doi%3D10.1038%2Fcddis.2013.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilda, P. J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial metabolism inhibitors for cancer therapy</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2731</span>â <span class="NLM_lpage">2744</span>, <span class="refDoi">Â DOI: 10.1007/s11095-011-0584-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1007%2Fs11095-011-0584-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=21918915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsbrL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=2731-2744&author=E.+E.+Ramsayauthor=P.+J.+Hoggauthor=P.+J.+Dilda&title=Mitochondrial+metabolism+inhibitors+for+cancer+therapy&doi=10.1007%2Fs11095-011-0584-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Metabolism Inhibitors for Cancer Therapy</span></div><div class="casAuthors">Ramsay, Emma E.; Hogg, Philip J.; Dilda, Pierre J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2731-2744</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cancer cells catabolize nutrients in a different way than healthy cells.  Healthy cells mainly rely on oxidative phosphorylation, while cancer cells employ aerobic glycolysis.  Glucose is the main nutrient catabolized by healthy cells, while cancer cells often depend on catabolism of both glucose and glutamine.  A key organelle involved in this altered metab. is mitochondria.  Mitochondria coordinate the catabolism of glucose and glutamine across the cancer cell.  Targeting mitochondrial metab. in cancer cells has potential for the treatment of this disease.  Perhaps the most promising target is the hexokinase-voltage dependent anion channel-adenine nucleotide translocase complex that spans the outer- and inner-mitochondrial membranes.  This complex links glycolysis, oxidative phosphorylation and mitochondrial-mediated apoptosis in cancer cells.  This review discusses cancer cell mitochondrial metab. and the small mol. inhibitors of this metab. that are in pre-clin. or clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7xMJ0QRGDo7Vg90H21EOLACvtfcHk0liykGjWh_FUHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKqsbrL&md5=a60df6faa02585df8699dd300f42986e</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1007%2Fs11095-011-0584-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-011-0584-5%26sid%3Dliteratum%253Aachs%26aulast%3DRamsay%26aufirst%3DE.%2BE.%26aulast%3DHogg%26aufirst%3DP.%2BJ.%26aulast%3DDilda%26aufirst%3DP.%2BJ.%26atitle%3DMitochondrial%2520metabolism%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DPharm.%2520Res.%26date%3D2011%26volume%3D28%26spage%3D2731%26epage%3D2744%26doi%3D10.1007%2Fs11095-011-0584-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tso, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernstedt-Asterholm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morlock, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherer, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span> <span> </span><span class="NLM_article-title">Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">4432</span>â <span class="NLM_lpage">4443</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M113.533885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1074%2Fjbc.M113.533885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=24356970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=4432-4443&author=S.+C.+Tsoauthor=X.+Qiauthor=W.+J.+Guiauthor=C.+Y.+Wuauthor=J.+L.+Chuangauthor=I.+Wernstedt-Asterholmauthor=L.+K.+Morlockauthor=K.+R.+Owensauthor=P.+E.+Schererauthor=N.+S.+Williams&title=Structure-guided+development+of+specific+pyruvate+dehydrogenase+kinase+inhibitors+targeting+the+ATP-binding+pocket&doi=10.1074%2Fjbc.M113.533885"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket</span></div><div class="casAuthors">Tso, Shih-Chia; Qi, Xiangbing; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Wernstedt-Asterholm, Ingrid; Morlock, Lorraine K.; Owens, Kyle R.; Scherer, Philipp E.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4432-4443</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase isoforms (PDKs 1-4) neg. regulate activity of the mitochondrial pyruvate dehydrogenase complex by reversible phosphorylation.  PDK isoforms are up-regulated in obesity, diabetes, heart failure, and cancer and are potential therapeutic targets for these important human diseases.  Here, the authors employed a structure-guided design to convert a known Hsp90 inhibitor to a series of highly specific PDK inhibitors, based on structural conservation in the ATP-binding pocket.  The key step involved the substitution of a carbonyl group in the parent compd. with a sulfonyl in the PDK inhibitors.  The final compd. of this series, 2-[(2,4-dihydroxyphenyl)sulfonyl]isoindoline-4,6-diol, designated PS10, inhibits all four PDK isoforms with IC50 = 0.8 Î¼m for PDK2.  The administration of PS10 (70 mg/kg) to diet-induced obese mice significantly augments pyruvate dehydrogenase complex activity with reduced phosphorylation in different tissues.  Prolonged PS10 treatments result in improved glucose tolerance and notably lessened hepatic steatosis in the mouse model.  The results support the pharmacol. approach of targeting PDK to control both glucose and fat levels in obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmYMKZrXKTrVg90H21EOLACvtfcHk0lh9CLLGguxiJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D&md5=e3bd48326cc1ab39c76f7bd19734a361</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.533885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.533885%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DGui%26aufirst%3DW.%2BJ.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DWernstedt-Asterholm%26aufirst%3DI.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DOwens%26aufirst%3DK.%2BR.%26aulast%3DScherer%26aufirst%3DP.%2BE.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26atitle%3DStructure-guided%2520development%2520of%2520specific%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%2520targeting%2520the%2520ATP-binding%2520pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D4432%26epage%3D4443%26doi%3D10.1074%2Fjbc.M113.533885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hitosugi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lythgoe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakiewicz, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesel, J. L.</span></span> <span> </span><span class="NLM_article-title">Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">864</span>â <span class="NLM_lpage">877</span>, <span class="refDoi">Â DOI: 10.1016/j.molcel.2011.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.molcel.2011.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=22195962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=864-877&author=T.+Hitosugiauthor=J.+Fanauthor=T.+W.+Chungauthor=K.+Lythgoeauthor=X.+Wangauthor=J.+Xieauthor=Q.+Geauthor=T.+L.+Guauthor=R.+D.+Polakiewiczauthor=J.+L.+Roesel&title=Tyrosine+phosphorylation+of+mitochondrial+pyruvate+dehydrogenase+kinase+1+is+important+for+cancer+metabolism&doi=10.1016%2Fj.molcel.2011.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism</span></div><div class="casAuthors">Hitosugi, Taro; Fan, Jun; Chung, Tae-Wook; Lythgoe, Katherine; Wang, Xu; Xie, Jianxin; Ge, Qingyuan; Gu, Ting-Lei; Polakiewicz, Roberto D.; Roesel, Johannes L.; Chen, Georgia Z.; Boggon, Titus J.; Lonial, Sagar; Fu, Haian; Khuri, Fadlo R.; Kang, Sumin; Chen, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">864-877</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Many tumor cells rely on aerobic glycolysis instead of oxidative phosphorylation for their continued proliferation and survival.  Myc and HIF-1 are believed to promote such a metabolic switch by, in part, upregulating gene expression of pyruvate dehydrogenase (PDH) kinase 1 (PDHK1), which phosphorylates and inactivates mitochondrial PDH and consequently pyruvate dehydrogenase complex (PDC).  Here we report that tyrosine phosphorylation enhances PDHK1 kinase activity by promoting ATP and PDC binding.  Functional PDC can form in mitochondria outside of the matrix in some cancer cells and PDHK1 is commonly tyrosine phosphorylated in human cancers by diverse oncogenic tyrosine kinases localized to different mitochondrial compartments.  Expression of phosphorylation-deficient, catalytic hypomorph PDHK1 mutants in cancer cells leads to decreased cell proliferation under hypoxia and increased oxidative phosphorylation with enhanced mitochondrial utilization of pyruvate and reduced tumor growth in xenograft nude mice.  Together, tyrosine phosphorylation activates PDHK1 to promote the Warburg effect and tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt7BASuMHOGLVg90H21EOLACvtfcHk0lh9CLLGguxiJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL7L&md5=d022eae26590b3fed9009260a692d67c</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DHitosugi%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DLythgoe%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DT.%2BL.%26aulast%3DPolakiewicz%26aufirst%3DR.%2BD.%26aulast%3DRoesel%26aufirst%3DJ.%2BL.%26atitle%3DTyrosine%2520phosphorylation%2520of%2520mitochondrial%2520pyruvate%2520dehydrogenase%2520kinase%25201%2520is%2520important%2520for%2520cancer%2520metabolism%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26spage%3D864%26epage%3D877%26doi%3D10.1016%2Fj.molcel.2011.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Saunier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortoli, S.</span></span> <span> </span><span class="NLM_article-title">The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">809</span>â <span class="NLM_lpage">817</span>, <span class="refDoi">Â DOI: 10.1002/ijc.29564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1002%2Fijc.29564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=25868605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFCktr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=809-817&author=E.+Saunierauthor=C.+Benelliauthor=S.+Bortoli&title=The+pyruvate+dehydrogenase+complex+in+cancer%3A+an+old+metabolic+gatekeeper+regulated+by+new+pathways+and+pharmacological+agents&doi=10.1002%2Fijc.29564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents</span></div><div class="casAuthors">Saunier, Elise; Benelli, Chantal; Bortoli, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-817</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Cancer cells exhibit an altered metab. which is characterized by a preference for aerobic glycolysis more than mitochondrial oxidn. of pyruvate.  This provides anabolic support and selective growth advantage for cancer cells.  Recently, a new concept has arisen suggesting that these metabolic changes may be due, in part, to an attenuated mitochondrial function which results from the inhibition of the pyruvate dehydrogenase complex (PDC).  This mitochondrial complex links glycolysis to the Krebs cycle and the current understanding of its regulation involves the cyclic phosphorylation and dephosphorylation by specific pyruvate dehydrogenase kinases (PDKs) and pyruvate dehydrogenase phosphatases (PDPs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHoUftek7vjrVg90H21EOLACvtfcHk0lh9CLLGguxiJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFCktr0%253D&md5=5ed6990e7c6e5d4619149746338f5582</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1002%2Fijc.29564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29564%26sid%3Dliteratum%253Aachs%26aulast%3DSaunier%26aufirst%3DE.%26aulast%3DBenelli%26aufirst%3DC.%26aulast%3DBortoli%26aufirst%3DS.%26atitle%3DThe%2520pyruvate%2520dehydrogenase%2520complex%2520in%2520cancer%253A%2520an%2520old%2520metabolic%2520gatekeeper%2520regulated%2520by%2520new%2520pathways%2520and%2520pharmacological%2520agents%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2016%26volume%3D138%26spage%3D809%26epage%3D817%26doi%3D10.1002%2Fijc.29564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. U.</span></span> <span> </span><span class="NLM_article-title">Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">44</span>â <span class="NLM_lpage">54</span>, <span class="refDoi">Â DOI: 10.3892/ijo.2012.1687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.3892%2Fijo.2012.1687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23135628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWntr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=44-54&author=H.+Hurauthor=Y.+Xuanauthor=Y.+B.+Kimauthor=G.+Leeauthor=W.+Shimauthor=J.+Yunauthor=I.+H.+Hamauthor=S.+U.+Han&title=Expression+of+pyruvate+dehydrogenase+kinase-1+in+gastric+cancer+as+a+potential+therapeutic+target&doi=10.3892%2Fijo.2012.1687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target</span></div><div class="casAuthors">Hur, Hoon; Xuan, Yi; Kim, Young Bae; Lee, Gwang; Shim, Wooyoung; Yun, Jisoo; Ham, In-Hye; Han, Sang-Uk</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-54</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">In contrast to mitochondria in healthy cells, which utilize oxidative phosphorylation, malignant cells undergo elevated glycolysis for energy prodn. using glucose.  The objectives of this study were to evaluate whether the expression of various mols., including pyruvate dehydrogenase kinase-1 (PDK-1), is involved in the altered glucose metab. assocd. with gastric cancer prognosis and to assess the role of a therapeutic agent in targeting glucose metab. in gastric cancer.  Immunohistochem. was performed on gastric cancer tissues obtained from 152 patients who underwent curative resection to assess the expression of hypoxia-inducible factor-1Î± (HIF-1Î±), glucose transporter-1 (GLUT-1), hexokinase-2 (HK-2) and PDK-1.  In an in vitro anal., the lactate prodn. and glucose uptake levels, cellular viability and 5-fluorouracil (5-FU) responses were evaluated before and after treatment with dichloroacetate (DCA), a PDK-1 inhibitor, in the MKN45 and AGS gastric cancer cell lines and in the non-cancerous HEK293 cell line.  GLUT-1 and PDK-1 expression was significantly assocd. with tumor progression, although only PDK-1 expression was an independent prognostic factor for patients who received 5-FU adjuvant treatment.  There was no significant difference in cell viability between the HEK293 and gastric cancer cell lines following DCA treatment.  However, DCA treatment reduced lactate prodn. and increased responsiveness to 5-FU in MKN45 cells, which expressed high levels of PDK-1 in comparison to the other cell lines.  Thus, PDK-1 may serve as a biomarker of poor prognosis in patients with gastric cancer.  In addn., PDK-1 inhibitors such as DCA may be considered an addnl. treatment option for patients with PDK-1-expressing gastric cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgDvVgrWla2LVg90H21EOLACvtfcHk0lhMEP3hAtXqTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWntr8%253D&md5=f9e2602bfd973bec91d910b604fba7f4</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.3892%2Fijo.2012.1687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2012.1687%26sid%3Dliteratum%253Aachs%26aulast%3DHur%26aufirst%3DH.%26aulast%3DXuan%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DY.%2BB.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DShim%26aufirst%3DW.%26aulast%3DYun%26aufirst%3DJ.%26aulast%3DHam%26aufirst%3DI.%2BH.%26aulast%3DHan%26aufirst%3DS.%2BU.%26atitle%3DExpression%2520of%2520pyruvate%2520dehydrogenase%2520kinase-1%2520in%2520gastric%2520cancer%2520as%2520a%2520potential%2520therapeutic%2520target%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2013%26volume%3D42%26spage%3D44%26epage%3D54%26doi%3D10.3892%2Fijo.2012.1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, H.</span></span> <span> </span><span class="NLM_article-title">PDK1 inhibition is a novel therapeutic target in multiple myeloma</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">170</span>â <span class="NLM_lpage">178</span>, <span class="refDoi">Â DOI: 10.1038/bjc.2012.527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fbjc.2012.527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23321518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCmtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2013&pages=170-178&author=S.+Fujiwaraauthor=Y.+Kawanoauthor=H.+Yukiauthor=Y.+Okunoauthor=K.+Nosakaauthor=H.+Mitsuyaauthor=H.+Hata&title=PDK1+inhibition+is+a+novel+therapeutic+target+in+multiple+myeloma&doi=10.1038%2Fbjc.2012.527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PDK1 inhibition is a novel therapeutic target in multiple myeloma</span></div><div class="casAuthors">Fujiwara, S.; Kawano, Y.; Yuki, H.; Okuno, Y.; Nosaka, K.; Mitsuya, H.; Hata, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-178</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells utilize the glycolytic pathway even when adequate oxygen is present, a phenomenon known as the Warburg effect.  We examd. whether this system is operative in multiple myeloma (MM) cells and whether glycolysis inhibition is a potential therapeutic modality.  The MM cells were purified from 59 patients using CD138-immunomagnetic beads.  The expression levels of genes assocd. with glycolysis, c-MYC, GLUT1, LDHA, HIF1A and pyruvate dehydrogenase kinase-1 (PDK1) were detd. by real-time PCR.  Glucose consumption and lactate prodn. by MM cell lines were analyzed.  Oxamate, an LDH inhibitor, and dichloroacetate (DCA), a PDK1 inhibitor, were employed.  Inhibition of PDK1 expression was achieved using a siRNA.  High LDHA expression was found to be an indicator of poor prognosis.  It was also pos. correlated with the expression of PDK1, c-MYC and GLUT1.  Greater glucose consumption and lactate prodn. in MM cells was assocd. with higher LDHA expression.  All the glycolysis inhibitors (oxamate, DCA and PDK1 siRNA) induced apoptosis in MM cells.  DCA combined with bortezomib showed additive cytotoxic effects.  The present data suggest that the Warburg effect is operative in MM cells.  As PDK1 is not overexpressed in normal tissues, PDK1 inhibition could serve as a novel therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR94YLXWvLtbVg90H21EOLACvtfcHk0lhMEP3hAtXqTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCmtro%253D&md5=b3e7af9d01088a9d28da69ad416c3e21</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.527%26sid%3Dliteratum%253Aachs%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DY.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DNosaka%26aufirst%3DK.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DHata%26aufirst%3DH.%26atitle%3DPDK1%2520inhibition%2520is%2520a%2520novel%2520therapeutic%2520target%2520in%2520multiple%2520myeloma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2013%26volume%3D108%26spage%3D170%26epage%3D178%26doi%3D10.1038%2Fbjc.2012.527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baumunk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichelt, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrandt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebbing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cash, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schostak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weikert, S.</span></span> <span> </span><span class="NLM_article-title">Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC)</span>. <i>World J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1191</span>â <span class="NLM_lpage">1196</span>, <span class="refDoi">Â DOI: 10.1007/s00345-012-0874-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1007%2Fs00345-012-0874-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=22544372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKqs7vM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=1191-1196&author=D.+Baumunkauthor=U.+Reicheltauthor=J.+Hildebrandtauthor=H.+Krauseauthor=J.+Ebbingauthor=H.+Cashauthor=K.+Millerauthor=M.+Schostakauthor=S.+Weikert&title=Expression+parameters+of+the+metabolic+pathway+genes+pyruvate+dehydrogenase+kinase-1+%28PDK-1%29+and+DJ-1%2FPARK7+in+renal+cell+carcinoma+%28RCC%29&doi=10.1007%2Fs00345-012-0874-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC)</span></div><div class="casAuthors">Baumunk, Daniel; Reichelt, Uta; Hildebrandt, Jannis; Krause, Hans; Ebbing, Jan; Cash, Hannes; Miller, Kurt; Schostak, Martin; Weikert, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Urology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1191-1196</span>CODEN:
                <span class="NLM_cas:coden">WJURDJ</span>;
        ISSN:<span class="NLM_cas:issn">0724-4983</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose Metabolic adaptations, such as increases in glucose and energy metab., play a pivotal role in the biol. of RCC.  PDK-1 and DJ-1/PARK7 are thought to control metabolic pathways in cancer.  We investigated the expression of PDK-1 and DJ-1/PARK7 in RCC and their prognostic relevance.  Methods RCC tumor tissue and corresponding normal parenchyma samples were obtained from 91 patients with clear cell RCC.  Expression of PDK-1 and DJ-1/PARK7 was detd. on the mRNA and protein levels using quant. RT-PCR and immunohistochem.  Expression ratios tumor/normal were analyzed for assocns. with pathol. stage and grade (Kruskal-Wallis ANOVA, chi-square test).  Potential assocns. with progression-free and overall survival were analyzed using Cox regression models.  Results PDK-1 mRNA expression was up-regulated as compared to normal tissue (p < 0.001).  Differences were obsd. by tumor stage (p < 0.05) with a trend toward lower expression with increasing stage (p > 0.01).  Expression ratio tumor/normal also showed differences by tumor stage with the lowest ratio obsd. in advanced (pT3) disease.  MRNA expression data were confirmed on the protein level with the lowest protein expression in pT3 tumors.  PDK-1 expression ratio tumor/normal was inversely assocd. with outcome after adjustment for stage and grade (HR, 0.54; 95 % CI, 0.31-0.94).  No assocns. obsd. for DJ-1/PARK7 expression.  Conclusions PDK is up-regulated in RCC, but down-regulation may be assocd. with progression toward a metastasizing behavior.  Given the role of PDK-1 in the control of glucose metab., aerobic glycolysis via up-regulation of PDK-1 may be an early event in RCC development, but less relevant for the progression toward an aggressive phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe8UV9vRe-b7Vg90H21EOLACvtfcHk0lhMEP3hAtXqTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKqs7vM&md5=240989dc2b53f10fc9b1ce9fecada74f</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1007%2Fs00345-012-0874-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00345-012-0874-5%26sid%3Dliteratum%253Aachs%26aulast%3DBaumunk%26aufirst%3DD.%26aulast%3DReichelt%26aufirst%3DU.%26aulast%3DHildebrandt%26aufirst%3DJ.%26aulast%3DKrause%26aufirst%3DH.%26aulast%3DEbbing%26aufirst%3DJ.%26aulast%3DCash%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DSchostak%26aufirst%3DM.%26aulast%3DWeikert%26aufirst%3DS.%26atitle%3DExpression%2520parameters%2520of%2520the%2520metabolic%2520pathway%2520genes%2520pyruvate%2520dehydrogenase%2520kinase-1%2520%2528PDK-1%2529%2520and%2520DJ-1%252FPARK7%2520in%2520renal%2520cell%2520carcinoma%2520%2528RCC%2529%26jtitle%3DWorld%2520J.%2520Urol.%26date%3D2013%26volume%3D31%26spage%3D1191%26epage%3D1196%26doi%3D10.1007%2Fs00345-012-0874-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">193</span>â <span class="NLM_lpage">200</span>, <span class="refDoi">Â DOI: 10.3892/or.2016.5253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.3892%2For.2016.5253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=27878287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A280%3ADC%252BC2snpsFajtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=193-200&author=T.+Liuauthor=H.+Yin&title=PDK1+promotes+tumor+cell+proliferation+and+migration+by+enhancing+the+Warburg+effect+in+non-small+cell+lung+cancer&doi=10.3892%2For.2016.5253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer</span></div><div class="casAuthors">Liu Tao; Yin Honglei</div><div class="citationInfo"><span class="NLM_cas:title">Oncology reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-200</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumor cells prefer glycolysis (Warburg effect) during the proliferation and metastasis.  The precise mechanism remains largely unknown.  Here, we demonstrated that pyruvate dehydrogenase kinase 1 (PDK1) was a critical enzyme that functioned as an oncogene to promote non-small cell lung cancer (NSCLC) growth and metastasis.  We discovered that PDK1 expression was significantly upregulated in NSCLC tissues and correlated with advanced T stage.  Moreover, high expression of PDK1 was an independent prognostic factor of NSCLC.  Ectopic overexpression of PDK1 promoted cell proliferation and inhibited apoptosis.  Also it was shown that PDK1 increased the cell mobility when Transwell assay was performed.  Further experiments indicated that PDK1 had a central role in metabolic reprogramming by phosphorylating pyruvate dehydrogenase, leading to enhanced Warburg effect.  Collectively, our data reveal a new function for PDK1, which could be used to indicate the prognosis of NSCLC, and provide targeted therapeutic strategy for clinical treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxnJ8WA5DjZFMGsG_HTXYFfW6udTcc2eZypWNMklxbHLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snpsFajtA%253D%253D&md5=c0970c18f900c9fc25b664ff6e2aebcd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3892%2For.2016.5253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2016.5253%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DPDK1%2520promotes%2520tumor%2520cell%2520proliferation%2520and%2520migration%2520by%2520enhancing%2520the%2520Warburg%2520effect%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2017%26volume%3D37%26spage%3D193%26epage%3D200%26doi%3D10.3892%2For.2016.5253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sutendra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dromparis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinnaird, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haromy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurtry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelakis, E.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1638</span>â <span class="NLM_lpage">1650</span>, <span class="refDoi">Â DOI: 10.1038/onc.2012.198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fonc.2012.198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=22614004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Cmsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1638-1650&author=G.+Sutendraauthor=P.+Dromparisauthor=A.+Kinnairdauthor=T.+Stensonauthor=A.+Haromyauthor=J.+Parkerauthor=M.+McMurtryauthor=E.+Michelakis&title=Mitochondrial+activation+by+inhibition+of+PDKII+suppresses+HIF1a+signaling+and+angiogenesis+in+cancer&doi=10.1038%2Fonc.2012.198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial activation by inhibition of PDKII suppresses HIF-1Î± signaling and angiogenesis in cancer</span></div><div class="casAuthors">Sutendra, G.; Dromparis, P.; Kinnaird, A.; Stenson, T. H.; Haromy, A.; Parker, J. M. R.; McMurtry, M. S.; Michelakis, E. D.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1638-1650</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Most solid tumors are characterized by a metabolic shift from glucose oxidn. to glycolysis, in part due to actively suppressed mitochondrial function, a state that favors resistance to apoptosis.  Suppressed mitochondrial function may also contribute to the activation of hypoxia-inducible factor 1Î± (HIF1Î±) and angiogenesis.  We have previously shown that the inhibitor of pyruvate dehydrogenase kinase (PDK) dichloroacetate (DCA) activates glucose oxidn. and induces apoptosis in cancer cells in vitro and in vivo.  We hypothesized that DCA will also reverse the pseudohypoxic' mitochondrial signals that lead to HIF1Î± activation in cancer, even in the absence of hypoxia and inhibit cancer angiogenesis.  We show that inhibition of PDKII inhibits HIF1Î± in cancer cells using several techniques, including HIF1Î± luciferase reporter assays.  Using pharmacol. and mol. approaches that suppress the prolyl-hydroxylase (PHD)-mediated inhibition of HIF1Î±, we show that DCA inhibits HIF1Î± by both a PHD-dependent mechanism (that involves a DCA-induced increase in the prodn. of mitochondria-derived Î±-ketoglutarate) and a PHD-independent mechanism, involving activation of p53 via mitochondrial-derived H2O2, as well as activation of GSK3Î².  Effective inhibition of HIF1Î± is shown by a decrease in the expression of several HIF1Î± regulated gene products as well as inhibition of angiogenesis in vitro in matrigel assays.  More importantly, in rat Xenotransplant models of non-small cell lung cancer and breast cancer, we show effective inhibition of angiogenesis and tumor perfusion in vivo, assessed by contrast-enhanced ultrasonog., nuclear imaging techniques and histol.  This work suggests that mitochondria-targeting metabolic modulators that increase pyruvate dehydrogenase activity, in addn. to the recently described pro-apoptotic and anti-proliferative effects, suppress angiogenesis as well, normalizing the pseudo-hypoxic signals that lead to normoxic HIF1Î± activation in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwpRW4kQDlOLVg90H21EOLACvtfcHk0lidZvvlflt8fQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Cmsrg%253D&md5=8a5ea78b008f38044951a718e620ef70</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.198%26sid%3Dliteratum%253Aachs%26aulast%3DSutendra%26aufirst%3DG.%26aulast%3DDromparis%26aufirst%3DP.%26aulast%3DKinnaird%26aufirst%3DA.%26aulast%3DStenson%26aufirst%3DT.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DJ.%26aulast%3DMcMurtry%26aufirst%3DM.%26aulast%3DMichelakis%26aufirst%3DE.%26atitle%3DMitochondrial%2520activation%2520by%2520inhibition%2520of%2520PDKII%2520suppresses%2520HIF1a%2520signaling%2520and%2520angiogenesis%2520in%2520cancer%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D1638%26epage%3D1650%26doi%3D10.1038%2Fonc.2012.198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S. J.</span></span> <span> </span><span class="NLM_article-title">Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">1405</span>â <span class="NLM_lpage">1414</span>, <span class="refDoi">Â DOI: 10.1016/j.ajpath.2011.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.ajpath.2011.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=21763680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsb%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=1405-1414&author=C.+W.+Luauthor=S.+C.+Linauthor=C.+W.+Chienauthor=S.+C.+Linauthor=C.+T.+Leeauthor=B.+W.+Linauthor=J.+C.+Leeauthor=S.+J.+Tsai&title=Overexpression+of+pyruvate+dehydrogenase+kinase+3+increases+drug+resistance+and+early+recurrence+in+colon+cancer&doi=10.1016%2Fj.ajpath.2011.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of pyruvate dehydrpgenase kinase 3 increases drug resistance and early recurrence in colon cancer</span></div><div class="casAuthors">Lu, Chun-Wun; Lin, Shau-Chieh; Chien, Chun-Wei; Lin, Shih-Chieh; Lee, Chung-Ta; Lin, Bo-Wen; Lee, Jenq-Chang; Tsai, Shaw-Jenq</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1405-1414</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The switch of cellular metab. from mitochondrial respiration to glycolysis is the hallmark of cancer cells and is assocd. with tumor malignancy.  Pyruvate dehydrogenase kinase-1 (PDK1) and PDK3 participate in the metabolic switch of cancer cells; however, the medical significance of PDK1 and PDK3 in cancer progression is not known.  Here, we assessed the expression profiles of PDK1 and PDK3 in colorectal cancer.  Western blot anal. (n = 74) demonstrated that PDK3 was markedly increased in colon cancer compared to that in adjacent normal tissues, whereas PDK1 was decreased in cancer cells.  In addn., PDK3 expression was pos. correlated with that of hypoxia inducible factor-1Î± (HIF-1Î±) in cancer cells.  Further anal. using immunohistochem. staining revealed that PDK3 levels were pos. assocd. with severity of cancer and neg. assocd. with disease-free survival.  In vitro studies using several colon cancer cell lines showed that PDK3 expression was controlled by HIF-1Î± and contributed to hypoxia-induced increased drug resistance, perhaps explaining why patients with PDK3 overexpression have a greater incidence of treatment failure.  Taken together, our findings suggest that PDK3 plays an important role in the metabolic switch and drug resistance of colon cancer and is potentially a novel target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQmjhmaIUuIrVg90H21EOLACvtfcHk0lhIAm5jDkyM1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2jsb%252FI&md5=44cb57fc1b370446524ecaa0a5a0fa05</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%2BW.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DChien%26aufirst%3DC.%2BW.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DLin%26aufirst%3DB.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DTsai%26aufirst%3DS.%2BJ.%26atitle%3DOverexpression%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25203%2520increases%2520drug%2520resistance%2520and%2520early%2520recurrence%2520in%2520colon%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26spage%3D1405%26epage%3D1414%26doi%3D10.1016%2Fj.ajpath.2011.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koukourakis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giatromanolaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivridis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatter, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">6</span>, <span class="refDoi">Â DOI: 10.1593/neo.04373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1593%2Fneo.04373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=15736311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Gnsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1-6&author=M.+I.+Koukourakisauthor=A.+Giatromanolakiauthor=E.+Sivridisauthor=K.+C.+Gatterauthor=A.+L.+Harris&title=Pyruvate+dehydrogenase+and+pyruvate+dehydrogenase+kinase+expression+in+non+small+cell+lung+cancer+and+tumor-associated+stroma&doi=10.1593%2Fneo.04373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma</span></div><div class="casAuthors">Koukourakis, Michael I.; Giatromanolaki, Alexandra; Sivridis, Efthimios; Gatter, Kevin C.; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Ann Arbor, MI, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase (PDH) catalyzes the conversion of pyruvate to acetyl-CoA, which enters into the Krebs cycle, providing ATP (ATP) to the cell.  PDH activity is under the control of pyruvate dehydrogenase kinases (PDKs).  Under hypoxic conditions, conversion of pyruvate to lactate occurs, a reaction catalyzed by lactate dehydrogenase 5 (LDH5).  In cancer cells, however, pyruvate is transformed to lactate occurs, regardless of the presence of oxygen (aerobic glycolysis/Warburg effect).  Although hypoxic intratumoral conditions account for HIF1Î± stabilization and induction of anaerobic metab., recent data suggest that high pyruvate concns. also result in HIF1Î± stabilization independently of hypoxia.  In the present immunohistochem. study, we provide evidence that the PDH/PDK pathway is repressed in 73% of non small cell lung carcinomas, which may be a key reason for HIF1Î± stabilization and "aerobic glycolysis.".  However, about half of PDH-deficient carcinomas are not able to switch on the HIF pathway, and patients harboring these tumors have an excellent postoperative outcome.  A small subgroup of clin. aggressive tumors maintains a coherent PDH and HIF/LDH5 expression.  In contrast to cancer cells, fibroblasts in the tumor-supporting stroma exhibit an intense PDH but reduced PDK1 expression favoring max. PDH activity.  This means that stroma may use lactic acid produced by tumor cells, preventing the creation of an intolerable intratumoral acidic environment at the same time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV1TgkNQIoR7Vg90H21EOLACvtfcHk0lhIAm5jDkyM1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Gnsb4%253D&md5=59d95598203762a351627ce808b5b32f</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1593%2Fneo.04373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.04373%26sid%3Dliteratum%253Aachs%26aulast%3DKoukourakis%26aufirst%3DM.%2BI.%26aulast%3DGiatromanolaki%26aufirst%3DA.%26aulast%3DSivridis%26aufirst%3DE.%26aulast%3DGatter%26aufirst%3DK.%2BC.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DPyruvate%2520dehydrogenase%2520and%2520pyruvate%2520dehydrogenase%2520kinase%2520expression%2520in%2520non%2520small%2520cell%2520lung%2520cancer%2520and%2520tumor-associated%2520stroma%26jtitle%3DNeoplasia%26date%3D2005%26volume%3D7%26spage%3D1%26epage%3D6%26doi%3D10.1593%2Fneo.04373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golias, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kery, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radenkovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papandreou, I.</span></span> <span> </span><span class="NLM_article-title">Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">674</span>â <span class="NLM_lpage">686</span>, <span class="refDoi">Â DOI: 10.1002/ijc.31812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1002%2Fijc.31812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=30121950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVCqtLjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2019&pages=674-686&author=T.+Goliasauthor=M.+Keryauthor=S.+Radenkovicauthor=I.+Papandreou&title=Microenvironmental+control+of+glucose+metabolism+in+tumors+by+regulation+of+pyruvate+dehydrogenase&doi=10.1002%2Fijc.31812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase</span></div><div class="casAuthors">Golias, Tereza; Kery, Martin; Radenkovic, Silvia; Papandreou, Ioanna</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">674-686</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">During malignant progression cancer cells undergo a series of changes, which promote their survival, invasiveness and metastatic process.  One of them is a change in glucose metab.  Unlike normal cells, which mostly rely on the tricarboxylic acid cycle (TCA), many cancer types rely on glycolysis.  Pyruvate dehydrogenase complex (PDC) is the gatekeeper enzyme between these two pathways and is responsible for converting pyruvate to acetyl-CoA, which can then be processed further in the TCA cycle.  Its activity is regulated by PDP (pyruvate dehydrogenase phosphatases) and PDHK (pyruvate dehydrogenase kinases).  Pyruvate dehydrogenase kinase exists in 4 tissue specific isoforms (PDHK1-4), the activities of which are regulated by different factors, including hormones, hypoxia and nutrients.  PDHK1 and PDHK3 are active in the hypoxic tumor microenvironment and inhibit PDC, resulting in a decrease of mitochondrial function and activation of the glycolytic pathway.  High PDHK1/3 expression is assocd. with worse prognosis in patients, which makes them a promising target for cancer therapy.  However, a better understanding of PDC's enzymic regulation in vivo and of the mechanisms of PDHK-mediated malignant progression is necessary for the design of better PDHK inhibitors and the selection of patients most likely to benefit from such inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsoidTi7vIWrVg90H21EOLACvtfcHk0liIvxFHASWAlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVCqtLjJ&md5=bcbdeb03b8a018d45bb647b635b5575e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fijc.31812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.31812%26sid%3Dliteratum%253Aachs%26aulast%3DGolias%26aufirst%3DT.%26aulast%3DKery%26aufirst%3DM.%26aulast%3DRadenkovic%26aufirst%3DS.%26aulast%3DPapandreou%26aufirst%3DI.%26atitle%3DMicroenvironmental%2520control%2520of%2520glucose%2520metabolism%2520in%2520tumors%2520by%2520regulation%2520of%2520pyruvate%2520dehydrogenase%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2019%26volume%3D144%26spage%3D674%26epage%3D686%26doi%3D10.1002%2Fijc.31812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truongcao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foulkes, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapienza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozen, R.</span></span> <span> </span><span class="NLM_article-title">Oncogenic role of PDK4 in human colon cancer cells</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">930</span>â <span class="NLM_lpage">936</span>, <span class="refDoi">Â DOI: 10.1038/bjc.2017.38</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fbjc.2017.38" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=28208156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVyktL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=930-936&author=D.+Leclercauthor=D.+Phamauthor=N.+Levesqueauthor=M.+Truongcaoauthor=W.+Foulkesauthor=C.+Sapienzaauthor=R.+Rozen&title=Oncogenic+role+of+PDK4+in+human+colon+cancer+cells&doi=10.1038%2Fbjc.2017.38"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic role of PDK4 in human colon cancer cells</span></div><div class="casAuthors">Leclerc, D.; Pham, D. N. T.; Levesque, N.; Truongcao, M.; Foulkes, W. D.; Sapienza, C.; Rozen, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">930-936</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Cancer cells maintain high rates of glycolysis.  Pyruvate dehydrogenase kinases (PDK) contribute to this phenomenon, which favors apoptosis resistance and cellular transformation.  We previously reported upregulation of PDK4 in normal mucosa of colorectal cancer (CRC) patients compared with controls and in preneoplastic intestine of our mouse model.  Decreased methylation of four consecutive PDK4 CpGs was obsd. in normal mucosa of patients.  Although other members of the PDK family have been investigated for transformation potential, PDK4 has not been extensively studied.  Methods: PDK4 methylation in blood of CRC patients and controls was evaluated by pyrosequencing.  PDK4 expression in human colon carcinoma cells was down-regulated by RNAi.  Cellular migration and invasion, apoptosis and qRT-PCR of key genes were assessed.  Results: Pyrosequencing revealed decreased methylation of the same four consecutive CpGs in the blood of patients compared with controls.  Cellular migration and invasion were reduced and apoptosis was increased following transient or stable inhibition of PDK4.  Expression of vimentin, HIF-1 and VEGFA was reduced.  Conclusions: These studies demonstrate the involvement of PDK4 in transformation.  Methylation assessment of PDK4 in the blood may be useful for non-invasive CRC detection.  PDK4 should be considered as a target for development of anticancer strategies and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-CUeJfoOW47Vg90H21EOLACvtfcHk0liIvxFHASWAlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVyktL4%253D&md5=9f1e136b96e59e3c5f6227b2150c7d75</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2017.38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2017.38%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DD.%26aulast%3DPham%26aufirst%3DD.%26aulast%3DLevesque%26aufirst%3DN.%26aulast%3DTruongcao%26aufirst%3DM.%26aulast%3DFoulkes%26aufirst%3DW.%26aulast%3DSapienza%26aufirst%3DC.%26aulast%3DRozen%26aufirst%3DR.%26atitle%3DOncogenic%2520role%2520of%2520PDK4%2520in%2520human%2520colon%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D116%26spage%3D930%26epage%3D936%26doi%3D10.1038%2Fbjc.2017.38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woolbright, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhary, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikhalyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trammel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilbeam, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. A.</span></span> <span> </span><span class="NLM_article-title">The role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in bladder cancer and chemoresistance</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2004</span>â <span class="NLM_lpage">2012</span>, <span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-18-0063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1158%2F1535-7163.MCT-18-0063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=29907593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit12qtLjK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=2004-2012&author=B.+L.+Woolbrightauthor=D.+Choudharyauthor=A.+Mikhalyukauthor=C.+Trammelauthor=S.+Shanmugamauthor=E.+Abbottauthor=C.+C.+Pilbeamauthor=J.+A.+Taylor&title=The+role+of+Pyruvate+Dehydrogenase+Kinase-4+%28PDK4%29+in+bladder+cancer+and+chemoresistance&doi=10.1158%2F1535-7163.MCT-18-0063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The role of pyruvate dehydrogenase kinase-4 (PDK4) in bladder cancer and chemoresistance</span></div><div class="casAuthors">Woolbright, Benjamin L.; Choudhary, Dharamainder; Mikhalyuk, Andrew; Trammel, Cassandra; Shanmugam, Sambantham; Abbott, Erika; Pilbeam, Carol C.; Taylor, John A., III.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2004-2012</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Advanced bladder cancer remains a major source of mortality, with poor treatment options.  Cisplatin-based chemotherapy is the std. treatment, however many patients are or become resistant.  One potential cause of chemoresistance is the Warburg effect, a metabolic switch to aerobic glycolysis that occurs in many cancers.  Upregulation of the pyruvate dehydrogenase kinase family (PDK1-PDK4) is assocd. with aerobic glycolysis and chemoresistance through inhibition of the pyruvate dehydrogenase complex (PDH).  We have previously obsd. upregulation of PDK4 in high-grade compared with low-grade bladder cancers.  We initiated this study to det. if inhibition of PDK4 could reduce tumor growth rates or sensitize bladder cancer cells to cisplatin.  Upregulation of PDK4 in malignant bladder cancer cell lines as compared with benign transformed urothelial cells was confirmed using qPCR.  Inhibition of PDK4 with dichloroacetate (DCA) resulted in increased PDH activity, reduced cell growth, and G0-G1 phase arrest in bladder cancer cells.  Similarly, siRNA knockdown of PDK4 inhibited bladder cancer cell proliferation.  Cotreatment of bladder cancer cells with cisplatin and DCA did not increase caspase-3 activity but did enhance overall cell death in vitro.  Although daily treatment with 200 mg/kg DCA alone did not reduce tumor vols. in a xenograft model, combination treatment with cisplatin resulted in dramatically reduced tumor vols. as compared with either DCA or cisplatin alone.  This was attributed to substantial intratumoral necrosis.  These findings indicate inhibition of PDK4 may potentiate cisplatin-induced cell death and warrant further studies investigating the mechanism through which this occurs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC7yypSx8LTbVg90H21EOLACvtfcHk0liIvxFHASWAlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit12qtLjK&md5=6fecb75e56961e5f14f76b77e5659fb4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-18-0063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-18-0063%26sid%3Dliteratum%253Aachs%26aulast%3DWoolbright%26aufirst%3DB.%2BL.%26aulast%3DChoudhary%26aufirst%3DD.%26aulast%3DMikhalyuk%26aufirst%3DA.%26aulast%3DTrammel%26aufirst%3DC.%26aulast%3DShanmugam%26aufirst%3DS.%26aulast%3DAbbott%26aufirst%3DE.%26aulast%3DPilbeam%26aufirst%3DC.%2BC.%26aulast%3DTaylor%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520role%2520of%2520Pyruvate%2520Dehydrogenase%2520Kinase-4%2520%2528PDK4%2529%2520in%2520bladder%2520cancer%2520and%2520chemoresistance%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D2004%26epage%3D2012%26doi%3D10.1158%2F1535-7163.MCT-18-0063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Targeting tumor metabolism for cancer treatment: is Pyruvate Dehydrogenase Kinases (PDKs) a viable anticancer target?</span>. <i>Int. J. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1390</span>â <span class="NLM_lpage">1400</span>, <span class="refDoi">Â DOI: 10.7150/ijbs.13325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.7150%2Fijbs.13325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=26681918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1ejsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=1390-1400&author=W.+Zhangauthor=S.+L.+Zhangauthor=X.+Huauthor=K.+Y.+Tam&title=Targeting+tumor+metabolism+for+cancer+treatment%3A+is+Pyruvate+Dehydrogenase+Kinases+%28PDKs%29+a+viable+anticancer+target%3F&doi=10.7150%2Fijbs.13325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumor metabolism for cancer treatment: is pyruvate dehydrogenase kinases (PDKs) a viable anticancer target?</span></div><div class="casAuthors">Zhang, Wen; Zhang, Shao-Lin; Hu, Xiaohui; Tam, Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1390-1400</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Cancer remains a lethal threat to global lives.  Development of novel anticancer therapeutics is still a challenge to scientists in the field of biomedicine.  In cancer cells, the metabolic features are significantly different from those of normal ones, which are hallmarks of several malignancies.  Recent studies brought atypical cellular metab., such as aerobic glycolysis or the Warburg effect, into the scientific limelight.  Targeting these altered metabolic pathways in cancer cells presents a promising therapeutic strategy.  Pyruvate dehydrogenase kinases (PDKs), key enzymes in the pathway of glucose metab., could inactivate the pyruvate dehydrogenase complex (PDC) by phosphorylating it and preserving the substrates pyruvate, lactate and alanine for gluconeogenesis.  Overexpression of PDKs could block the oxidative decarboxylation of pyruvate to satisfy high oxygen demand in cancer cells, while inhibition of PDKs could upregulate the activity of PDC and rectify the balance between the demand and supply of oxygen, which could lead to cancer cell death.  Thus, inhibitors targeting PDKs represent a promising strategy for cancer treatment by acting on glycolytic tumors while showing minimal side effects on the oxidative healthy organs.  This review considers the role of PDKs as regulator of PDC that catalyzes the oxidative decarboxylation of pyruvate in mitochondrion.  It is concluded that PDKs are solid therapeutic targets.  Inhibition of PDKs could be an attractive therapeutic approach for the development of anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWBd1-X2WBlbVg90H21EOLACvtfcHk0lg2qIesoafORg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1ejsLo%253D&md5=897a9100a5400807ae4043598d592aff</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7150%2Fijbs.13325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.13325%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DTargeting%2520tumor%2520metabolism%2520for%2520cancer%2520treatment%253A%2520is%2520Pyruvate%2520Dehydrogenase%2520Kinases%2520%2528PDKs%2529%2520a%2520viable%2520anticancer%2520target%253F%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2015%26volume%3D11%26spage%3D1390%26epage%3D1400%26doi%3D10.7150%2Fijbs.13325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Knoechel, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungay, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasten, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span> <span> </span><span class="NLM_article-title">Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">402</span>â <span class="NLM_lpage">415</span>, <span class="refDoi">Â DOI: 10.1021/bi051402s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051402s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=402-415&author=T.+R.+Knoechelauthor=A.+D.+Tuckerauthor=C.+M.+Robinsonauthor=C.+Phillipsauthor=W.+Taylorauthor=P.+J.+Bungayauthor=S.+A.+Kastenauthor=T.+E.+Rocheauthor=D.+G.+Brown&title=Regulatory+roles+of+the+N-terminal+domain+based+on+crystal+structures+of+human+pyruvate+dehydrogenase+kinase+2+containing+physiological+and+synthetic+ligands&doi=10.1021%2Fbi051402s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands</span></div><div class="casAuthors">Knoechel, Thorsten R.; Tucker, Alec D.; Robinson, Colin M.; Phillips, Chris; Taylor, Wendy; Bungay, Peter J.; Kasten, Shane A.; Roche, Thomas E.; Brown, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-415</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDHK) regulates the activity of the pyruvate dehydrogenase multienzyme complex.  PDHK inhibition provides a route for therapeutic intervention in diabetes and cardiovascular disorders.  We report crystal structures of human PDHK isoenzyme 2 (PDHK2) complexed with physiol. and synthetic ligands.  Several of the PDHK2 structures disclosed have C-terminal cross arms that span a large trough region between the N-terminal regulatory (R) domains of the PDHK2 dimers.  The structures contg. bound ATP and ADP demonstrate variation in the conformation of the active site lid, residues 316-321, which enclose the nucleotide Î² and Î³ phosphates at the active site in the C-terminal catalytic domain.  We have identified three novel ligand binding sites located in the R domain of PDHK2.  Dichloroacetate (DCA) binds at the pyruvate binding site in the center of the R domain, which together with ADP, induces significant changes at the active site.  Nov3r and AZ12 inhibitors bind at the lipoamide binding site that is located at one end of the R domain.  Pfz3 (an allosteric inhibitor) binds in an extended site at the other end of the R domain.  We conclude that the N-terminal domain of PDHK has a key regulatory function and propose that the different inhibitor classes act by discrete mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0BAYhcMgn7Vg90H21EOLACvtfcHk0lg2qIesoafORg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L&md5=62e6162ff1191e7b5ae88014dcb71830</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fbi051402s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051402s%26sid%3Dliteratum%253Aachs%26aulast%3DKnoechel%26aufirst%3DT.%2BR.%26aulast%3DTucker%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DW.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DKasten%26aufirst%3DS.%2BA.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26atitle%3DRegulatory%2520roles%2520of%2520the%2520N-terminal%2520domain%2520based%2520on%2520crystal%2520structures%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520containing%2520physiological%2520and%2520synthetic%2520ligands%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D402%26epage%3D415%26doi%3D10.1021%2Fbi051402s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allalunis-Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haromy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopaschuk, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puttagunta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">37</span>â <span class="NLM_lpage">51</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2006.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.ccr.2006.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=17222789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=37-51&author=S.+Bonnetauthor=S.+L.+Archerauthor=J.+Allalunis-Turnerauthor=A.+Haromyauthor=C.+Beaulieuauthor=R.+Thompsonauthor=C.+T.+Leeauthor=G.+D.+Lopaschukauthor=L.+Puttaguntaauthor=S.+Bonnet&title=A+mitochondria-K%2B+channel+axis+is+suppressed+in+cancer+and+its+normalization+promotes+apoptosis+and+inhibits+cancer+growth&doi=10.1016%2Fj.ccr.2006.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span></div><div class="casAuthors">Bonnet, Sebastien; Archer, Stephen L.; Allalunis-Turner, Joan; Haromy, Alois; Beaulieu, Christian; Thompson, Richard; Lee, Christopher T.; Lopaschuk, Gary D.; Puttagunta, Lakshmi; Bonnet, Sandra; Harry, Gwyneth; Hashimoto, Kyoko; Porter, Christopher J.; Andrade, Miguel A.; Thebaud, Bernard; Michelakis, Evangelos D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-51</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The unique metabolic profile of cancer (aerobic glycolysis) might confer apoptosis resistance and be therapeutically targeted.  Compared to normal cells, several human cancers have high mitochondrial membrane potential (ÎÎ¨m) and low expression of the K+ channel Kv1.5, both contributing to apoptosis resistance.  Dichloroacetate (DCA) inhibits mitochondrial pyruvate dehydrogenase kinase (PDK), shifts metab. from glycolysis to glucose oxidn., decreases ÎÎ¨m, increases mitochondrial H2O2, and activates Kv channels in all cancer, but not normal, cells; DCA upregulates Kv1.5 by an NFAT1-dependent mechanism.  DCA induces apoptosis, decreases proliferation, and inhibits tumor growth, without apparent toxicity.  Mol. inhibition of PDK2 by siRNA mimics DCA.  The mitochondria-NFAT-Kv axis and PDK are important therapeutic targets in cancer; the orally available DCA is a promising selective anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocAukkjsEmZLVg90H21EOLACvtfcHk0lg2qIesoafORg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D&md5=ce8b45e3292469a3ce1af91803785bee</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DArcher%26aufirst%3DS.%2BL.%26aulast%3DAllalunis-Turner%26aufirst%3DJ.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DLopaschuk%26aufirst%3DG.%2BD.%26aulast%3DPuttagunta%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DS.%26atitle%3DA%2520mitochondria-K%252B%2520channel%2520axis%2520is%2520suppressed%2520in%2520cancer%2520and%2520its%2520normalization%2520promotes%2520apoptosis%2520and%2520inhibits%2520cancer%2520growth%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D11%26spage%3D37%26epage%3D51%26doi%3D10.1016%2Fj.ccr.2006.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of N-arylphenyl-2,2-dichloroacetamide analogues as anti-cancer agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">7268</span>â <span class="NLM_lpage">7271</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2012.07.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.bmcl.2012.07.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23067553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFWhsrjO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7268-7271&author=T.+Liauthor=Y.+Yangauthor=C.+Chengauthor=A.+K.+Tiwariauthor=K.+Sodaniauthor=Y.+Zhaoauthor=I.+Abrahamauthor=Z.+S.+Chen&title=Design%2C+synthesis+and+biological+evaluation+of+N-arylphenyl-2%2C2-dichloroacetamide+analogues+as+anti-cancer+agents&doi=10.1016%2Fj.bmcl.2012.07.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of N-arylphenyl-2,2-dichloroacetamide analogues as anti-cancer agents</span></div><div class="casAuthors">Li, Tianwen; Yang, Yongchong; Cheng, Changmei; Tiwari, Amit K.; Sodani, Kamlesh; Zhao, Yufen; Abraham, Ioana; Chen, Zhe-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7268-7271</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our earlier research has shown that N-phenyl-2,2-dichloroacetamide analogs had much higher anti-cancer activity than the lead compd. sodium dichloroacetate (DCA).  In this current study, a variety of N-arylphenyl-2,2-dichloroacetamide analogs were synthesized via Suzuki coupling reaction and their anti-cancer activity was evaluated.  The results showed that N-terphenyl-2,2-dichloroacetamide analogs had satisfactory anti-cancer activity.  Among them, N-(3,5-bis(benzo[d][1,3]dioxol-5-yl)phenyl)-2,2-dichloroacetamide had an IC50 of 2.40 Î¼M against KB-3-1 cells, 1.04 Î¼M against H460 cells and 1.73 Î¼M against A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGyQg9q24gdrVg90H21EOLACvtfcHk0lgSavNqvcHCkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFWhsrjO&md5=5c4537ff62f29610e70b2905a1a253d4</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.057%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DTiwari%26aufirst%3DA.%2BK.%26aulast%3DSodani%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAbraham%26aufirst%3DI.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520N-arylphenyl-2%252C2-dichloroacetamide%2520analogues%2520as%2520anti-cancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7268%26epage%3D7271%26doi%3D10.1016%2Fj.bmcl.2012.07.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: design, synthesis and biological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4300</span>â <span class="NLM_lpage">4306</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2010.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.ejmech.2010.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=20663593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4300-4306&author=Y.+Yangauthor=P.+Shangauthor=C.+Chengauthor=D.+Wangauthor=P.+Yangauthor=F.+Zhangauthor=T.+Liauthor=A.+Luauthor=Y.+Zhao&title=Novel+N-phenyl+dichloroacetamide+derivatives+as+anticancer+reagents%3A+design%2C+synthesis+and+biological+evaluation&doi=10.1016%2Fj.ejmech.2010.06.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: Design, synthesis and biological evaluation</span></div><div class="casAuthors">Yang, Yongchong; Shang, Peihua; Cheng, Changmei; Wang, Dongchun; Yang, Ping; Zhang, Feng; Li, Tianwen; Lu, Aijun; Zhao, Yufen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4300-4306</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A current study shows that sodium dichloroacetate (DCA) can induce cancer cell apoptosis and inhibit tumor growth, but its cytotoxic activity is low (IC50 > 1000 Î¼M for A549).  In this paper, a variety of DCA derivs. were synthesized, and their cytotoxic activities were evaluated.  The result showed that the N-phenyl-2,2-dichloroacetamide analogs had satisfactory potencies.  Among them, N-(3-iodophenyl)-2,2-dichloroacetamide, an optimized lead compd., has an IC50 against A549 as low as 4.76 Î¼M.  Furthermore, it can induce cancer cell apoptosis and has a low toxicity in mice (LD50 = 1117 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvkHzJq8OK77Vg90H21EOLACvtfcHk0lgSavNqvcHCkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLY%253D&md5=a3eef328bc5c3ff3fdc8b2ebd81e73ff</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DShang%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DNovel%2520N-phenyl%2520dichloroacetamide%2520derivatives%2520as%2520anticancer%2520reagents%253A%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4300%26epage%3D4306%26doi%3D10.1016%2Fj.ejmech.2010.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrache, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harn, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span> <span> </span><span class="NLM_article-title">Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1178</span>â <span class="NLM_lpage">1187</span>, <span class="refDoi">Â DOI: 10.1021/cb400944y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400944y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1178-1187&author=R.+K.+Pathakauthor=S.+Marracheauthor=D.+A.+Harnauthor=S.+Dhar&title=Mito-DCA%3A+a+mitochondria+targeted+molecular+scaffold+for+efficacious+delivery+of+metabolic+modulator+dichloroacetate&doi=10.1021%2Fcb400944y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate</span></div><div class="casAuthors">Pathak, Rakesh K.; Marrache, Sean; Harn, Donald A.; Dhar, Shanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1178-1187</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor growth is fueled by the use of glycolysis, which normal cells use only in the scarcity of oxygen.  Glycolysis makes tumor cells resistant to normal death processes.  Targeting this unique tumor metab. can provide an alternative strategy to selectively destroy the tumor, leaving normal tissue unharmed.  The orphan drug dichloroacetate (DCA) is a mitochondrial kinase inhibitor that has the ability to show such characteristics.  However, its mol. form shows poor uptake and bioavailability and limited ability to reach its target mitochondria.  Here, we describe a targeted mol. scaffold for construction of a multiple DCA loaded compd., Mito-DCA, with three orders of magnitude enhanced potency and cancer cell specificity compared to DCA.  Incorporation of a lipophilic triphenylphosphonium cation through a biodegradable linker in Mito-DCA allowed for mitochondria targeting.  Mito-DCA did not show any significant metabolic effects toward normal cells but tumor cells with dysfunctional mitochondria were affected by Mito-DCA, which caused a switch from glycolysis to glucose oxidn. and subsequent cell death via apoptosis.  Effective delivery of DCA to the mitochondria resulted in significant redn. in lactate levels and played important roles in modulating dendritic cell (DC) phenotype evidenced by secretion of interleukin-12 from DCs upon activation with tumor antigens from Mito-DCA treated cancer cells.  Targeting mitochondrial metabolic inhibitors to the mitochondria could lead to induction of an efficient antitumor immune response, thus introducing the concept of combining glycolysis inhibition with immune system to destroy tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_tg-468e5JrVg90H21EOLACvtfcHk0lgqQz-B7vyL9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D&md5=d9a7041a1c8f3417e5bf290e00b092d4</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fcb400944y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400944y%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DR.%2BK.%26aulast%3DMarrache%26aufirst%3DS.%26aulast%3DHarn%26aufirst%3DD.%2BA.%26aulast%3DDhar%26aufirst%3DS.%26atitle%3DMito-DCA%253A%2520a%2520mitochondria%2520targeted%2520molecular%2520scaffold%2520for%2520efficacious%2520delivery%2520of%2520metabolic%2520modulator%2520dichloroacetate%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1178%26epage%3D1187%26doi%3D10.1021%2Fcb400944y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Unexpected discovery of Dichloroacetate derived adenosine triphosphate competitors targeting pyruvate dehydrogenase kinase to inhibit cancer proliferation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3562</span>â <span class="NLM_lpage">3568</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b01828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eis7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3562-3568&author=S.+L.+Zhangauthor=X.+Huauthor=W.+Zhangauthor=K.+Y.+Tam&title=Unexpected+discovery+of+Dichloroacetate+derived+adenosine+triphosphate+competitors+targeting+pyruvate+dehydrogenase+kinase+to+inhibit+cancer+proliferation&doi=10.1021%2Facs.jmedchem.5b01828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12dR"><div class="casContent"><span class="casTitleNuber">12d</span><div class="casTitle"><span class="NLM_cas:atitle">Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation</span></div><div class="casAuthors">Zhang, Shao-Lin; Hu, Xiaohui; Zhang, Wen; Tam, Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3562-3568</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinases (PDKs) have recently emerged as an attractive target for cancer therapy.  Herein, the authors prepd. a series of compds. derived from dichloroacetate (DCA) which inhibited cancer cells proliferation.  For the first time, the authors have successfully developed DCA derived inhibitors that preferentially bind to the ATP pocket of PDK isoform 1 (PDK1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmY3Q84QJe_bVg90H21EOLACvtfcHk0lgqQz-B7vyL9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eis7k%253D&md5=fa825a672c4c481c0cc55f59da38b43f</span></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01828%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DUnexpected%2520discovery%2520of%2520Dichloroacetate%2520derived%2520adenosine%2520triphosphate%2520competitors%2520targeting%2520pyruvate%2520dehydrogenase%2520kinase%2520to%2520inhibit%2520cancer%2520proliferation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3562%26epage%3D3568%26doi%3D10.1021%2Facs.jmedchem.5b01828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butlin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgour, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myatt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, B. R.</span></span> <span> </span><span class="NLM_article-title">AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1165</span>â <span class="NLM_lpage">1167</span>, <span class="refDoi">Â DOI: 10.1042/bst0311165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1042%2Fbst0311165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=14641018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1165-1167&author=R.+M.+Mayersauthor=R.+J.+Butlinauthor=E.+Kilgourauthor=B.+Leightonauthor=D.+Martinauthor=J.+Myattauthor=J.+P.+Ormeauthor=B.+R.+Holloway&title=AZD7545%2C+a+novel+inhibitor+of+pyruvate+dehydrogenase+kinase+2+%28PDHK2%29%2C+activates+pyruvate+dehydrogenase+in+vivo+and+improves+blood+glucose+control+in+obese+%28fa%2Ffa%29+Zucker+rats&doi=10.1042%2Fbst0311165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats</span></div><div class="casAuthors">Mayers, R. M.; Butlin, R. J.; Kilgour, E.; Leighton, B.; Martin, D.; Myatt, J.; Orme, J. P.; Holloway, B. R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-1167</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">PDH (pyruvate dehydrogenase) is a key enzyme controlling the rate of glucose oxidn., and the availability of gluconeogenic precursors.  Activation of PDH in skeletal muscle and liver may increase glucose uptake and reduce glucose prodn.  This study describes the properties of AZD7545, a novel, small-mol. inhibitor of PDHK (PDH kinase).  In the presence of PDHK2, AZD7545 increased PDH activity with an EC50 value of 5.2 nM.  In rat hepatocytes, the rate of pyruvate oxidn. was stimulated 2-fold (EC50 105 nM).  A single dose of AZD7545 to Wistar rats increased the proportion of liver PDH in its active, dephosphorylated form in a dose-related manner from 24.7 to 70.3% at 30 mg/kg; and in skeletal muscle from 21.1 to 53.3%.  A single dose of 10 mg/kg also significantly elevated muscle PDH activity in obese Zucker (fa / fa) rats.  Obese, insulin-resistant, Zucker rats show elevated postprandial glucose levels compared with their lean counterparts (8.7 vs. 6.1 mM at 12 wk old).  AZD7545 (10 mg/kg) twice daily for 7 days markedly improved the 24-h glucose profile, by eliminating the postprandial elevation in blood glucose.  These results suggest that PDHK inhibitors may be beneficial agents for improving glucose control in the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3Q4M5QmmjLVg90H21EOLACvtfcHk0lgqQz-B7vyL9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsr4%253D&md5=409b3a21f3cd550e2c04311446e5d0a0</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1042%2Fbst0311165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311165%26sid%3Dliteratum%253Aachs%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DKilgour%26aufirst%3DE.%26aulast%3DLeighton%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DMyatt%26aufirst%3DJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DB.%2BR.%26atitle%3DAZD7545%252C%2520a%2520novel%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520%2528PDHK2%2529%252C%2520activates%2520pyruvate%2520dehydrogenase%2520in%2520vivo%2520and%2520improves%2520blood%2520glucose%2520control%2520in%2520obese%2520%2528fa%252Ffa%2529%2520Zucker%2520rats%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1165%26epage%3D1167%26doi%3D10.1042%2Fbst0311165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butlin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgour, E.</span></span> <span> </span><span class="NLM_article-title">AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1168</span>â <span class="NLM_lpage">1170</span>, <span class="refDoi">Â DOI: 10.1042/bst0311168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1042%2Fbst0311168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=14641019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1168-1170&author=J.+A.+Morrellauthor=J.+Ormeauthor=R.+J.+Butlinauthor=T.+E.+Rocheauthor=R.+M.+Mayersauthor=E.+Kilgour&title=AZD7545+is+a+selective+inhibitor+of+pyruvate+dehydrogenase+kinase+2&doi=10.1042%2Fbst0311168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2</span></div><div class="casAuthors">Morrell, J. A.; Orme, J.; Butlin, R. J.; Roche, T. E.; Mayers, R. M.; Kilgour, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1168-1170</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The PDH (pyruvate dehydrogenase) multi-enzyme complex catalyzes a key regulatory step in oxidative glycolysis.  Phosphorylation of the E1 subunit of the complex on serine residues results in the inactivation of enzyme activity.  A family of four dedicated PDH kinase isoenzymes exists, each of which displays a distinct tissue-specific expression profile.  AZD7545 is one of a series of PDH kinase inhibitors developed for the treatment of type 2 diabetes.  The isoenzyme-selectivity profile of AZD7545 and related compds. is described and the consequences for their in vivo mode of action are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRKIXN95mX-bVg90H21EOLACvtfcHk0lgQx84NYPh7qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsr8%253D&md5=86c9fe03c05f86792c14953c381d3beb</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1042%2Fbst0311168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311168%26sid%3Dliteratum%253Aachs%26aulast%3DMorrell%26aufirst%3DJ.%2BA.%26aulast%3DOrme%26aufirst%3DJ.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DKilgour%26aufirst%3DE.%26atitle%3DAZD7545%2520is%2520a%2520selective%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25202%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1168%26epage%3D1170%26doi%3D10.1042%2Fbst0311168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hiromasa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, T. E.</span></span> <span> </span><span class="NLM_article-title">Specific ion influences on self-association of pyruvate dehydrogenase kinase isoform 2 (PDHK2), binding of PDHK2 to the L2 lipoyl domain, and effects of the lipoyl group-binding site inhibitor, Nov3r</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2312</span>â <span class="NLM_lpage">2324</span>, <span class="refDoi">Â DOI: 10.1021/bi7014772</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi7014772" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyitbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=2312-2324&author=Y.+Hiromasaauthor=X.+Yanauthor=T.+E.+Roche&title=Specific+ion+influences+on+self-association+of+pyruvate+dehydrogenase+kinase+isoform+2+%28PDHK2%29%2C+binding+of+PDHK2+to+the+L2+lipoyl+domain%2C+and+effects+of+the+lipoyl+group-binding+site+inhibitor%2C+Nov3r&doi=10.1021%2Fbi7014772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Ion Influences on Self-Association of Pyruvate Dehydrogenase Kinase Isoform 2 (PDHK2), Binding of PDHK2 to the L2 Lipoyl Domain, and Effects of the Lipoyl Group-Binding Site Inhibitor, Nov3r</span></div><div class="casAuthors">Hiromasa, Yasuaki; Yan, Xiaohua; Roche, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2312-2324</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Assocn. of the PDHK2 and GST-L2 (glutathione-S-transferase fused to the inner lipoyl domain (L2) of dihydrolipoyl acetyltransferase (E2)) dimers was enhanced by K+ with higher affinity K+ binding than occurs at the PDHK2 active site.  Supporting a distinct K+ binding site, the NH4+ ion did not effectively replace K+ in aiding GST-L2 binding.  With 50 mM K+, Pi enhanced interference by ADP, ATP, or pyruvate of PDHK2 binding to GST-L2.  The inclusion of Pi with ADP or ATP plus pyruvate greatly hindered PDHK2 binding to GST-L2 and promoted PDHK2 forming a tetramer.  Reciprocally, GST-L2 interference with ATP/ADP binding also required elevated K+ and was increased by Pi.  Potent inhibition by Nov3r of E2-activated PDHK2 activity (IC50 of â¼7.8 nM) required elevated K+ and Pi.  Nov3r only modestly inhibited the low activity of PDHK2 without E2.  By binding at the lipoyl group binding site, Nov3r prevented PDHK2 binding to E2 and GST-L2.  Nov3r interfered with high-affinity binding of ADP and pyruvate via a Pi-dependent mechanism.  Thus, GST-L2 binding to PDHK2 is supported by K+ binding at a site distinct from the active site.  Pi makes major contributions to ligands interfering with PDHK2 binding to GST-L2, the conversion of PDHK2 dimer to a tetramer, and Nov3r (an acetyl-lipoate analog) interfering with binding of ADP and pyruvate.  Pi is suggested to facilitate transmission within PDHK2 of the stimulatory signal of acetylation from the distal lipoyl-group binding site to the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4vmP7rusb0bVg90H21EOLACvtfcHk0lgQx84NYPh7qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyitbw%253D&md5=92d9b85afe55be2b4baacb4178f08ed7</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fbi7014772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7014772%26sid%3Dliteratum%253Aachs%26aulast%3DHiromasa%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26atitle%3DSpecific%2520ion%2520influences%2520on%2520self-association%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520isoform%25202%2520%2528PDHK2%2529%252C%2520binding%2520of%2520PDHK2%2520to%2520the%2520L2%2520lipoyl%2520domain%252C%2520and%2520effects%2520of%2520the%2520lipoyl%2520group-binding%2520site%2520inhibitor%252C%2520Nov3r%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D2312%26epage%3D2324%26doi%3D10.1021%2Fbi7014772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">92</span>, <span class="refDoi">Â DOI: 10.1016/j.ejps.2017.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.ejps.2017.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=28347773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOqtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2017&pages=87-92&author=S.+L.+Zhangauthor=W.+Zhangauthor=Z.+Yangauthor=X.+Huauthor=K.+Y.+Tam&title=Synthesis+and+biological+evaluation+of+%28R%29-3%2C3%2C3-trifluoro-2-hydroxy-2-methylpropionamides+as+pyruvate+dehydrogenase+kinase+1+%28PDK1%29+inhibitors+to+reduce+the+growth+of+cancer+cells&doi=10.1016%2Fj.ejps.2017.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells</span></div><div class="casAuthors">Zhang, Shao-Lin; Zhang, Wen; Yang, Zheng; Hu, Xiaohui; Tam, Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Most cancer cells exhibit a high rate of glycolysis and reduced capacity in mitochondrial oxidative phosphorylation.  The expression of pyruvate dehydrogenase kinases (PDKs) was found to be increased in many cancer cells.  Inhibition of PDKs increases the oxidative phosphorylation of glucose, which may disrupt the balance between the demand and supply of oxygen in cancer cell, thus leading to cell death.  Several reports suggested that compds. contg. (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide group could inhibit PDKs in pyruvate dehydrogenase primary enzymic assay.  However, none of them were capable of reducing the growth of cancer cells.  Herein, we report the synthesis and biol. evaluation of some novel PDK1 inhibitors contg. the (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide warhead.  Excitingly, these novel PDK1 inhibitors exhibited good potency to reduce the growth of cancer cells.  We have demonstrated that these compds. could phys. assoc. with PDK1 and activate pyruvate dehydrogenase in low micromolar levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxXedalvtbQ7Vg90H21EOLACvtfcHk0lgQx84NYPh7qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOqtLk%253D&md5=7383daf75ee4cfcb3bf5d489b70dfa0d</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2017.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2017.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520%2528R%2529-3%252C3%252C3-trifluoro-2-hydroxy-2-methylpropionamides%2520as%2520pyruvate%2520dehydrogenase%2520kinase%25201%2520%2528PDK1%2529%2520inhibitors%2520to%2520reduce%2520the%2520growth%2520of%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D110%26spage%3D87%26epage%3D92%26doi%3D10.1016%2Fj.ejps.2017.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dijk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hekelaar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwisscha
van Scheltinga, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moman, E.</span></span> <span> </span><span class="NLM_article-title">Furoates and thenoates inhibit pyruvate dehydrogenase kinase 2 allosterically by binding to its pyruvate regulatory site</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">170</span>â <span class="NLM_lpage">175</span>, <span class="refDoi">Â DOI: 10.1080/14756366.2016.1201812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1080%2F14756366.2016.1201812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=27435185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktbbK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=170-175&author=T.+Masiniauthor=B.+Birkayaauthor=S.+van+Dijkauthor=M.+Mondalauthor=J.+Hekelaarauthor=M.+Jagerauthor=A.+C.+Terwisscha%0Avan+Scheltingaauthor=M.+S.+Patelauthor=A.+K.+Hirschauthor=E.+Moman&title=Furoates+and+thenoates+inhibit+pyruvate+dehydrogenase+kinase+2+allosterically+by+binding+to+its+pyruvate+regulatory+site&doi=10.1080%2F14756366.2016.1201812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Furoates and thenoates inhibit pyruvate dehydrogenase kinase 2 allosterically by binding to its pyruvate regulatory site</span></div><div class="casAuthors">Masini, Tiziana; Birkaya, Barbara; van Dijk, Simon; Mondal, Milon; Hekelaar, Johan; Jaeger, Manuel; Terwisscha van Scheltinga, Anke C.; Patel, Mulchand S.; Hirsch, Anna K. H.; Moman, Edelmiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup4</span>),
    <span class="NLM_cas:pages">170-175</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The last decade has witnessed the reawakening of cancer metab. as a therapeutic target.  In particular, inhibition of pyruvate dehydrogenase kinase (PDK) holds remarkable promise.  Dichloroacetic acid (DCA), currently undergoing clin. trials, is a unique PDK inhibitor in which it binds to the allosteric pyruvate site of the enzyme.  However, the safety of DCA as a drug is compromised by its neurotoxicity, whereas its usefulness as an investigative tool is limited by the high concns. required to exert observable effects in cell culture.  Herein, we report the identification - by making use of satn.-transfer difference NMR spectroscopy, enzymic assays and computational methods - of furoate and thenoate derivs. as allosteric pyruvatesite-binding PDK2 inhibitors.  This work substantiates the pyruvate regulatory pocket as a druggable target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJOOvduZ3b67Vg90H21EOLACvtfcHk0liZjPxX_VH2Dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktbbK&md5=710eeccceb190c6041c92c790e8aa691</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1201812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1201812%26sid%3Dliteratum%253Aachs%26aulast%3DMasini%26aufirst%3DT.%26aulast%3DBirkaya%26aufirst%3DB.%26aulast%3Dvan%2BDijk%26aufirst%3DS.%26aulast%3DMondal%26aufirst%3DM.%26aulast%3DHekelaar%26aufirst%3DJ.%26aulast%3DJager%26aufirst%3DM.%26aulast%3DTerwisscha%2Bvan%2BScheltinga%26aufirst%3DA.%2BC.%26aulast%3DPatel%26aufirst%3DM.%2BS.%26aulast%3DHirsch%26aufirst%3DA.%2BK.%26aulast%3DMoman%26aufirst%3DE.%26atitle%3DFuroates%2520and%2520thenoates%2520inhibit%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520allosterically%2520by%2520binding%2520to%2520its%2520pyruvate%2520regulatory%2520site%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D170%26epage%3D175%26doi%3D10.1080%2F14756366.2016.1201812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gahlot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakkar, R.</span></span> <span> </span><span class="NLM_article-title">Docking modes of Pfz3 and its analogues into the lipoamide binding site on PDHK2</span>. <i>Int. Res. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">33</span>â <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKlt7jN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=33-41&author=P.+Gahlotauthor=R.+Kakkar&title=Docking+modes+of+Pfz3+and+its+analogues+into+the+lipoamide+binding+site+on+PDHK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Docking modes of Pfz3 and its analogues into the lipoamide binding site on PDHK2</span></div><div class="casAuthors">Gahlot, Pragya; Kakkar, Rita</div><div class="citationInfo"><span class="NLM_cas:title">International Research Journal of Pharmaceuticals</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-41</span>CODEN:
                <span class="NLM_cas:coden">IRJPCT</span>;
        ISSN:<span class="NLM_cas:issn">2048-4143</span>.
    
            (<span class="NLM_cas:orgname">Scientific Journals</span>)
        </div><div class="casAbstract">Inhibitors based on the PDHK2 synthetic inhibitor Pfz3 have been docked into the lipoamide binding site of PDHK2.  It is found that all analogs bind at the same site and most of the proposed structural modifications lead to better binding.  This suggests that homologous inhibitors have similar binding patterns in and modes of interaction with PDHK2 and have a similar inhibitory mechanism.  In particular, replacement of the iso-Pr group docking in the hydrophobic region by its fluoro analog leads to better docking.  Another potential improvement can be brought out by replacement of chlorine by bromine.  Replacement of the carbonyl oxygen by sulfur, however, has a deleterious effect, as it reduces the hydrogen bond energy.  Most of the considered modifications improve the score and all but one of the new compds. score higher than Pfz3 itself.  Further, ADME screening provided a peer anal. for the final selection of potential candidates from the compd. library generated.  This approach promises to suggest future leads for rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqleuIf1S4KrrVg90H21EOLACvtfcHk0liZjPxX_VH2Dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKlt7jN&md5=d0588af18be4f77d1497bbcd65977804</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGahlot%26aufirst%3DP.%26aulast%3DKakkar%26aufirst%3DR.%26atitle%3DDocking%2520modes%2520of%2520Pfz3%2520and%2520its%2520analogues%2520into%2520the%2520lipoamide%2520binding%2520site%2520on%2520PDHK2%26jtitle%3DInt.%2520Res.%2520J.%2520Pharm.%26date%3D2011%26volume%3D1%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, D. T.</span></span> <span> </span><span class="NLM_article-title">Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">992</span>â <span class="NLM_lpage">1004</span>, <span class="refDoi">Â DOI: 10.1016/j.str.2007.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.str.2007.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=17683942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=992-1004&author=M.+Katoauthor=J.+Liauthor=J.+L.+Chuangauthor=D.+T.+Chuang&title=Distinct+structural+mechanisms+for+inhibition+of+pyruvate+dehydrogenase+kinase+isoforms+by+AZD7545%2C+dichloroacetate%2C+and+radicicol&doi=10.1016%2Fj.str.2007.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Structural Mechanisms for Inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545, Dichloroacetate, and Radicicol</span></div><div class="casAuthors">Kato, Masato; Li, Jun; Chuang, Jacinta L.; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">992-1004</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) isoforms are mol. switches that downregulate the pyruvate dehydrogenase complex (PDC) by reversible phosphorylation in mitochondria.  We have detd. structures of human PDK1 or PDK3 bound to the inhibitors AZD7545, dichloroacetate (DCA), and radicicol.  We show that the trifluoromethylpropanamide end of AZD7545 projects into the lipoyl-binding pocket of PDK1.  This interaction results in inhibition of PDK1 and PDK3 activities by aborting kinase binding to the PDC scaffold.  Paradoxically, AZD7545 at satg. concns. robustly increases scaffold-free PDK3 activity, similar to the inner lipoyl domain.  Good DCA d. is present in the helix bundle in the N-terminal domain of PDK1.  Bound DCA promotes local conformational changes that are communicated to both nucleotide-binding and lipoyl-binding pockets of PDK1, leading to the inactivation of kinase activity. Finally, radicicol inhibits kinase activity by binding directly to the ATP-binding pocket of PDK3, similar to Hsp90 and Topo VI from the same ATPase/kinase superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCpzfnlsNVarVg90H21EOLACvtfcHk0liZjPxX_VH2Dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D&md5=3efc7e8b434566932ef28ca3486c401a</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DDistinct%2520structural%2520mechanisms%2520for%2520inhibition%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520isoforms%2520by%2520AZD7545%252C%2520dichloroacetate%252C%2520and%2520radicicol%26jtitle%3DStructure%26date%3D2007%26volume%3D15%26spage%3D992%26epage%3D1004%26doi%3D10.1016%2Fj.str.2007.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regenass, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of 4, 5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9832</span>â <span class="NLM_lpage">9843</span>, <span class="refDoi">Â DOI: 10.1021/jm5010144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9832-9843&author=T.+Mengauthor=D.+Zhangauthor=Z.+Xieauthor=T.+Yuauthor=S.+Wuauthor=L.+Wyderauthor=U.+Regenassauthor=K.+Hilpertauthor=M.+Huangauthor=M.+Geng&title=Discovery+and+optimization+of+4%2C+5-diarylisoxazoles+as+potent+dual+inhibitors+of+pyruvate+dehydrogenase+kinase+and+heat+shock+protein+90&doi=10.1021%2Fjm5010144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span></div><div class="casAuthors">Meng, Tao; Zhang, Dadong; Xie, Zuoquan; Yu, Ting; Wu, Shuchao; Regenass, Urs; Hilpert, Kurt; Huang, Min; Geng, Meiyu; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9832-9843</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Upregulation of pyruvate dehydrogenase kinase (PDHK) has been obsd. in a variety of cancers.  Inhibition of PDHK offers an attractive opportunity for the development of novel cancer therapies.  To obtain novel PDHK inhibitors, the authors took advantage of the homol. of the ATP-binding pocket between Heat Shock Protein 90 (HSP90) and PDHK, and utilized 4,5-diarylisoxazole based HSP90 inhibitor for structural design.  The efforts led to the identification of I that inhibited PDHK1 with an IC50 value of 17 nM, which, however, showed marginal cellular activity.  Further structural optimization resulted in compd. II with improved cellular activity which could effectively modulate the metabolic profile of cancer cells and lead to the inhibition of cancer cell proliferation, evidenced by the increased oxidative phosphorylation and decreased glycolysis and assocd. oxidative stress.  The results suggested II as an excellent lead compd. and a favorable biol. tool to further evaluate the therapeutic potential of PDHK and HSP90 dual inhibitors in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpX1cvlKuuz7Vg90H21EOLACvtfcHk0liZjPxX_VH2Dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK&md5=ab2f08b46344868b81247a228b149755</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm5010144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010144%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWyder%26aufirst%3DL.%26aulast%3DRegenass%26aufirst%3DU.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25204%252C%25205-diarylisoxazoles%2520as%2520potent%2520dual%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520and%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9832%26epage%3D9843%26doi%3D10.1021%2Fjm5010144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâAlessandro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, P. C.</span></span> <span> </span><span class="NLM_article-title">VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12862</span>â <span class="NLM_lpage">12876</span>, <span class="refDoi">Â DOI: 10.18632/oncotarget.2656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.18632%2Foncotarget.2656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=25404640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ovVyjtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=12862-12876&author=J.+D.+Mooreauthor=A.+Staniszewskaauthor=T.+Shawauthor=J.+D%E2%80%99Alessandroauthor=B.+Davisauthor=A.+Surgenorauthor=L.+Bakerauthor=N.+Matassovaauthor=J.+Murrayauthor=A.+Maciasauthor=P.+Broughauthor=M.+Woodauthor=P.+C.+Mahon&title=VER-246608%2C+a+novel+pan-isoform+ATP+competitive+inhibitor+of+pyruvate+dehydrogenase+kinase%2C+disrupts+Warburg+metabolism+and+induces+context-dependent+cytostasis+in+cancer+cells&doi=10.18632%2Foncotarget.2656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells</span></div><div class="casAuthors">Moore Jonathan D; Staniszewska Anna; Shaw Terence; D'Alessandro Jalanie; Davis Ben; Surgenor Alan; Baker Lisa; Matassova Natalia; Murray James; Macias Alba; Brough Paul; Wood Mike; Mahon Patrick C</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">12862-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) is a pivotal enzyme in cellular energy metabolism that has previously been implicated in cancer through both RNAi based studies and clinical correlations with poor prognosis in several cancer types.  Here, we report the discovery of a novel and selective ATP competitive pan-isoform inhibitor of PDK, VER-246608.  Consistent with a PDK mediated MOA, VER-246608 increased pyruvate dehydrogenase complex (PDC) activity, oxygen consumption and attenuated glycolytic activity.  However, these effects were only observed under D-glucose-depleted conditions and required almost complete ablation of PDC E1Î± subunit phosphorylation.  VER-246608 was weakly anti-proliferative to cancer cells in standard culture media; however, depletion of either serum or combined D-glucose/L-glutamine resulted in enhanced cellular potency.  Furthermore, this condition-selective cytostatic effect correlated with reduced intracellular pyruvate levels and an attenuated compensatory response involving deamination of L-alanine.  In addition, VER-246608 was found to potentiate the activity of doxorubicin.  In contrast, the lipoamide site inhibitor, Nov3r, demonstrated sub-maximal inhibition of PDK activity and no evidence of cellular activity.  These studies suggest that PDK inhibition may be effective under the nutrient-depleted conditions found in the tumour microenvironment and that combination treatments should be explored to reveal the full potential of this therapeutic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQq_Bxi2o-MqOxsqfvU0ziafW6udTcc2ea15szZXwUVOLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ovVyjtQ%253D%253D&md5=6480086dc38b2ebcbfa93b2e611d40f1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2656%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DStaniszewska%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMacias%26aufirst%3DA.%26aulast%3DBrough%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DMahon%26aufirst%3DP.%2BC.%26atitle%3DVER-246608%252C%2520a%2520novel%2520pan-isoform%2520ATP%2520competitive%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%252C%2520disrupts%2520Warburg%2520metabolism%2520and%2520induces%2520context-dependent%2520cytostasis%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D12862%26epage%3D12876%26doi%3D10.18632%2Foncotarget.2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knorr, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperbeck, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinluan, C. C.</span></span> <span> </span><span class="NLM_article-title">Secondary amides of (R)-3, 3, 3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">236</span>â <span class="NLM_lpage">249</span>, <span class="refDoi">Â DOI: 10.1021/jm990358+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990358%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVWktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=236-249&author=T.+D.+Aicherauthor=R.+C.+Andersonauthor=J.+Gaoauthor=S.+S.+Shettyauthor=G.+M.+Coppolaauthor=J.+L.+Stantonauthor=D.+C.+Knorrauthor=D.+M.+Sperbeckauthor=L.+J.+Brandauthor=C.+C.+Vinluan&title=Secondary+amides+of+%28R%29-3%2C+3%2C+3-trifluoro-2-hydroxy-2-methylpropionic+acid+as+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm990358%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Secondary Amides of (R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase</span></div><div class="casAuthors">Aicher, Thomas D.; Anderson, Robert C.; Gao, Jiaping; Shetty, Suraj S.; Coppola, Gary M.; Stanton, James L.; Knorr, Douglas C.; Sperbeck, Donald M.; Brand, Leonard J.; Vinluan, Christine C.; Kaplan, Emma L.; Dragland, Carol J.; Tomaselli, Hollis C.; Islam, Amin; Lozito, Robert J.; Liu, Xilin; Maniara, Wieslawa M.; Fillers, William S.; DelGrande, Dominick; Walter, R. Eric; Mann, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-249</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N'-Methyl-N-(4-tert-butyl-1,2,5,6-tetrahydropyridine)thiourea, SDZ048-619, is a modest inhibitor (IC50 = 180 Î¼M) of pyruvate dehydrogenase kinase (PDHK).  In an optimization of the N-methylcarbothioamide moiety of SDZ048-619, it was discovered that amides with a small acyl group, in particular appropriately substituted amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, are inhibitors of PDHK.  Utilizing this acyl moiety, herein is reported the rationale leading to the optimization of a series of acylated piperazine derivs.  Me substitution of the piperazine at the 2- and 5-positions (with S and R abs. stereochem.) markedly increased the potency of the lead compd. (>1000-fold).  Oral bioavailability of the compds. in this series is good and is optimal (as measured by AUC) when the 4-position of the piperazine is substituted with an electron-poor benzoyl moiety.  (+)-1-N-[2,5-(S,R)-Dimethyl-4-N-(4-cyanobenzoyl)piperazine]-(R)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide inhibits PDHK in the primary enzymic assay with an IC50 of 16 nM, enhances the oxidn. of [14C]lactate into 14CO2 in human fibroblasts with an EC50 of 57 nM, diminishes lactate significantly 2.5 h post-oral-dose at doses as low as 1 Î¼mol/kg, and increases the ex vivo activity of pyruvate dehydrogenase in muscle, liver, and fat tissues in normal Sprague-Dawley rats.  These PDHK inhibitors, however, do not lower glucose in diabetic animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIKZ8HyLQA-LVg90H21EOLACvtfcHk0lgRdRiUddPZ-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVWktQ%253D%253D&md5=fc326e00ff7db4addc99eee6073620fb</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm990358%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990358%252B%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BC.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DSperbeck%26aufirst%3DD.%2BM.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DVinluan%26aufirst%3DC.%2BC.%26atitle%3DSecondary%2520amides%2520of%2520%2528R%2529-3%252C%25203%252C%25203-trifluoro-2-hydroxy-2-methylpropionic%2520acid%2520as%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D236%26epage%3D249%26doi%3D10.1021%2Fjm990358%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, L. W.</span></span> <span> </span><span class="NLM_article-title">Anemone rivularis inhibits pyruvate dehydrogenase kinase activity and tumor growth</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">47</span>â <span class="NLM_lpage">54</span>, <span class="refDoi">Â DOI: 10.1016/j.jep.2017.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.jep.2017.03.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=28341246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFens78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2017&pages=47-54&author=T.+W.+Chungauthor=J.+H.+Leeauthor=H.+J.+Choiauthor=M.+J.+Parkauthor=E.+Y.+Kimauthor=S.+Jangauthor=S.+O.+Leeauthor=S.+W.+Leeauthor=J.+Hangauthor=L.+W.+Yi&title=Anemone+rivularis+inhibits+pyruvate+dehydrogenase+kinase+activity+and+tumor+growth&doi=10.1016%2Fj.jep.2017.03.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Anemone rivularis inhibits pyruvate dehydrogenase kinase activity and tumor growth</span></div><div class="casAuthors">Chung, Tae-Wook; Lee, Jung Hee; Choi, Hee-Jung; Park, Mi-Ju; Kim, Eun-Yeong; Han, Jung Ho; Jang, Sebok; Lee, Syng-Ook; Lee, Sang Woo; Hang, Jin; Yi, Li Wan; Ha, Ki-Tae</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Anemone rivularis Buch.-Ham. ex DC. (Ranunculaceae) have been used as a traditional remedy for treatment of inflammation and cancer.  However, there is no report demonstrating exptl. evidence on anti-tumor action of A. rivularis.  The Warburg's effect, preference of aerobic glycolysis rather than oxidative phosphorylation (OXPHOS) even in oxygen rich condition, is focused as one of major characteristics of malignant tumor.  Thus, we investigated the effect of A. rivularis on the Pyruvate dehydrogenase (PDH) kinases (PDHKs), a major mol. targets for reducing aerobic glycolysis.  The ethanol ext. of whole plant of A. rivularis (ARE), fingerprinted by high performance liq. chromatog. (HPLC), was applied to in vitro and cell-based PDHK activity assays.  The effect of ARE on cell viabilities of several tumor cells was estd. by MTT assay.  The expression of phosphor-PDH, PDH and PDHK1 were measured by Western blot anal.  The prodn. of reactive oxygen species (ROS) and apoptosis was measured by fluorescence-activated cell sorting anal., using 5-(and-6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) and Annexin V/propidium iodide (PI) staining, resp.  Mitochondrial membrane potential was examd. by tetramethylrhodamine Me ester (TMRM) staining.  In vivo anti-tumor efficacy of ARE was estd. by means of tumor vol. and wt. using allograft injection of murine Lewis lung carcinoma (LLC) cells to dorsa of C57BL/6 mice.  ARE inhibited the viabilities of several cancer cells, including MDA-MB321, K562, HT29, Hep3B, DLD-1, and LLC.  ARE suppressed PDHK activity in in vitro kinase assay, and also inhibited aerobic glycolysis by reducing phosphorylation of PDHA in human DLD-1 colon cancer and murine LLC cells.  The expression of PDHK1, a major isoform of PDHKs in cancer, was not affected by ARE treatment.  Moreover, ARE increased the both ROS prodn. and mitochondrial damage.  In addn., ARE suppressed the in vitro tumor growth through mitochondria-mediated apoptosis.  The growth rates of allograft LLC cells were also reduced by ARE treatment.  Here, we firstly report that ARE inhibits PDHK activity and growth of tumor in both in vitro and in vivo expts.  Therefore, we suggest ARE as a potential candidate for developing anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6kewK8V5fbrVg90H21EOLACvtfcHk0lgGIAysBrq_SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFens78%253D&md5=4e6530d04102ee1631fb16116c494542</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2017.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2017.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DE.%2BY.%26aulast%3DJang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BO.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DHang%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DL.%2BW.%26atitle%3DAnemone%2520rivularis%2520inhibits%2520pyruvate%2520dehydrogenase%2520kinase%2520activity%2520and%2520tumor%2520growth%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2017%26volume%3D203%26spage%3D47%26epage%3D54%26doi%3D10.1016%2Fj.jep.2017.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bebernitz, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shetty, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knorr, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohschein, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span> <span> </span><span class="NLM_article-title">Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2248</span>â <span class="NLM_lpage">2257</span>, <span class="refDoi">Â DOI: 10.1021/jm0000923</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0000923" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVGqt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2248-2257&author=G.+R.+Bebernitzauthor=T.+D.+Aicherauthor=J.+L.+Stantonauthor=J.+Gaoauthor=S.+S.+Shettyauthor=D.+C.+Knorrauthor=R.+J.+Strohscheinauthor=J.+Tanauthor=L.+J.+Brandauthor=C.+Liu&title=Anilides+of+%28R%29-trifluoro-2-hydroxy-2-methylpropionic+acid+as+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm0000923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Anilides of (R)-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase</span></div><div class="casAuthors">Bebernitz, Gregory R.; Aicher, Thomas D.; Stanton, James L.; Gao, Jiaping; Shetty, Suraj S.; Knorr, Douglas C.; Strohschein, Robert J.; Tan, Jennifer; Brand, Leonard J.; Liu, Charles; Wang, Wei H.; Vinluan, Christine C.; Kaplan, Emma L.; Dragland, Carol J.; DelGrande, Dominick; Islam, Amin; Lozito, Robert J.; Liu, Xilin; Maniara, Wieslawa M.; Mann, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2248-2257</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The optimization of a series of anilide derivs. of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase (PDHK) is described that started from N-phenyl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide 1 (IC50 = 35 Â± 1.4 Î¼M).  It was found that small electron-withdrawing groups on the ortho position of the anilide, i.e., chloro, acetyl, or bromo, increased potency 20-40-fold.  The oral bioavailability of the compds. in this series is optimal (as measured by AUC) when the anilide is substituted at the 4-position with an electron-withdrawing group (i.e., carboxyl, carboxyamide, and sulfoxyamide). N-(2-Chloro-4-isobutylsulfamoylphenyl)-(R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide inhibits PDHK in the primary enzymic assay with an IC50 of 13 Â± 1.5 nM, enhances the oxidn. of [14C]lactate into 14CO2 in human fibroblasts, lowers blood lactate levels significantly 2.5 and 5 h after oral doses as low as 30 Î¼mol/kg, and increases the ex vivo activity of PDH in muscle, kidney, liver, and heart tissues. However, in contrast to sodium dichloroacetate, these PDHK inhibitors did not lower blood glucose levels. Nevertheless, they are effective at increasing the utilization and disposal of lactate and could be of utility to ameliorate conditions of inappropriate blood lactate elevation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMhDErIEuIjrVg90H21EOLACvtfcHk0lgGIAysBrq_SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVGqt7Y%253D&md5=39c46f8cea151e8d159487f57f0b15d4</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1021%2Fjm0000923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0000923%26sid%3Dliteratum%253Aachs%26aulast%3DBebernitz%26aufirst%3DG.%2BR.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DStrohschein%26aufirst%3DR.%2BJ.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DAnilides%2520of%2520%2528R%2529-trifluoro-2-hydroxy-2-methylpropionic%2520acid%2520as%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2248%26epage%3D2257%26doi%3D10.1021%2Fjm0000923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagire, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagire, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dighe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaladi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gim, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Y. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel pyruvate dehydrogenase kinase 4 inhibitors for potential oral treatment of metabolic diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">575</span>â <span class="NLM_lpage">588</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01168</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01168" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvFakuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=575-588&author=D.+Leeauthor=H.+S.+Pagireauthor=S.+H.+Pagireauthor=E.+J.+Baeauthor=M.+Digheauthor=M.+Kimauthor=K.+M.+Leeauthor=Y.+K.+Jangauthor=A.+K.+Jaladiauthor=K.+Y.+Jungauthor=E.+K.+Yooauthor=H.+E.+Gimauthor=S.+Leeauthor=W.+I.+Choiauthor=Y.+I.+Chiauthor=J.+S.+Songauthor=M.+A.+Baeauthor=Y.+H.+Jeonauthor=G.+H.+Leeauthor=K.+H.+Liuauthor=T.+Leeauthor=S.+Parkauthor=J.+H.+Jeonauthor=I.+K.+Leeauthor=J.+H.+Ahn&title=Discovery+of+novel+pyruvate+dehydrogenase+kinase+4+inhibitors+for+potential+oral+treatment+of+metabolic+diseases&doi=10.1021%2Facs.jmedchem.8b01168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases</span></div><div class="casAuthors">Lee, Dahye; Pagire, Haushabhau S.; Pagire, Suvarna H.; Bae, Eun Jung; Dighe, Mahesh; Kim, Minhee; Lee, Kyu Myung; Jang, Yoon Kyung; Jaladi, Ashok Kumar; Jung, Kwan-Young; Yoo, Eun Kyung; Gim, Hee Eon; Lee, Seungmi; Choi, Won-Il; Chi, Young-In; Song, Jin Sook; Bae, Myung Ae; Jeon, Yong Hyun; Lee, Ga-Hyun; Liu, Kwang-Hyeon; Lee, Taeho; Park, Sungmi; Jeon, Jae-Han; Lee, In-Kyu; Ahn, Jin Hee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">575-588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase 4 (PDK4) activation is assocd. with metabolic diseases including hyperglycemia, insulin resistance, allergies, and cancer.  Structural modifications of hit anthraquinone led to the identification of a new series of allosteric PDK4 inhibitors.  Among this series, compd. 8c showed promising in vitro activity with an IC50 value of 84 nM.  Good metabolic stability, pharmacokinetic profiles, and possible metabolites were suggested.  Compd. 8c improved glucose tolerance in diet-induced obese mice and ameliorated allergic reactions in a passive cutaneous anaphylaxis mouse model.  Addnl., compd. 8c exhibited anticancer activity by controlling cell proliferation, transformation, and apoptosis.  From the mol. docking studies, compd. 8c displayed optimal fitting in the lipoamide binding site (allosteric) with a full fitness, providing a new scaffold for drug development toward PDK4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodAERNQ0GcMLVg90H21EOLACvtfcHk0lgGIAysBrq_SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvFakuw%253D%253D&md5=31b365c1d241ac0d121d6a4a7bc13a54</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01168%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%26aulast%3DPagire%26aufirst%3DH.%2BS.%26aulast%3DPagire%26aufirst%3DS.%2BH.%26aulast%3DBae%26aufirst%3DE.%2BJ.%26aulast%3DDighe%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%2BM.%26aulast%3DJang%26aufirst%3DY.%2BK.%26aulast%3DJaladi%26aufirst%3DA.%2BK.%26aulast%3DJung%26aufirst%3DK.%2BY.%26aulast%3DYoo%26aufirst%3DE.%2BK.%26aulast%3DGim%26aufirst%3DH.%2BE.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.%2BI.%26aulast%3DChi%26aufirst%3DY.%2BI.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DBae%26aufirst%3DM.%2BA.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DLiu%26aufirst%3DK.%2BH.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DJeon%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DI.%2BK.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26atitle%3DDiscovery%2520of%2520novel%2520pyruvate%2520dehydrogenase%2520kinase%25204%2520inhibitors%2520for%2520potential%2520oral%2520treatment%2520of%2520metabolic%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D575%26epage%3D588%26doi%3D10.1021%2Facs.jmedchem.8b01168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tso, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gui, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morlock, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynn, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, D. T.</span></span> <span> </span><span class="NLM_article-title">Development of dihydroxyphenyl sulfonylisoindoline derivatives as liver-targeting pyruvate dehydrogenase Kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1142</span>â <span class="NLM_lpage">1150</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01540</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01540" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKisrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1142-1150&author=S.+C.+Tsoauthor=M.+Louauthor=C.+Y.+Wuauthor=W.+J.+Guiauthor=J.+L.+Chuangauthor=L.+K.+Morlockauthor=N.+S.+Williamsauthor=R.+M.+Wynnauthor=X.+Qiauthor=D.+T.+Chuang&title=Development+of+dihydroxyphenyl+sulfonylisoindoline+derivatives+as+liver-targeting+pyruvate+dehydrogenase+Kinase+inhibitors&doi=10.1021%2Facs.jmedchem.6b01540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors</span></div><div class="casAuthors">Tso, Shih-Chia; Lou, Mingliang; Wu, Cheng-Yang; Gui, Wen-Jun; Chuang, Jacinta L.; Morlock, Lorraine K.; Williams, Noelle S.; Wynn, R. Max; Qi, Xiangbing; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1142-1150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinases 1-4 (PDK1-4) neg. control activity of the pyruvate dehydrogenase complex (PDC) and are up-regulated in obesity, diabetes, heart failure and cancer.  The authors reported earlier two novel pan-PDK inhibitors PS8 [4-((5-hydroxyisoindolin-2-yl)sulfonyl)benzene-1,3-diol] and PS10 [2-((2,4-dihydroxyphenyl)sulfonyl)isoindoline-4,6-diol] that targeted the ATP-binding pocket in PDKs.  Here, the authors developed a new generation of PDK inhibitors by extending the dihydroxyphenyl sulfonylisoindoline scaffold in PS8 and PS10 to the entrance region of the ATP-binding pocket in PDK2.  The lead inhibitor PS46 [(S)-3-amino-4-(4-((2-((2,4-dihydroxyphenyl)sulfonyl)isoindolin-5-yl)amino)piperidin-1-yl)-4-oxobutanamide] (17) shows a â¼8-fold lower IC50 (58 nM) than 2 (456 nM).  In the crystal structure, the asparagine moiety in 17 provides addnl. interactions with Glu 262 from PDK2.  Treatment of diet-induced obese mice with 17 resulted in significant liver-specific augmentation of PDC activity, accompanied by improved glucose tolerance and drastically reduced hepatic steatosis.  These findings support 17 as a potential glucose-lowering therapeutic targeting liver for obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKDNbLY3_4KrVg90H21EOLACvtfcHk0liDotyOhOPYjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKisrs%253D&md5=70c22064b3920f8ff871e0265818a201</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01540%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DLou%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DGui%26aufirst%3DW.%2BJ.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DWynn%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DDevelopment%2520of%2520dihydroxyphenyl%2520sulfonylisoindoline%2520derivatives%2520as%2520liver-targeting%2520pyruvate%2520dehydrogenase%2520Kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1142%26epage%3D1150%26doi%3D10.1021%2Facs.jmedchem.6b01540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Development of the first generation of disulfide-based subtype-selective and potent covalent pyruvate dehydrogenase kinase 1 (PDK1) Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2227</span>â <span class="NLM_lpage">2244</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlyjtr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2227-2244&author=Y.+Liuauthor=Z.+Xieauthor=D.+Zhaoauthor=J.+Zhuauthor=F.+Maoauthor=S.+Tangauthor=H.+Xuauthor=C.+Luoauthor=M.+Gengauthor=M.+Huangauthor=J.+Li&title=Development+of+the+first+generation+of+disulfide-based+subtype-selective+and+potent+covalent+pyruvate+dehydrogenase+kinase+1+%28PDK1%29+Inhibitors&doi=10.1021%2Facs.jmedchem.6b01245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors</span></div><div class="casAuthors">Liu, Yifu; Xie, Zuoquan; Zhao, Dan; Zhu, Jin; Mao, Fei; Tang, Shuai; Xu, Hui; Luo, Cheng; Geng, Meiyu; Huang, Min; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2227-2244</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinases (PDKs) are overexpressed in most cancer cells and are responsible for aberrant glucose metab.  The authors previously described Bis(4-morpholinyl thiocarbonyl)-disulfide (JX06, 16) as the first covalent inhibitor of PDK1.  Here, based on the scaffold of JX06, the authors identify two novel types of disulfide-based PDK1 inhibitors.  The most potent analog, bis(1,4-oxazepan-4-yl-thiocarbonyl)disulfide (3a), effectively inhibits PDK1 both at the mol. (kinact/Ki = 4.17 Ã 103 M-1s-1) and the cellular level (down to 0.1 Î¼M).  In contrast to JX06, 3a is a potent and subtype-selective inhibitor of PDK1 with >40-fold selectivity for PDK2-4.  Compd. 3a also significantly alters glucose metabolic pathways in A549 cells by decreasing ECAR and increasing ROS.  Moreover, in the xenograft models, 3a shows significant antitumor activity with no neg. effect to the mice wt.  Collectively, these data demonstrate that 3a may be an excellent lead compd. for the treatment of cancer as a first-generation subtype-selective and covalent PDK1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEpZNCUKK6MrVg90H21EOLACvtfcHk0liDotyOhOPYjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlyjtr0%253D&md5=7529ce2fc9d1a138a8d1405a23f7e4e8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01245%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520the%2520first%2520generation%2520of%2520disulfide-based%2520subtype-selective%2520and%2520potent%2520covalent%2520pyruvate%2520dehydrogenase%2520kinase%25201%2520%2528PDK1%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2227%26epage%3D2244%26doi%3D10.1021%2Facs.jmedchem.6b01245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chell, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâAlessandro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Strat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macias, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmonite, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span> <span> </span><span class="NLM_article-title">Application of off-rate screening in the identification of novel pan-isoform inhibitors of pyruvate dehydrogenase kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2271</span>â <span class="NLM_lpage">2286</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01478</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01478" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1agt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2271-2286&author=P.+A.+Broughauthor=L.+Bakerauthor=S.+Bedfordauthor=K.+Brownauthor=S.+Chavdaauthor=V.+Chellauthor=J.+D%E2%80%99Alessandroauthor=N.+G.+Daviesauthor=B.+Davisauthor=L.+Le+Stratauthor=A.+T.+Maciasauthor=D.+Maddoxauthor=P.+C.+Mahonauthor=A.+J.+Masseyauthor=N.+Matassovaauthor=S.+McKennaauthor=J.+W.+Meissnerauthor=J.+D.+Mooreauthor=J.+B.+Murrayauthor=C.+J.+Northfieldauthor=C.+Parryauthor=R.+Parsonsauthor=S.+D.+Roughleyauthor=T.+Shawauthor=H.+Simmoniteauthor=S.+Stokesauthor=A.+Surgenorauthor=E.+Stefaniakauthor=A.+Robertsonauthor=Y.+Wangauthor=P.+Webbauthor=N.+Whiteheadauthor=M.+Wood&title=Application+of+off-rate+screening+in+the+identification+of+novel+pan-isoform+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Facs.jmedchem.6b01478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase Kinase</span></div><div class="casAuthors">Brough, Paul A.; Baker, Lisa; Bedford, Simon; Brown, Kirsten; Chavda, Seema; Chell, Victoria; D'Alessandro, Jalanie; Davies, Nicholas G. M.; Davis, Ben; Le Strat, Loic; Macias, Alba T.; Maddox, Daniel; Mahon, Patrick C.; Massey, Andrew J.; Matassova, Natalia; McKenna, Sean; Moore, Jonathan D.; Murray, James B.; Northfield, Christopher J.; Parry, Charles; Parsons, Rachel; Roughley, Stephen D.; Shaw, Terry; Simmonite, Heather; Stokes, Stephen; Surgenor, Allan; Stefaniak, Emma; Robertson, Alan; Wang, Yikang; Webb, Paul; Whitehead, Neil; Wood, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2271-2286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Libraries of non-purified resorcinol amide derivs. were screened by surface plasmon resonance (SPR) to det. the binding dissocn. const. (off-rate, kd) for compds. binding to the pyruvate dehydrogenase kinase (PDHK) enzyme.  Parallel off-rate measurements against HSP90 and application of structure-based drug design enabled rapid hit to lead progression in a program to identify pan-isoform ATP-competitive inhibitors of PDHK.  Lead optimization identified selective sub-100-nM inhibitors of the enzyme which significantly reduced phosphorylation of the E1Î± subunit in the PC3 cancer cell line in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAus8qHW4d3bVg90H21EOLACvtfcHk0licMzqeak6n5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1agt7o%253D&md5=9727ca9e73096f63bbbb604c534155d8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01478%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DBedford%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DChavda%26aufirst%3DS.%26aulast%3DChell%26aufirst%3DV.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DLe%2BStrat%26aufirst%3DL.%26aulast%3DMacias%26aufirst%3DA.%2BT.%26aulast%3DMaddox%26aufirst%3DD.%26aulast%3DMahon%26aufirst%3DP.%2BC.%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DMcKenna%26aufirst%3DS.%26aulast%3DMeissner%26aufirst%3DJ.%2BW.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DParry%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DStefaniak%26aufirst%3DE.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWhitehead%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DApplication%2520of%2520off-rate%2520screening%2520in%2520the%2520identification%2520of%2520novel%2520pan-isoform%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2271%26epage%3D2286%26doi%3D10.1021%2Facs.jmedchem.6b01478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korotchkina, L. G.</span></span> <span> </span><span class="NLM_article-title">Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">191</span>â <span class="NLM_lpage">197</span>, <span class="refDoi">Â DOI: 10.1038/emm.2001.32</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Femm.2001.32" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=11795479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFehsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=191-197&author=M.+S.+Patelauthor=L.+G.+Korotchkina&title=Regulation+of+mammalian+pyruvate+dehydrogenase+complex+by+phosphorylation%3A+complexity+of+multiple+phosphorylation+sites+and+kinases&doi=10.1038%2Femm.2001.32"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: Complexity of multiple phosphorylation sites and kinases</span></div><div class="casAuthors">Patel, Mulchand S.; Korotchkina, Lioubov G.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">191-197</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1226-3613</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Medical Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review with 39 refs., summarizing recent developments in the regulation of the human pyruvate dehydrogenase complex (PDC) by site-specific phosphorylation with 4 kinases.  Mutagenic anal. of the 3 phosphorylation sites of human pyruvate dehydrogenase (E1) shows the site-independent mechanism of phosphorylation as well as site-independent dephosphorylation of the 3 phosphorylation sites and the importance of each phosphorylation site for the inactivation of E1.  Both the neg. charge and size of the group introduced at site 1 are involved in human E1 inactivation.  The mechanism of inactivation of E1 has been suggested to be site-specific.  Phosphorylation of site 1 affects E1 interaction with the lipoyl domain of dihydrolipoamide acetyltransferase, whereas phosphorylation site 3 appears to be closer to the thiamin pyrophosphate-binding region affecting coenzyme interaction with human E1.  Four isoenzymes of pyruvate dehydrogenase kinase (PDK) show different specificities for the 3 phosphorylation sites of E1.  All 4 PDKs phosphorylate sites 1 and 2 in PDC with different rates, and only PDK1 phosphorylates site 3.  PDK2 is maximally stimulated by the redn./acetylation of the lipoyl groups of E2.  The presence of the multiple phosphorylation sites and isoenzymes of PDK is important for the tissue-specific regulation of PDC under different physiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDcX-BoOs-J7Vg90H21EOLACvtfcHk0licMzqeak6n5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFehsA%253D%253D&md5=90879723a72a13f353c1af1c67d282ce</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Femm.2001.32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femm.2001.32%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BS.%26aulast%3DKorotchkina%26aufirst%3DL.%2BG.%26atitle%3DRegulation%2520of%2520mammalian%2520pyruvate%2520dehydrogenase%2520complex%2520by%2520phosphorylation%253A%2520complexity%2520of%2520multiple%2520phosphorylation%2520sites%2520and%2520kinases%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2001%26volume%3D33%26spage%3D191%26epage%3D197%26doi%3D10.1038%2Femm.2001.32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knight, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">621</span>â <span class="NLM_lpage">637</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2005.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors&doi=10.1016%2Fj.chembiol.2005.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0licMzqeak6n5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637%26doi%3D10.1016%2Fj.chembiol.2005.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alkarakooly, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilaparty, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Anbaky, Q. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, N.</span></span> <span> </span><span class="NLM_article-title">Dichloroacetic acid (DCA)-induced cytotoxicity in human breast cancer cells accompanies changes in mitochondrial membrane permeability and production of reactive oxygen species</span>. <i>J. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1234</span>â <span class="NLM_lpage">1248</span>, <span class="refDoi">Â DOI: 10.4236/jct.2014.513125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.4236%2Fjct.2014.513125" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1234-1248&author=Z.+Alkarakoolyauthor=S.+P.+Kilapartyauthor=Q.+A.+Al-Anbakyauthor=M.+S.+Khanauthor=N.+Ali&title=Dichloroacetic+acid+%28DCA%29-induced+cytotoxicity+in+human+breast+cancer+cells+accompanies+changes+in+mitochondrial+membrane+permeability+and+production+of+reactive+oxygen+species&doi=10.4236%2Fjct.2014.513125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4236%2Fjct.2014.513125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fjct.2014.513125%26sid%3Dliteratum%253Aachs%26aulast%3DAlkarakooly%26aufirst%3DZ.%26aulast%3DKilaparty%26aufirst%3DS.%2BP.%26aulast%3DAl-Anbaky%26aufirst%3DQ.%2BA.%26aulast%3DKhan%26aufirst%3DM.%2BS.%26aulast%3DAli%26aufirst%3DN.%26atitle%3DDichloroacetic%2520acid%2520%2528DCA%2529-induced%2520cytotoxicity%2520in%2520human%2520breast%2520cancer%2520cells%2520accompanies%2520changes%2520in%2520mitochondrial%2520membrane%2520permeability%2520and%2520production%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DJ.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D5%26spage%3D1234%26epage%3D1248%26doi%3D10.4236%2Fjct.2014.513125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachtel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haupt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzur, A.</span></span> <span> </span><span class="NLM_article-title">JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e430</span>, <span class="refDoi">Â DOI: 10.1038/cddis.2012.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1038%2Fcddis.2012.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=23171850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsV2ntA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=e430&author=A.+Perelmanauthor=C.+Wachtelauthor=M.+Cohenauthor=S.+Hauptauthor=H.+Shapiroauthor=A.+Tzur&title=JC-1%3A+alternative+excitation+wavelengths+facilitate+mitochondrial+membrane+potential+cytometry&doi=10.1038%2Fcddis.2012.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry</span></div><div class="casAuthors">Perelman, A.; Wachtel, C.; Cohen, M.; Haupt, S.; Shapiro, H.; Tzur, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">e430, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mitochondrial membrane potential provides a valuable indicator of cells' health and functional status.  Cytometry- and microscopy-based analyses, in combination with fluorescent probes, are widely used to study mitochondrial behavior related to cellular pathways, most notably - apoptosis.  The cyanine dye JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide) facilitates discrimination of energized and deenergized mitochondria because the normally green fluorescent dye forms red fluorescent aggregates when concd. in energized mitochondria in response to their higher membrane potential.  JC-1 fluorescence is usually excited by the 488 nm laser wavelength common in flow cytometers.  In this study, we show that in practice this approach is not optimal for monitoring mitochondrial behavior.  Investigation of fluorescence of JC-1 in soln. and in cells using spectrofluorimetry, microscopy and flow cytometry reveals that excitation at 405 nm wavelength, now available on std. instruments, produces signals from aggregate fluorescence with considerably less spillover from dye monomer fluorescence than can be obtained using 488 nm excitation.  The improved data are more accurate and eliminate the necessity for fluorescence compensation, making the use of the alternative excitation wavelengths beneficial for mitochondria-related biol. and biomedial research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsyFk_xkRMyrVg90H21EOLACvtfcHk0lgLONhxSe8a9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsV2ntA%253D%253D&md5=9e281700eb1c4053b628761f49b3077c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.171%26sid%3Dliteratum%253Aachs%26aulast%3DPerelman%26aufirst%3DA.%26aulast%3DWachtel%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DM.%26aulast%3DHaupt%26aufirst%3DS.%26aulast%3DShapiro%26aufirst%3DH.%26aulast%3DTzur%26aufirst%3DA.%26atitle%3DJC-1%253A%2520alternative%2520excitation%2520wavelengths%2520facilitate%2520mitochondrial%2520membrane%2520potential%2520cytometry%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26spage%3De430%26doi%3D10.1038%2Fcddis.2012.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubb, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawen, A.</span></span> <span> </span><span class="NLM_article-title">The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">115</span>â <span class="NLM_lpage">128</span>, <span class="refDoi">Â DOI: 10.1023/A:1022945107762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1023%2FA%3A1022945107762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=12766472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit12ksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=115-128&author=J.+D.+Lyauthor=D.+R.+Grubbauthor=A.+Lawen&title=The+mitochondrial+membrane+potential+%28deltapsi%28m%29%29+in+apoptosis%3B+an+update&doi=10.1023%2FA%3A1022945107762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The mitochondrial membrane potential (ÎÏm) in apoptosis; an update</span></div><div class="casAuthors">Ly, J. D.; Grubb, D. R.; Lawen, A.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-128</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Mitochondrial dysfunction has been shown to participate in the induction of apoptosis and has even been suggested to be central to the apoptotic pathway.  Indeed, opening of the mitochondrial permeability transition pore has been demonstrated to induce depolarization of the transmembrane potential (ÎÏm), release of apoptogenic factors, and loss of oxidative phosphorylation.  In some apoptotic systems, loss of ÎÏm may be an early event in the apoptotic process.  However, there are emerging data suggesting that, depending on the model of apoptosis, the loss of ÎÏm may not be an early requirement for apoptosis, but on the contrary may be a consequence of the apoptotic-signaling pathway.  Furthermore, to add to these conflicting data, loss of ÎÏm has been demonstrated to not be required for cytochrome c release, whereas release of apoptosis-inducing factor AIF is dependent upon disruption of ÎÏm early in the apoptotic pathway.  Together, the existing literature suggests that depending on the cell system under investigation and the apoptotic stimuli used, dissipation of ÎÏm may or may not be an early event in the apoptotic pathway.  Discrepancies in this area of apoptosis research may be attributed to the fluorochromes used to detect ÎÏm.  Differential degrees of sensitivity of these fluorochromes exist, and there are also important factors that contribute to their ability to accurately discriminate changes in ÎÏm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOzp4dhnT9xLVg90H21EOLACvtfcHk0lgLONhxSe8a9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit12ksb4%253D&md5=f1369780028cb13a045faf2a3db73c87</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022945107762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022945107762%26sid%3Dliteratum%253Aachs%26aulast%3DLy%26aufirst%3DJ.%2BD.%26aulast%3DGrubb%26aufirst%3DD.%2BR.%26aulast%3DLawen%26aufirst%3DA.%26atitle%3DThe%2520mitochondrial%2520membrane%2520potential%2520%2528deltapsi%2528m%2529%2529%2520in%2520apoptosis%253B%2520an%2520update%26jtitle%3DApoptosis%26date%3D2003%26volume%3D8%26spage%3D115%26epage%3D128%26doi%3D10.1023%2FA%3A1022945107762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Cytochrome C-mediated apoptosis</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1146/annurev.biochem.73.011303.073706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1146%2Fannurev.biochem.73.011303.073706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=15189137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=87-106&author=X.+Jiangauthor=X.+Wang&title=Cytochrome+C-mediated+apoptosis&doi=10.1146%2Fannurev.biochem.73.011303.073706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome C-mediated apoptosis</span></div><div class="casAuthors">Jiang, Xuejun; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-106</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Apoptosis, or programmed cell death, is involved in development, elimination of damaged cells, and maintenance of cell homeostasis.  Deregulation of apoptosis may cause diseases, such as cancers, immune diseases, and neurodegenerative disorders.  Apoptosis is executed by a subfamily of cysteine proteases known as caspases.  In mammalian cells, a major caspase activation pathway is the cytochrome c-initiated pathway.  In this pathway, a variety of apoptotic stimuli cause cytochrome c release from mitochondria, which in turn induces a series of biochem. reactions that result in caspase activation and subsequent cell death.  This review focused on the recent progress in understanding the biochem. mechanisms and regulation of the pathway, the roles of the pathway in physiol. and disease, and their potential therapeutic values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaXd15zPESYLVg90H21EOLACvtfcHk0lgLONhxSe8a9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslagsrY%253D&md5=a8e668a41a4b4d0994a128019967f28d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.73.011303.073706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.73.011303.073706%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DCytochrome%2520C-mediated%2520apoptosis%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2004%26volume%3D73%26spage%3D87%26epage%3D106%26doi%3D10.1146%2Fannurev.biochem.73.011303.073706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olszewski, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulsperger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, G.</span></span> <span> </span><span class="NLM_article-title">In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds</span>. <i>Clin. Pharmacol.: Adv. Appl.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">177</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.2147/CPAA.S11795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.2147%2FCPAA.S11795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=22291503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVGgt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=177-183&author=U.+Olszewskiauthor=T.+T.+Poulsenauthor=E.+Ulspergerauthor=H.+S.+Poulsenauthor=K.+Geisslerauthor=G.+Hamilton&title=In+vitro+cytotoxicity+of+combinations+of+dichloroacetate+with+anticancer+platinum+compounds&doi=10.2147%2FCPAA.S11795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds</span></div><div class="casAuthors">Olszewski, Ulrike; Poulsen, Thomas Tuxen; Ulsperger, Ernst; Poulsen, Hans Skovgard; Geissler, Klaus; Hamilton, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology: Advances and Applications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-183</span>CODEN:
                <span class="NLM_cas:coden">CPAAGX</span>;
        ISSN:<span class="NLM_cas:issn">1179-1438</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Purpose: Dichloroacetate (DCA) inhibits pyruvate dehydrogenase kinase (PDK), and thus promotes glucose oxidn. over glycolysis and induces apoptotic death of tumor cells.  The present study investigated the potential of DCA to increase the antitumor effects of platinum-based compds. against a panel of permanent cell lines, including small cell lung cancer (SCLC), ovarian cancer, and Ewing's sarcoma in vitro.  Methods: DCA at a concn. of 10 mM was combined with cisplatin, carboplatin, satraplatin, the satraplatin metabolite JM118, oxaliplatin, oxoplatin, and picoplatin, and the cytotoxic activity was evaluated in proliferation tests employing a panel of different cell lines.  Addnl., cells were pretreated with DCA and then exposed to the platinum drugs and etoposide, or incubated with cisplatin or etoposide followed by application of DCA, resp.  Results: DCA 10 mM significantly increased the cytotoxicity of the platinum-based drugs carboplatin, satraplatin, JM118, and oxoplatin, but not cisplatin, picoplatin, and oxaliplatin in vitro.  Preincubation of cell lines with DCA 10 mM for three days reduced the antiproliferative activity of platinum-based agents in sequential application, but exposure of cells pretreated with cisplatin or etoposide to DCA resulted in minor sensitization.  The inhibitory effect of DCA showed no correlation with sensitization to the platinum compds.  Conclusion: DCA alone in a concn. that shows low antiproliferative activity is capable of increasing the cytotoxicity of selected platinum compds. upon coincubation, and such combinations may be interesting for clin. application in tumors like SCLC, Ewing's sarcoma, and ovarian cancer refractory to cisplatin chemotherapy as std. care.  The mechanism of this synergistic effect of DCA in combination with specific platinum species remains to be investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Cv9w1q-NPrVg90H21EOLACvtfcHk0lgR3OujJGe7CQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitVGgt7s%253D&md5=006821ec90e9b077f56cb8f06a5569b9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2147%2FCPAA.S11795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCPAA.S11795%26sid%3Dliteratum%253Aachs%26aulast%3DOlszewski%26aufirst%3DU.%26aulast%3DPoulsen%26aufirst%3DT.%2BT.%26aulast%3DUlsperger%26aufirst%3DE.%26aulast%3DPoulsen%26aufirst%3DH.%2BS.%26aulast%3DGeissler%26aufirst%3DK.%26aulast%3DHamilton%26aufirst%3DG.%26atitle%3DIn%2520vitro%2520cytotoxicity%2520of%2520combinations%2520of%2520dichloroacetate%2520with%2520anticancer%2520platinum%2520compounds%26jtitle%3DClin.%2520Pharmacol.%253A%2520Adv.%2520Appl.%26date%3D2010%26volume%3D2%26spage%3D177%26epage%3D183%26doi%3D10.2147%2FCPAA.S11795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. K.</span></span> <span> </span><span class="NLM_article-title">The role of pyruvate dehydrogenase kinase in diabetes and obesity</span>. <i>Diabetes Metab</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">181</span>â <span class="NLM_lpage">186</span>, <span class="refDoi">Â DOI: 10.4093/dmj.2014.38.3.181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.4093%2Fdmj.2014.38.3.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A280%3ADC%252BC2cbgt12iuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=181-186&author=I.+K.+Lee&title=The+role+of+pyruvate+dehydrogenase+kinase+in+diabetes+and+obesity&doi=10.4093%2Fdmj.2014.38.3.181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The role of pyruvate dehydrogenase kinase in diabetes and obesity</span></div><div class="casAuthors">Lee In-Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes & metabolism journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-6</span>
        ISSN:<span class="NLM_cas:issn">2233-6079</span>.
    </div><div class="casAbstract">The pyruvate dehydrogenase complex (PDC) is an emerging target for the treatment of metabolic syndrome.  To maintain a steady-state concentration of adenosine triphosphate during the feed-fast cycle, cells require efficient utilization of fatty acid and glucose, which is controlled by the PDC.  The PDC converts pyruvate, coenzyme A (CoA), and oxidized nicotinamide adenine dinucleotide (NAD(+)) into acetyl-CoA, reduced form of nicotinamide adenine dinucleotide (NADH), and carbon dioxide.  The activity of the PDC is up- and down-regulated by pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase, respectively.  In addition, pyruvate is a key intermediate of glucose oxidation and an important precursor for the synthesis of glucose, glycerol, fatty acids, and nonessential amino acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNxZINmSrmWsrRqEXsZufAfW6udTcc2eYIQ574AJGLPrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbgt12iuw%253D%253D&md5=651dc166587d0757d8ae5bbb6e24dd90</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.4093%2Fdmj.2014.38.3.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4093%252Fdmj.2014.38.3.181%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DI.%2BK.%26atitle%3DThe%2520role%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520in%2520diabetes%2520and%2520obesity%26jtitle%3DDiabetes%2520Metab%26date%3D2014%26volume%3D38%26spage%3D181%26epage%3D186%26doi%3D10.4093%2Fdmj.2014.38.3.181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leighton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgour, E.</span></span> <span> </span><span class="NLM_article-title">PDH kinase inhibitors: a novel therapy for Type II diabetes?</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">367</span>â <span class="NLM_lpage">370</span>, <span class="refDoi">Â DOI: 10.1042/BST0330367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1042%2FBST0330367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=15787608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFWjsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=367-370&author=R.+M.+Mayersauthor=B.+Leightonauthor=E.+Kilgour&title=PDH+kinase+inhibitors%3A+a+novel+therapy+for+Type+II+diabetes%3F&doi=10.1042%2FBST0330367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PDH kinase inhibitors: a novel therapy for Type II diabetes?</span></div><div class="casAuthors">Mayers, R. M.; Leighton, B.; Kilgour, E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">367-370</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The pyruvate dehydrogenase multienzyme complex catalyzes the oxidative decarboxylation of pyruvate, which is an important regulatory step in oxidative metab.  Phosphorylation of the E1 (pyruvate decarboxylase) subunit on one of 3 specific serine residues results in loss of enzyme activity.  Four dedicated PDHK (pyruvate dehydrogenase kinase) isoenzymes were identified, each of which display a distinct tissue-specific expression profile, and have differential regulatory properties.  Thus PDHK play a key role in controlling the balance between glucose and lipid oxidn. according to substrate supply.  Increasing glucose oxidn. by inhibiting PDHK may be an effective mechanism to increase glucose utilization; addnl., increasing pyruvate oxidn. may further contribute to lowering of glucose level by decreasing the supply of gluconeogenic substrates.  A no. of PDHK inhibitors are now available to enable this mechanism to be evaluated as a therapy for diabetes.  The isoenzyme selectivity profile of AZD7545 and related compds. will be described and evidence for their non-ATP-competitive mode of action presented.  These compds. increase PDH activity in vivo, and when dosed chronically, improve glycemic control in Zucker rats.  Furthermore, glucose lowering was demonstrated in the hyperglycemic Zucker diabetic fatty rat.  This result supports the hypothesis that inhibition of PDHK may be an effective therapy for Type II diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGposPHvIBu3p7Vg90H21EOLACvtfcHk0lgR3OujJGe7CQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFWjsbw%253D&md5=881054109c4efa8fcea12a5979190cf4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1042%2FBST0330367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0330367%26sid%3Dliteratum%253Aachs%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DLeighton%26aufirst%3DB.%26aulast%3DKilgour%26aufirst%3DE.%26atitle%3DPDH%2520kinase%2520inhibitors%253A%2520a%2520novel%2520therapy%2520for%2520Type%2520II%2520diabetes%253F%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2005%26volume%3D33%26spage%3D367%26epage%3D370%26doi%3D10.1042%2FBST0330367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bahcall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paweletz, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alden, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacher, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lydon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaklitsch, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sholl, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oxnard, G. R.</span></span> <span> </span><span class="NLM_article-title">Acquired METD1228V mutation and resistance to MET inhibition in lung cancer</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1334</span>â <span class="NLM_lpage">1341</span>, <span class="refDoi">Â DOI: 10.1158/2159-8290.CD-16-0686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=10.1158%2F2159-8290.CD-16-0686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=27694386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGnt7zE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1334-1341&author=M.+Bahcallauthor=T.+Simauthor=C.+P.+Paweletzauthor=J.+D.+Patelauthor=R.+S.+Aldenauthor=Y.+Kuangauthor=A.+G.+Sacherauthor=N.+D.+Kimauthor=C.+A.+Lydonauthor=M.+M.+Awadauthor=M.+T.+Jaklitschauthor=L.+M.+Shollauthor=P.+A.+Janneauthor=G.+R.+Oxnard&title=Acquired+METD1228V+mutation+and+resistance+to+MET+inhibition+in+lung+cancer&doi=10.1158%2F2159-8290.CD-16-0686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer</span></div><div class="casAuthors">Bahcall, Magda; Sim, Taebo; Paweletz, Cloud P.; Patel, Jyoti D.; Alden, Ryan S.; Kuang, Yanan; Sacher, Adrian G.; Kim, Nam Doo; Lydon, Christine A.; Awad, Mark M.; Jaklitsch, Michael T.; Sholl, Lynette M.; Janne, Pasi A.; Oxnard, Geoffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1334-1341</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Amplified and/or mutated MET can act as both a primary oncogenic driver and as a promoter of tyrosine kinase inhibitor (TKI) resistance in non-small cell lung cancer (NSCLC).  However, the landscape of MET-specific targeting agents remains underdeveloped, and understanding of mechanisms of resistance to MET TKIs is limited.  Here, it present a case of a patient with lung adenocarcinoma harboring both a mutation in EGFR and an amplification of MET, who after progression on erlotinib responded dramatically to combined MET and EGFR inhibition with savolitinib and osimertinib.  When resistance developed to this combination, a new MET kinase domain mutation, D1228V, was detected.  Thus in vitro findings demonstrate that METD1228V induces resistance to type I MET TKIs through impaired drug binding, while sensitivity to type II MET TKIs is maintained.  Based on these findings, the patient was treated with erlotinib combined with cabozantinib, a type II MET inhibitor, and exhibited a response.  With several structurally distinct MET inhibitors undergoing development for treatment of NSCLC, it is crit. to identify mechanism-based therapies for drug resistance.  It demonstrate that an acquired METD1228V mutation mediates resistance to type I, but not type II, MET inhibitors, having therapeutic implications for the clin. use of sequential MET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowh81IU_F_VLVg90H21EOLACvtfcHk0lhCsFULMCqd8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGnt7zE&md5=b1e34064a7fb314b7e35538b5c305015</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-16-0686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-16-0686%26sid%3Dliteratum%253Aachs%26aulast%3DBahcall%26aufirst%3DM.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DPaweletz%26aufirst%3DC.%2BP.%26aulast%3DPatel%26aufirst%3DJ.%2BD.%26aulast%3DAlden%26aufirst%3DR.%2BS.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DSacher%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DLydon%26aufirst%3DC.%2BA.%26aulast%3DAwad%26aufirst%3DM.%2BM.%26aulast%3DJaklitsch%26aufirst%3DM.%2BT.%26aulast%3DSholl%26aufirst%3DL.%2BM.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DOxnard%26aufirst%3DG.%2BR.%26atitle%3DAcquired%2520METD1228V%2520mutation%2520and%2520resistance%2520to%2520MET%2520inhibition%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2016%26volume%3D6%26spage%3D1334%26epage%3D1341%26doi%3D10.1158%2F2159-8290.CD-16-0686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8G" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8G','PDB','2Q8G'); return false;">PDB: 2Q8G</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V26" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V26','PDB','4V26'); return false;">PDB: 4V26</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8I','PDB','2Q8I'); return false;">PDB: 2Q8I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E0A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E0A','PDB','2E0A'); return false;">PDB: 2E0A</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00565">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_43021"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00565">10.1021/acs.jmedchem.9b00565</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00565/suppl_file/jm9b00565_si_001.csv">CSV</a>)</p></li><li><p class="inline">Ligand interaction diagrams of molecular dynamic simulations of <b>6</b> with PDHK isoforms, <i>in vitro</i> selectivity profiling of <b>19b</b> at 1 Î¼Î against 366 human kinase, <i>in vitro</i> selectivity profiling of <b>19t</b> at 1 Î¼Î against 366 human kinase, overall kinase selectivity profiling of <b>19b</b>, inhibitory activities of <b>19n</b> at three different ATP concentration against PDHK1/2/3, antiproliferation assay of compound <b>6</b> and <b>19n</b> in H1299 and DU145, knockdown of PDHK expression affects the antiproliferative activity of <b>19n</b> on H1299 cells, 1H, 13C NMR spectra and HPLC traces of all final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00565/suppl_file/jm9b00565_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00565/suppl_file/jm9b00565_si_001.csv">jm9b00565_si_001.csv (3.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00565/suppl_file/jm9b00565_si_002.pdf">jm9b00565_si_002.pdf (9.63 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00565&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00565%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00565" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a0091f8e9d95a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
